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Thesis Abstract  
Background: Despite the importance of physical activity to physical and psychological 
health in chronic obstructive pulmonary disease (COPD), levels of physical activity in COPD 
patients are significantly lower than age matched healthy individuals. Pulmonary 
rehabilitation, a structured physical activity intervention, is one of the essential treatments for 
COPD, and results in benefits such as improved exercise capacity, symptoms, and quality of 
life. However, this does not translate to an increase in long term physical activity and 
previous interventions to promote physical activity following pulmonary rehabilitation have 
had limited efficacy. 
 
Aim: The overarching aim of this thesis was to develop and test the feasibility and 
acceptability of an intervention to promote physical activity following pulmonary 
rehabilitation in patients with COPD. 
 
Methods: This mixed methods thesis developed and tested the feasibility of an intervention 
in line with the stages outlined in the Medical Research Council framework. The intervention 
was informed by a qualitative systematic review and the development of the intervention was 
facilitated by the Behaviour Change Wheel and collaboration with stakeholders. The 
intervention was tested in a feasibility cluster randomised controlled trial with an embedded 
process evaluation. The primary outcome of the feasibility study was the acceptability of the 
intervention and secondary outcomes included other feasibility outcomes and a range of 
clinical measures proposed for a definitive trial. Acceptability of the intervention and the 
research procedures were also explored via semi-structured interviews with patients and 
focus groups with personnel involved in delivery of the intervention (health care 
professionals and WhatsApp leaders). An inductive analysis was conducted to analyse the 
data. The factors which impacted patients’ physical activity were also identified via a 
deductive analysis of the interviews with patients, and mapped to the capability, opportunity, 
motivation behaviour change model (COM-B).  
 
Results: A thematic synthesis of fourteen studies revealed that beliefs, social support, and the 
environment encapsulate the factors which are important in physical activity following 
pulmonary rehabilitation in patients with COPD. The Behaviour Change Wheel guided the 
development of an intervention that included the provision of a pedometer and step diary, and 
the addition of patients to a WhatsApp group populated by fellow pulmonary rehabilitation 
graduates and a ‘WhatsApp leader’ for 52 weeks following pulmonary rehabilitation. A total 
of 74 patients enrolled in the feasibility study (consent rate, 55%) and there was an attrition 
rate of 35% at 52 weeks. By 52 weeks, 49% had engaged in the step diary, and 58% of 
participants who had consented to use WhatsApp had sent at least one WhatsApp message to 
the group. The Control Group had a larger decline in their daily steps at 52 weeks compared 
to the Intervention Group, MD, -180, (-765, 1126). Participants in the intervention group who 
engaged in the step diary had a smaller decline in their daily steps at 52 weeks compared to 
those who did not engage in the step diary, MD, 45.5 (-1796, 1889). Participants in the 
intervention group who engaged in WhatsApp had a smaller decline in daily steps at 52 
weeks compared to those who did not engage in WhatsApp, MD, 730 (-992, 2454). However, 
results also suggest there was a larger detrimental decline in secondary health outcomes in the 
Intervention Group compared to the Control Group. WhatsApp leaders adhered to sending a 
minimum of weekly physical activity messages throughout the 52 weeks period. Common 
themes from interviews and focus groups were that patients would benefit from more 
 
familiarity with the intervention components (e.g. earlier introduction of the intervention to 
patients during PR from health care professionals), and that the convenience of the 
intervention components and research procedures could be improved (e.g. options for 
participants to use their personal mobile and pedometer devices). Rapport between the 
patients and WhatsApp leaders was considered important and face to face support should 
complement social networking following Pulmonary Rehabilitation. Facilitators unique to 
those with higher intervention engagement related to physical capability and reflective 
motivation (e.g. reduction in exacerbations following Pulmonary Rehabilitation and the 
ability to overcome mental obstacles). Barriers unique to those with lower intervention 
engagement related to automatic motivation and physical opportunity (e.g. low mood and the 
distance of physical activity opportunities). 
 
Conclusion: This thesis addressed the gaps in previous literature and adopted a step wise 
approach in the development and feasibility testing of the intervention. The intervention was 
considered acceptable and feasible, yet modifications are required to optimise the 
acceptability and feasibility of the study prior to a definitive cluster randomised controlled 
trial, which are possible during an intervention revision period. 
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Chronic obstructive pulmonary disease (COPD) is a common and preventable condition, 
characterised by persistent respiratory symptoms and airflow limitation that is caused by 
significant exposure to noxious particles or gases (GOLD, 2019). Physical activity (PA) is 
important for patients’ physical and psychological health, yet PA in COPD is significantly 
lower than age matched healthy individuals. Pulmonary Rehabilitation (PR) is a structured 
PA intervention and results in benefits such as improved exercise capacity, symptoms, and 
disease specific Quality of Life (QoL). However, this does not translate to an increase in 
long-term PA. There are various gaps in our knowledge of how best to support individuals to 
stay active following PR. These factors include limited understanding of the determinants of 
PA following PR; limited understanding of the processes that contributed to the efficacy of 
interventions; limited application of theory and behaviour change frameworks in intervention 
development; and limited involvement of Patient and Public Involvement (PPI) in previous 
interventions.  
 
Aims, research questions and objectives 
 
Aims: 
The overarching aim of this PhD was to develop and test the feasibility of an intervention 
aimed to promote PA following PR in chronic obstructive pulmonary disease (COPD).  
Research questions:  
1) What are the patient reported facilitators and barriers to PA following PR in COPD? 
(Chapter 2) 




3) What is the feasibility of the developed intervention? (Chapter 5) 
4) What are the likely effects of the intervention on PA and other health outcomes following 
PR? (Chapter 5) 
5) What is the acceptability of the intervention and research procedures for patients, patient 
volunteers, and health care professionals? (Chapter 5) 
6) Are there differences in the facilitators and barriers of PA of patients with higher 
engagement in the intervention compared to those with lower engagement in the 
intervention? (Chapter 6) 
These research questions were addressed in the following objectives: 
Objectives:  
• Chapter 2: To conduct a systematic review: “Facilitators and barriers to PA following 
PR in chronic obstructive pulmonary disease (COPD): a systematic review of 
qualitative studies”. This systematic review will inform the development of the 
feasibility study of an intervention aimed to promote PA following PR in COPD.  
• Chapter 3:To conduct a behavioural analysis and diagnosis to inform intervention 
development. 
• Chapter 5: To conduct a feasibility cluster randomised controlled trial of the 
intervention and report the quantitative outcomes: recruitment rates, consent rates, 
attrition rates and intervention fidelity, PA, anxiety and depression and quality of life. 
• Chapter 5: To conduct a process evaluation to assess the acceptability of the 
intervention and research procedures for patients, patient volunteers, and health care 
professionals? 
• Chapter 6: To integrate the qualitative and quantitative results to identify and 
understand differences between patients with higher engagement in the intervention, 
compared to those with lower engagement in the intervention. 
1 
 
1 Chapter 1: Literature review  
1.1 Introduction 
This chapter introduces the concepts discussed in this thesis, including Chronic Obstructive 
Pulmonary Disease (COPD); physical activity (PA); Pulmonary Rehabilitation (PR), and 
complex interventions. The following text outlines the gap in knowledge and the limitations 
in previous research that this thesis aims to address. This chapter concludes with an outline of 
the rationale of the thesis.   
1.2 COPD 
Definition  
COPD is a common and preventable condition, characterised by persistent respiratory 
symptoms and airflow limitation that is caused by significant exposure to noxious particles or 
gases.1 COPD is treatable but there currently is no cure.  
Prevalence  
Based on figures in 2016, an estimated 1.2 million people were living with COPD in the UK, 
and 4% of people over 40 were diagnosed with the condition.2 Findings from the global 
disease burden study stated that there were approximately 251 million people living with 
COPD worldwide.3 There are large discrepancies between studies when predicting 
prevalence, though a systematic review and meta-analysis conducted in 2015 reported that 
there were 384 million people living with COPD in 2010.4 However, there is an 
overwhelming consensus that these figures are rising.3–5  
Mortality  
Globally, COPD is the third leading cause of death and a leading cause of mortality and 
morbidity following heart disease and stroke.6,7 However, due to the predicted underdiagnosis 
in COPD (attributed to the discrepancies in the methods used to assess symptoms), the global 
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burden of the disease is under represented by these figures.8 Approximately 30,000 people in 
the UK die every year from COPD, and mortality rates are increasing.9 
Risk factors  
Risk factors for COPD include environmental and behavioural factors. Prevalence of the 
disease varies across countries and cultures due to a complex interplay of external and 
internal factors, for example long term exposure to noxious gases and particles, genetics, lung 
growth during childhood and airway hyper-responsiveness.10,11 Tobacco smoking is a 
behavioural factor that is directly related to the prevalence of COPD, but environmental 
factors such as indoor and outdoor pollution also represent a major risk.12–14 However, in the 
UK, the main lifestyle risk factor is smoking.1,9 COPD is also related to age, and generally 
affects older adults.1   
Economic and social impact  
COPD constitutes large economic and social costs15,16, which is predicted to continue to 
grow.17,18  The UK alone spends £11 billion each year on COPD and was believed to 
represent almost 1% of the UK GDP in 2014.19 Due to the prevalence of COPD and the 
associated symptom burden, this condition represents a significant economic challenge for 
health care systems globally. Research published in 2014 reported that COPD accounts for 
more than half of the costs spent on respiratory diseases within the European Union20, with 
hospitalisations contributing to the majority of associated costs. In the UK, annual hospital 
admissions for COPD are over 140,000 and include one million bed days, accounting for 
1.7% of all hospital admissions and bed days. Almost all hospital admissions are for 
emergency care.9 
The severity of COPD is therefore positively associated with the economic burden to 
the NHS. In addition, the progressive and sometimes debilitating nature of the condition 
impacts individuals’ social network. For example, patients may require further support with 
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daily activities, and patients’ family, friends or partners are often appointed carers for 
patients.21 Whether full or part time carers, this role may impact their ability to work and 
therefore earn money. Caregivers are also more vulnerable to anxiety and depression, thus 
potentially increasing the burden on the health care system22,23, as well as the demand and 
reliance on local council and governments for financial support.24 
Although respiratory diseases represent approximately 9% of the total economic 
burden of illness, expenditure in health research directed at respiratory conditions is much 
lower (at approximately 2%).19 More research is therefore necessary to identify methods of 
reducing the negative impacts of COPD on patients, as well as reducing the wider social and 
economic burden.   
Symptoms and health burden  
Common physical symptoms of COPD include dyspnoea (breathlessness), coughing and 
sputum production. Less common symptoms include wheezing and chest pain. Wheezing and 
chest tightness can be variable, and sometimes varies across the same day. Chest tightness 
often follows PA upon exertion.1 Chronic breathlessness, which means difficult or laboured 
breathing over a long period of time, represents the most characteristic symptom of COPD 
and the main reason that patients seek medical attention.1 However, individuals may also 
experience acute breathlessness.1 This symptom can be disabling for many individuals due to 
its effect on mobility and psychological wellbeing.   Coughing is a common symptom, which 
is often, though not always, coupled with sputum production. Some individuals with COPD 
are also predisposed to frequent exacerbations, known as ‘an acute worsening of respiratory 
symptoms that result in additional therapy’.26,27 Exacerbation risk significantly increases with 
COPD severity.1 Other symptoms of COPD, classically in more severe cases, may include, 




It is also common for individuals with COPD to have comorbid conditions1, particularly as 
COPD is associated with older age.1 The number of comorbidities is positively associated 
with mortality and hospitalisations, specifically when there are three or more comorbidities.29 
Common comorbidities include both physical and psychological conditions and include, but 
are not limited to, cardiovascular disease, skeletal muscle dysfunction, osteoporosis, 
depression and anxiety.1 
The presence and number of comorbid conditions, as well as the frequency, duration 
and severity of COPD exacerbations are not the same for any one individual.25 Symptoms 
vary between individuals, and often vary across the day and seasonally.30 Additionally, the 
way that individuals perceive and experience their physical symptoms differs. For example, 
some patients may experience all symptoms daily, whereas others may not even notice some 
symptoms.31 Unfortunately, exacerbations are negatively associated with QoL.32 
Quality of Life  
COPD can have a significant impact on individuals’ psychological well-being. Psychological 
well-being includes ‘the ability to maintain a sense of autonomy, self-acceptance, personal 
growth, purpose in life and self-esteem.33 COPD can restrict patients’ mobility, mood, and 
independence, and there is a large body of research outlining the negative impact that COPD 
has on individuals’ QoL34.  
Anxiety and Depression  
Mental health disorders contribute to increased disability and impaired QoL.35 Mental health 
disorders such as anxiety and depression are higher in COPD than the general population34,38 
and a high prevalence of individuals with COPD live with either diagnoses or symptoms of 
anxiety and/or depression.38 Previous studies report that depression is almost doubled in 
COPD compared to healthy controls40,  and that the development of anxiety is much higher in 
COPD compared to those without COPD. Clinical anxiety in COPD has been found to range 
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between 13-46%38, with depression between 8-80%41, yet there are differences between their 
estimated prevalence due to differences in diagnostic tools.41 Anxiety and depression are 
associated with poorer physical and social functioning, combined with low help seeking 
behaviour and adherence to COPD treatment.41 For example, increased smoking, insomnia, 
fatigue, loss of social functioning, exercise capacity and emotional liability are associated 
with anxiety and depression.42  
Causes of anxiety and depression in COPD vary between individuals.34 However, a 
common cause of fear, hopelessness and panic attacks includes breathlessness43 and patients 
have reported anxiety and emotional vulnerability as being directly linked to events of acute 
breathlessness.43,44 A common phenomenon often reported in COPD patients is known as the 
vicious cycle between breathlessness upon exertion, a reduction of PA to avoid 
uncomfortable symptoms, and worsening of physical capacity and worsening of 
breathlessness.43 This avoidance of PA is also connected to diminished levels of autonomy 
and self-esteem, which negatively effects patients’ ability to cope.45 The complexity 
surrounding the causes of COPD mean that recognition, treatment and adherence to treatment 
remains sub-ideal.34 
Activities ranging from participation in sport and structured exercise, to daily 
activities such as getting out of bed, washing, and going up the stairs can be limited by 
COPD. The range of activities affected may have a detrimental impact on individuals’ sense 
of independence, which may lead to a decrease in motivation to be active and activate a self-
perpetuating cycle of reduced PA and QoL.1,25  
1.3 Physical Activity 
PA is defined as any bodily movement produced by skeletal muscles that results in energy 
expenditure, generally measured by kcal per unit time.48 The level of activity varies for 
everyone and can be divided into subsets of activities, e.g. sleep, occupational, leisure and 
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conditioning. PA is different to ‘exercise’ which is a subcategory of PA, and is defined as  
‘PA that is planned, structured, repetitive, and purposive in the sense that improvement or 
maintenance of one or more components of physical fitness is an objective’.48 Different PA 
intensities include sedentary, light, moderate, vigorous, and very vigorous intensities, which 
can be identified via measurement of the Metabolic Equivalent of Task (MET). For example, 
one MET is equivalent to sitting, light physical activity (< 3 METS) is equivalent to activities 
such as light walking, moderate activity (3 to 6 METS) is equivalent to activities such as 
yoga and vacuuming, and vigorous ( ≥6 METS) is equivalent to tasks such as aerobic 
exercises such as jogging and dancing.49 
There are various methods to measures PA which can be divided into objective and 
subjective measurements. Objective measures assess at least one dimension of PA and can 
use a variety of metrics such as intensity and time.50 Objective measures include the 
quantification of PA by an external device such as an accelerometer or a pedometer. 
Subjective measurements are based on the individual self-reporting their PA, for example via 
a PA diary or a questionnaire.  There are benefits and limitations associated with each 
method. For example, subjective measures such as questionnaires are often low cost and can 
easily be distributed to many people. However, subjective measurements are often open to 
recall bias and participants can misinterpret questions and forget periods of short bursts of 
PA. Subjective measures can therefore have limited reliability and validity.51 Comparatively, 
objective measures are beneficial as they are often more precise, and can capture various PA 
dimensions, such as PA intensity and type.52 However, objective measures can be less 
accessible due to high cost and use of specific software.53  
Physical activity prevalence in COPD 
There is a large body of evidence which identifies that PA in COPD is significantly lower 
than age matched healthy individuals54,55, which is consistent across settings and cultures.55 
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Previous research has reported that healthy controls consistently achieve higher daily PA and 
higher levels of exercise intensity than patients with COPD54, with the exception of one 
study, which reported that COPD patients more time in higher intensity activities, such as 
brisk walking.56 Evidence suggests that COPD patients participate in just over half the 
amount (duration) of DPA, and two thirds of the intensity of the DPA compared to healthy 
controls.54  
To understand the relationship with COPD and PA, researchers have studied the 
impact of disease severity on PA.56–65 Most studies reported that higher levels of PA were 
positively associated with lung function (e.g. FEV1% predicted). However, the relationship 
between the rate of lung decline and lower PA levels has not been consistently reported.55 In 
a review of the level of daily PA in individuals with COPD compared with healthy controls, 
the results outlined that that there were no strong associations between the severity of COPD 
and DPA54, Table 1:1.  
However, the outcome measure of PA widely varies across these studies, and these 
include both subjective and objective measures. Objective measures include measures such as 
accelerometers; uniaxial54,61,64,67, ;biaxial64,68; triaxial59,60,69; and pedometers62, and subjective 
measures include questionnaires57,70,71, Table 1:1. Compared to objective measures, the 
subjective measures often result in higher reported changes in PA.54 The wide variety in 
outcome measures adds heterogeneity across the studies and thus may contribute to 
differences in outcomes.53 This has been attributed to limited agreement in the 
implementations guidelines of outcome measures such as activity monitors.53 Currently, 
accelerometery is considered the most reliable measure of physical activity, specifically 
triaxial accelerometers such as the Dynaport MiniMod, Actigraph GT3X and SenseWear 
Armband, which measure postural changes.53,72 
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 Further research is necessary to identify and validate activity monitors in COPD 
research.53 Use of solely objective or subjective outcome measures have been criticised as 
they do not thoroughly capture all aspects of physical activity in COPD. To address this 
limitation, a hybrid tool including an accelerometer and a patient-reported questionnaire, 







Table 1:1: Comparison of PA between COPD patients and healthy controls, and the relationship between PA and exercise tolerance and/or lung function 
in COPD 






outcome measures  
Comparison of PA 
between COPD patients 
and healthy controls  
Relationship between PA and 
exercise tolerance in COPD/ 
Relationship between PA and 





Time spent in inactivity, low and medium level activity 
(%);  
Uni-axial accelerometer 




FEV1 (% pred) 
The control group were 
more active and spent more 
time walking and in low 
and medium intensity 
activity than COPD patients 
PA was positively correlated 
with exercise tolerance  
 








Time spent in different activities and body positions 
(walking, standing, sitting or lying); intensity of the 
movement during time spent walking;  
Tri-axial accelerometer 




FEV1 % pred/ FEV1/ FVC 
The control group spent 
more time walking per day 
and spent more time in 
higher PA intensity than 
COPD patients 
PA was positively correlated 
with exercise tolerance 
 
Time spent standing per day was 
positively correlated with 
pulmonary function but walking 
time per day was not 
significantly correlated with 
pulmonary function 
Lores (2006)69 35 
(23/12) 
Activity counts;  
Tri-axial accelerometer 
 
The control group had more 




Pitta (2005)74 88 
(62/26) 
Time spent in different activities and body positions 
(walking, standing, sitting or lying); intensity of the 
movement during time spent walking;  
Tri-axial accelerometer 
(DynaPort activity monitor) 
 
6MWT, Wmax, Peak VO2 % pred 
 
The control group walked 
for longer than COPD 
patients and had higher 
movement intensity when 
walking. COPD patients 
were inactive 
PA was positively correlated 
with exercise tolerance 
 
PA was positively correlated 
with pulmonary function 
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Pedometer (Fitty 3) 
  
Pa,O2; Pa,CO2; FEV1; FVC; PI,max; PE,max: 
;fR; VT; tI/ttot 
The control group were 
more active than COPD 
and CRF patients 
  
PA was positively correlated 
with pulmonary function 
Singh (2001)56 20 (11/9) Activity counts; 
Uni-axial accelerometer 
(Z80-32k V1 INT activity monitors) 
 
FEV1 
The control group were 
more active than COPD 
patients, though COPD 
patients spent more time in 
higher intensity activity 
than the control group. 
PA was positively correlated 
with pulmonary function, but 






Daily steps; time spent in mild and moderate PA; 
Multisensor armband  
(SenseWear) 
 
FEV1 % pred 
The control group spent 
more time in mild, 
moderate, and high 
intensity activities 
PA was reduced early in the 
disease progression. Patients 
reduced their moderate intensity 
activities before reducing their 












The control group spent 
more time in daily activities 
and higher intensity 
activities 
PA was positively correlated 
with exercise tolerance 
 
PA and pulmonary function 











The control group were 
more active than patients 
with moderate and severe 
COPD 
 
PA was positively correlated 





70* Steps; time spent active; PAL; 
Accelerometer; SenseWear ProTM armband 
 
n/a PA was not reliably predicted by 








236* Daily steps; 
DynaPort MoveMonitor (DAM) 
 
6MWT and CPET 
 
FEV1, FEV, FRC, TLC, TL,CO, % pred 
n/a PA was positively correlated 
with exercise tolerance 
 
PA was positively associated 
with pulmonary function    
Cheng (2003)58 5707* 
 





n/a PA was positively associated 
with pulmonary function  
 
Pitta (2008)59 40* Time spent in METS; 




MVV, IC, FEV1 
n/a PA was positively associated 
with pulmonary function  
 
Steele (2000)61 47* Activity counts; 




FEV1 % pred 
n/a PA was positively correlated 
with exercise tolerance 
 
PA was positively associated 
with pulmonary function  
Watz (2008)65 170* Daily steps; energy expenditure; 
Accelerometer (SenseWear Pro Armband) 
 
FEV1 % pred 
n/a PA was negatively associated 
with disease severity  
 
*COPD patients only 
6MWT: six-minute walk test; FEV1% pred: Forced Expiratory Volume percentage predicted; FVC: Forced Vital Capacity; VMU: Vector Magnitude 
Units; FRC: Functional Residual Capacity: TLC: Total Lung Capacity, TL,CO % pred: Total carbon monoxide diffusion capacity; Pa,O2: arterial oxygen 
tension; Pa,CO2: arterial carbon dioxide tension; PI, max: peak expiratory mouth pressure; PE, max: peak inspiratory mouth pressure fR: respiratory 
frequency; VT: tidal volume; tI/ttot: ratio of inspiratory time to the duration of the total breathing cycle; m/s2: metre per second squared; STST: Sit To Stand 
Test; CPET: Cycle Ergometer Cardiopulmonary Exercise Test; MTT: maximal treadmill test; IC: inspiratory capacity; CRF: chronic respiratory failure 
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Physical activity guidelines  
PA guidelines are tailored to individuals’ age range. People with COPD tend to be older 
adults, over the age of 40.76 The UK government guidelines for PA for 18-64 years states that 
adults should: aim to be active daily; aim to strengthen their major muscle groups (two days a 
week); meet up to at least 150 minutes of moderate intensity activity, or by doing 75 minutes 
of vigorous activity or even shorter durations of very vigorous activity (or a combination of 
activity intensities) spread across the week; and finally, to minimise sedentary time.77  
The guidelines for individuals who are 65 years and above state that individuals should also: 
undertake PA to improve balance and co-ordination at least two days a week and to reduce 
sedentary time by introducing light activity or even standing.78 The focus has shifted from the 
total measures of PA per day, to the importance of PA across the whole day, also considering 
the pattern of sleep.82–78  
Physical activity guidelines for COPD  
There is limited research on specific PA recommendations in COPD.83 Due to the rate of 
disease progression and the large individual differences between individuals’ disease stage 
and aerobic fitness levels, individualised recommendations have been suggested as more 
appropriate than general recommendations.83 This is particularly true for individuals with 
more severe COPD or with limited mobility, as it is possible that the national government 
guidelines are too high. For example, a study to measure daily step counts in patients with 
COPD found that the average daily step count was 5680.84 However, baseline measures of 
daily steps in more recent studies (prior to a PA intervention) ranged between 1644-8069 
steps per day51,84–92, outlining that PA widely varies between individuals with COPD. Thirty 
minutes per day of moderate vigorous PA is roughly equivalent to 7,000-10,000 steps per 
day.93 Although some studies have identified COPD cohorts with daily steps higher than 
700086,94, most studies have reported that COPD patients walked less than 7,000 steps per 
day.84,83,91,91    
The minimally clinical important difference (MCID) refers to an effect that the patient 
may recognise as either positive or negative, which may then implicate the management of 
the condition.98 In studies reporting the MCID for PA in COPD, research initially reported 
that an increase in 600-1100 daily steps96 was associated with a reduced risk in 
hospitalisation. However, more recent research has reported the MCID as between 350-1100 
daily steps99, suggesting that a much smaller change in steps may be associated with a 
reduction in risk of hospitalisation.  
Importance of physical activity  
PA is a lifestyle behaviour that is important for general well-being.77 Physical inactivity 
represents a global public health issue and is believed to be a key leading cause of death 
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worldwide, especially within non-communicable diseases such as COPD.100 Physical 
inactivity is both a cause and consequence of chronic diseases55 and reductions in PA are 
associated with the development of various chronic conditions such as cancer and physical 
disability.55 However, PA is capable of reducing health burdens of non-communicable 
diseases, as well as improving the general populations’ QoL.77,95–97  
In a recent study to estimate the cost effectiveness of regular PA compared to a 
sedentary lifestyle in COPD in the UK, the results supported the likelihood of total cost 
savings for the NHS103, based on the likelihood of PA resulting in lower mortality and fewer 
hospitalisations. These results provided support of the relevance of PA in the management of 
COPD, providing savings to the NHS, as well as improved QoL in patients.103  
Benefits of physical activity in COPD 
PA is particularly important in COPD, as inactivity is associated with reduced QoL, risk of 
hospitalisation and mortality.71,104–101 The pattern of PA behaviour over 24 hours is believed 
to relate to changes in physical and psychological well-being in COPD. For example, 
spending more time in higher intensity PA and more time sleeping has been associated with 
benefits in HRQoL and less symptoms82, whereas spending more time sedentary has been 
associated with more COPD symptoms and lower HRQoL.107 This evidence supports the 
suggestion of the health benefits of substituting sedentary time for time spent in light 
activities throughout the day.108  
Rationale for physical activity interventions 
A priority of COPD management is to equip patients with the necessary skills and confidence 
to self-manage their condition, thereby increasing patients’ general well-being and decreasing 
incidences of exacerbations and hospitalisations.1,52 Promotion of PA in COPD is a priority in 
COPD management due to its beneficial impact on patients’ overall health.1  
1.4 Pulmonary rehabilitation 
One of the leading treatments for COPD is pulmonary rehabilitation (PR),  defined as “a 
comprehensive intervention based on a thorough patient assessment followed by patient-
tailored therapies that include, but are not limited to, exercise training, education, and 
behaviour change, designed to improve the physical and psychological condition of people 
with chronic respiratory disease and to promote the long-term adherence to health-enhancing 
behaviour”.109  
PR course characteristics such as setting, intensity and duration differ slightly 
according to contexts. Recommendations state that patients should attend at least twelve 
sessions of PR for optimal benefits. However, in programmes shorter than 6 weeks, sessions 
should be tailored to the individual.110 The setting ranges between programmes, for example 
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some are delivered within hospitals, whereas others are community or home-based 
programmes. Hospital based PR is the most common type of programme, yet barriers such as 
funding and travel issues for patients limit the availability and appropriateness of these. 
Community based PR is an alternative for those patients who can only travel a short distance. 
Home based programmes are therefore an alternative for those who cannot travel to 
community centres or for patients who have mobility issues. Importantly, these types of PR 
are found to result in similar benefits to patients.111–113 The recommended intensity and 
duration also range between programmes, but the general recommendation is to deliver two 
exercise sessions per week.110 Optimum benefits of programmes are believed to be achieved 
for PR programmes delivered for at least 6-8 weeks.114 PR delivered within hospitals and 
other areas of the community are group based, including approximately 8-16 patients.  
The exercise component of PR includes a variety of activities, dependent on the 
setting but usually contains an aerobic exercise component and resistance exercises. For 
example, hospital-based settings may have specialist equipment. However, community 
programmes require minimal equipment (e.g. ‘sit to stand’ exercises using a chair), so they 
are transferable to the home. Home based PR is tailored to the equipment individuals have at 
home and patients are encouraged to engage in regular PA five times weekly, for 30 
minutes.110 The educational component of PR contains information on various topics, such as 
the benefits of regular PA, and the management of exacerbations and breathlessness. The 
team delivering PR is multidisciplinary and includes a clinical lead and other trained HCPs 
such as nurses and physiotherapists. The impact of PR is assessed by a change in exercise 
capacity and QoL based on assessments pre and post PR. These assessments include the 
Incremental Shuttle Walk Test (ISWT)115, Endurance Shuttle Walk Test (ESWT)116, Chronic 
Respiratory Disease Questionnaire (CRQ)117 and the Hospital and Anxiety Depression Scale 
(HADS).118  
Benefits of pulmonary rehabilitation 
The key benefits of PR include clinically important improvements in breathlessness, QoL, 
and exercise capacity and reductions in anxiety and depression symptoms.110–122 It is  
recognised as one of the leading cost-effective treatments provided by the NHS, with the cost 
per quality-adjusted year (QULY) as £2000-£8000.123 Evidence for the impact and benefits of 
PR are widely recognised in a series of systematic reviews that compare PR to usual care. 
The consistent evidence in this area have led to the consensus that PR is beneficial to 
patients, and that research is no longer warranted to test whether PR alone has beneficial 
impact on patient outcomes.119 Findings from the clinical and organisational audits of PR 
services in England and Wales 2017 (National Asthma and COPD Audit Programme 
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 2018) identified clinical outcomes for those who complete PR are excellent.124 PR is 
recognised as successful in increasing patients’ exercise capacity and the audit identified a 
medium improvement in the incremental shuttle walk test (ISWT) and six-minute walk test 
(6MWT). However, these benefits appear return to baseline (pre-PR levels) within 6-12 
months.125,127  
1.5 Physical activity following pulmonary rehabilitation  
Exercise capacity has been regarded by some to be key to modifying PA in COPD.128 
However, increased exercise capacity is not necessarily accompanied by an increase in daily 
PA and the benefits of PR decrease over time.1,127 One recent study examined the relationship 
between baseline exercise tolerance (prior to PR) and PA maintenance following PR and 
found a positive association between performance on the 6MWT and PA improvement.75 
These findings are contested by results in a longitudinal study which identified a decline in 
PA despite the maintenance of exercise capacity over time.129 However, there have been 
many studies which identify that PA is not maintained in the long-term following PR.55,128 
This evidence suggests that PR is not yet successful at achieving long term behaviour change 
in patients, which represents a global challenge of PR.1  
Physical activity options following pulmonary rehabilitation  
Usual care following completion of PR generally includes discharging patients and referring 
them to their primary care provider with no formal follow-up or support to maintain the 
benefits of PR.110 The latest GOLD (Global Initiative for Chronic Obstructive Lung Disease) 
report and the British Thoracic Society guidelines on PR in adults states that patients should 
be offered a maintenance programme or sufficiently supported to engage in daily PA.1,105 
Patients are generally encouraged to maintain PA and to explore their options post PR, for 
example to discuss their home exercise plan, to identify local exercise and PA ‘follow on’ 
groups and classes suitable for the participant.110 However, the method for supporting 
patients beyond PR is not made clear and the referral of the patient back to their GP makes it 
difficult to ensure maintenance of PA.   
Evidence suggests that behavioural interventions to promote PA can help support 
patients to stay active following PR130, yet these interventions have not been adopted by the 
NHS. One ‘follow on’ option for patients includes structured exercises classes. Following 
completion of PR, HCPs may refer eligible patients (those not meeting the recommended PA 
guidelines) to an exercise referral scheme. An exercise referral scheme includes an 
assessment from a HCP to determine whether an inactive person, with an existing health 
condition, would benefit from the opportunity to participate in a PA programme.131 The 
exercise referral scheme should include techniques outlined in the 'Behaviour change: 
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individual approaches' NICE public health guidance, such as the recognition when people are 
more open to change, agreement of goals and the development of action plans to facilitate 
behaviour change.132 Though exercise referrals are a positive option for patients133, barriers 
such as time constraints impacted HCPs likelihood of making referrals134 and limitations 
associated with the service, e.g. including cost, travel and general maintenance. However, the 
levels of patient uptake and adherence in the general population is limited, which can be 
attributed to various factors133, such as age and gender. For example, females were more 
likely to uptake exercise referral schemes, though males were more likely to adhere to the 
scheme, and increasing age was positively linked to both uptake and adherence.133 
Furthermore, evidence suggests that patients enjoy the peer social support in PR137,127, and 
limited uptake and adherence of the exercise referral scheme is possibly based on the limited 
peer support this scheme enables.   
Follow on groups are another option for patients following PR. One such follow on 
group includes Breathe Easy groups, support networks of the British Lung Foundation (BLF), 
which are voluntary support groups which aim to promote self-management.138 Evidence 
suggests that individuals gain beneficial advice from these groups. Previously, the NHS were 
involved in integrating Breathe Easy groups into a respiratory pathway, however this has not 
been streamlined. There has also been evidence of limited discussion of Breathe Easy groups 
from HCPs during PR, which represents a barrier for patients in accessing these groups.139  
Another option for patients is to join a non-formal exercise group (those which are not 
supported by the BLF), which are generally formed by patients who have already completed 
PR, and hence provide peer social support for group members. These groups offer a 
continuation of peer support following participation in PR. However, lack of formal 
supervision from HCPs means that there are variations in the focus of PA. For example, some 
groups may focus on social support, whereas others may focus on maintenance of PA. Due to 
limited research on non-formal exercise groups, it is not possible to report the prevalence and 
popularity of these groups post PR.  
Understanding the determinants of physical activity in patients with COPD 
Previous research has attempted to identify the factors that affect patients’ PA levels140 and 
reports themes which include, but are not limited to, peer social support, interactions with 
HCPs, mobility and transport limitations, loneliness, anxiety and depression.137,127 The large 
number of factors that affect peoples’ PA reflects the complexity of PA behaviour. 
These findings are reflected in the results from previous systematic reviews which identified 
the factors that impacted PA before and during PR for patients with COPD and general lung 
conditions140,143. For example, facilitators included social and professional support, 
recognition of improvements, the environment and opportunities following PR. The barriers 
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included lack of support, fear, or apprehension of changes in health and environmental 
factors. Results from these reviews highlighted the multitude of factors associated with PA 
and PR, and that individual differences exist regarding perceived facilitators and barriers to 
PA.  
Despite the research in this area140, PA is not maintained following PR. This could be 
attributed to limited understanding of the patient reported facilitators and barriers of PA of 
those that attend and complete PR. No review has addressed the factors which influence the 
maintenance of PA and long-term behaviour change following PR, where the focus shifts to 
self-management of PA. The themes reported in previous reviews may not represent patients 
who attend and complete PR. These patients may represent a subgroup who are proactive and 
motivated to engage in a programme to enhance self-management of their condition. It is 
possible that interventions based on existing research have been unsuccessful due to limited 
insight of the target population. Specific factors are proposed to be involved in maintenance 
of behaviour, different from those involved in behaviour initiation.144 However, these factors 
have not been explored in this specific population. Understanding behavioural factors is key 
in designing a successful intervention aimed at maintaining PA behaviour.145  
1.6 Interventions to promote physical activity in patients with COPD 
There is an accumulation of research which has investigated the efficacy of interventions 
aimed to promote PA in patients with COPD.130,140 In 2014, the official European Respiratory 
Society’s statement on PA in COPD reported key areas for further research.55 These included 
conducting research to understand the factors that optimise the impact of non-
pharmacological interventions to promote PA in COPD and to incorporate behaviour change 
strategies such a self-monitoring and goal setting.55  
A more recent systematic review and a meta-analyses of interventions demonstrated 
the efficacy of counselling in conjunction with PR to improve PA.130,140 Assessment and 
feedback of PA levels, tailored motivational messages and individualised PA goals were also 
considered effective behavioural strategies130 in promoting PA.  
These results support recommendations from the ERS.55 Interventions to promote PA 
in COPD including only bronchodilators, non-invasive ventilations or dietary lifestyle 
changes, have not been considered efficacious in promoting PA. However, they may facilitate 
interventions if combined with counselling.130,141 Whilst there was limited evidence to support 
the efficacy of interventions such as inspiratory muscle training, walking and high intensity 
interval training, researchers have called for these strategies to be explored.130  
However, studies not included in these reviews, or recent studies conducted following 
the publication of these systematic reviews, provide conflicting results, and the incorporation 
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of pedometers and counselling have had mixed results.82,83,91,92,90,137 For example, some 
studies which have incorporated pedometer and/or counselling as an intervention component 
have been successful86,87,94,148, though others have not.91,92 
Interventions to promote physical activity following pulmonary rehabilitation 
The results from a systematic review of interventions to modify physical activity in COPD 
outlined that most interventions that were combined with PR programmes resulted in 
increased PA levels.130 It is possible that the intensity of an intervention also impacts the 
efficacy of the intervention in promoting PA, which may explain why PR combined with 
counselling results in more beneficial outcomes. This evidence was based on the 
identification of studies which had a positive effect of on patients’ PA, yet there was no meta-
synthesis to identify the intervention components which were associated with better patient 
outcomes, due to large levels of heterogeneity across the included studies.130 Despite these 
results, interventions to promote long term PA following PR have reported limited 
efficacy.130,140 Research has measured the impact of the length of PR on long-term PA, and 
evidence suggests that longer-lasting PR programmes are more effective than shorter 
programmes in increasing PA levels130, perhaps because the translation of exercise capacity to 
PA requires a longer training period.74 Evidence suggests that exercise training has short-term 
increases in PA.146,149 However, interventions solely based on exercise training do not appear 
to support long term PA in COPD.109,146,150   
Interventions with a primary aim to promote PA following PR often include 
intervention components such as counselling91 (often based on motivational interviewing 
principles)85,88, pedometers84,91,90,137, step diaries91,90, goal setting91,90 and social 
support.84,84,91,90 These components are often grouped together, for example pedometer and 
counselling/social support methods are often reported strategies.84,91,90 Though some of these 
studies reported a statistically significant impact of the intervention on PA85,94,148,151, this was 
not unanimous across studies84,91,143, questioning the appropriateness of these intervention 
components. The heterogeneity of these studies (including wide variation in the context, 
duration, and frequency of these interventions) add complexity into the measurement of 
intervention efficacy. For example, intervention providers varied between studies and 
included physiotherapists94,148, trained counsellors85, and/or the research team themselves.84,91  
Duration ranged from 12 weeks to 12 months and the frequency of components delivered 
across the intervention, such as counselling, widely ranged between the studies.84,84,91 The 
context of the interventions also varied, for example many interventions were delivered in 
conjunction with PR84,84,91,90,137,143, a programme which also varied in setting, duration and 
frequency.  
Methodological limitations of previous interventions 
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The results of previous interventions should be considered alongside their methodological 
limitations. Previous systematic reviews of interventions to promote PA have reported 
general low quality of evidence, including a lack of randomised controlled trials, allocation 
concealment, small sample size and blinding procedures.130,140 Lack of information about 
important intervention characteristics, such as patients’ prior completion of PR, also 
prevented researchers from understanding potential moderating factors.153 Small sample sizes 
of studies were the primary concern for one author153, who called for further larger scale trials 
to corroborate the true effects on intervention components such as counselling.  
Furthermore, researchers reported a lack of long-term interventions.130,140 Although 
there has since been a number of interventions delivered for longer than 6 
months82,84,91,137,145,142,  there has been very few interventions which have been delivered for 
up to one year.86,148 Though longer-term interventions may acquire additional resources 
(time; cost), components such as pedometers and technical/telephone support would 
contribute to relatively low-maintenance interventions.86,87,94 Longer term application of 
intervention with these components therefore represent a feasible option for HCPs and 
warrant further investigation.  
Limited efficacy in previous interventions has been attributed to limited 
understanding and insight into the patient reported facilitators and barriers of PA following 
PR in COPD.155 This is because the methods used to measure the impact of previous 
interventions relied on objective measures of PA such as device measures (activity 
monitors).130,140 Application of qualitative research can gain insight into the acceptability of 
interventions and their mechanisms of action. Use of mixed methods enables researchers to 
gain a comprehensive understanding of the effectiveness of health interventions, providing 
complementary data to explain quantitative findings in randomised controlled trials. For 
example, a qualitative study investigating the application of mobile health in self-
management in COPD156 enabled researchers to identify patients’ concerns, transitions and 
experiences of mobile health, and the reasons why the majority of individuals ultimately 
accepted the intervention. Also, a qualitative study on patient views on self-management 
programmes in COPD enabled researchers to identify the importance of factors such as social 
support and practical, physical and emotional barriers to attendance.157 Results from these 
studies highlight the value of qualitative methods158, as they were able to capture individuals’ 
insights and experiences from interventions, as they go beyond objective data that is collected 
in quantitative studies, such as randomised controlled trials. 
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1.7 Development of Complex Interventions 
Interventions to promote behaviour change are often categorised as complex.159,151 Limited 
efficacy in the promotion of PA following PR in COPD may reflect the challenges involved 
in the development of a complex intervention, which lead to methodological 
limitations.130,140,152 Interventions can be classed as complex for various reasons, for example 
when there are: interactions between intervention components; variability of outcomes and 
flexibility/tailoring of the intervention and various behaviours of those delivering and 
receiving the intervention.159 Researchers are required to take steps in the development and 
evaluation of the interventions to account for this complexity. The Medical Research Council 
(MRC) provides guidance on the development and evaluation of complex interventions and 
outlines four intervention stages: development, feasibility and piloting, evaluation and 
implementation.159 The steps involved in intervention development include the identification 
of the evidence base, the identification/development of an appropriate theory; and finally, 
modelling the process and outcomes (Figure 1:1). In other words, the intervention developers 
need to have a theoretical understanding of how the intervention may cause change. The next 
stage includes the feasibility and piloting of an intervention, which is beneficial as it enables 
an assessment of the recruitment and retention rates within an intervention, as well as the 
fidelity and overarching acceptability of an intervention. This stage therefore enables the 
identification of any teething problems prior to the design and completion of a full-scale 
trial.145 
  The evaluation of an intervention requires consideration of the study design, outcome 
measures and follow up periods. Process evaluations are recommended by the MRC as these 
enable the identification of how and why an intervention may or may not be successful, for 
example by identifying the contextual factors that may have impacted the outcomes, as well 
and the quality of intervention implementation (Figure 1:2).160 
The MRC framework reports the importance of theory in the development of a 
complex intervention159, but does not direct intervention development towards a specific 
theory.161 Theory has previously been defined as “a set of statements that organise, predict 
and explain observations”.144 Use of theory in the development and evaluation of 
interventions is beneficial as it enables the researcher to systematically identify what needs to 
change, how this needs to change, and the outcomes that need to be evaluated. However, 
evidence outlines limited use of theory in health behaviour interventions. In a systematic 
review and meta-analysis to investigate the extent and role of theory in the effectiveness of 
the health behaviour interventions, the results outlined limited reporting of a theory base 
(approximately half of the studies reported theory).162 Of these studies, the majority (90%) 
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did not clearly link their chosen behaviour change strategies (active ingredients of the 
intervention) with a theoretical construct. This prevents researchers understanding the role of 
specific theories in the development of interventions, and how a specific construct may 
contribute to intervention efficacy.145 Limited role of theory in this area reflects a gap 
between intervention design recommendations and research practice.  
A recent review of the role of theory in the effectiveness of PA interventions in adults 
with chronic disease reported the promising impact of theory in intervention development.163 
Also, in a recent systematic review of the role of behaviour change theory in interventions to 
enhance adherence in chronic respiratory disease, the results support the role of behaviour 
change theory in intervention efficacy.164 
Despite the beneficial role of theory, only few behavioural interventions aimed to 
promote PA following PR in COPD have referred to theory.84,84,92,90,165 The extent to which 
these interventions are based on theory is not well understood. For example, one study 
reported that their intervention was based on the Social Cognitive Theory166, whereas others 
report using Motivational Interviewing techniques85,88, but they do not describe the extent to 
which theory contributed to the development of the intervention. Limited detail of the 
theoretical constructs further contributes to low understanding of the role of specific theory in 
the efficacy of interventions.  
1.7.1 Behaviour change theories  
When selecting a behaviour change theory to apply to the development and delivery of an 
intervention, it is important to consider the strengths, limitations, and relevance of the types 
of theories available. Behavioural theories are selected based on the relevance of the 
constructs in explaining the target behaviour. Early models, such as social learning theory167 
and the Health Belief Model168, are extremely prevalent in behaviour change literature169 and 
their simplistic design provide an understandable explanation for behaviour. However, one 
limitation of these models is that they are reductionist in nature and focus on the role of 
beliefs and intentions on health behaviour170, while ignoring factors such as motivation and 
external factors. More recent models, including the social cognitive theory166 and the 
transtheoretical model171 build upon these limitations. For example, the social cognitive 
theory recognises the importance of socio-structural factors166 and the transtheoretical 
model171 recognises that behaviour change is dynamic and does not occur in a linear fashion. 
However, these models are still contested. For example, the social cognitive theory continues 
to omit factors such as habits and emotions and the transtheoretical model may ignore factors 
such as the role of factors such as socioeconomic status in behaviour change. 
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Evidence suggests that there are a wide range of factors that may prevent or support 
people with COPD to be active.140 However, there is still limited understanding of the specifc 
factors that impact patients’ PA following PR.128,155 When little is known about the factors 
that determine an individuals’ behaviour, it is important to select a model which is 
sufficiently broad enough to capture a wide range of behavioural sources.145 More recent 
models, such as the COM-B (Capability, Opportunity, Motivation- Behaviour) model, which 
is situated at the core of a behaviour change framework known as the Behaviour Change 
Wheel (BCW)145, recognises the potential impact of various behavioural sources.  
 
 
Figure 1:1: The key elements of the development and evaluation process of a complex 




Figure 1:2: An edited MRC diagram which outlines the behavioural constructs linked to an 





1.7.2 Behaviour Change Frameworks 
The MRC states that intervention development should be a systematic process, based on a 
coherent and relevant theoretical framework159, using the best available evidence. Despite this 
guidance, many previous interventions are believed to simply be the result of intervention 
designers’ belief that they ‘seemed like a good idea at the time’.145 There is limited detail 
reporting the rationale and evidence base and it is not clear how these interventions are the 
result of prior evidence development.145  
The development of an intervention requires many decisions to be made, which are 
not just limited to the content. The diversity and complexity of interventions makes the 
evaluation of their effectiveness challenging.145 For example, interventions can be single or 
multicomponent and the content, intensity, duration, and fidelity of interventions all differ. 
This means that identifying the active ingredients of interventions is challenging. These 
decisions may be guided by the target behaviour (e.g. PA) but are also underpinned by 
contextual factors such as setting and available resources (e.g. time and money). Behaviour 
change frameworks are developed to facilitate the design of interventions by drawing 
attention to the range of options available, specifically those that may complement the 
behavioural target, and subsequently using the framework to systematically design an 
intervention. By implementing a systematic approach to the development of interventions, 
this removes the likelihood of designing interventions based on favoured theory or a 
‘common sense approach’, based on individuals’ previous experiences without explicit use of 
evidence-based theory.145  
1.7.3 The Behaviour Change Wheel (BCW) 
Behavioural frameworks such as Mindspace172 and Intervention Mapping173 are popular 
frameworks which can provide intervention development guidance. However, the 
comprehensiveness of these frameworks are limited, for example they are not necessarily 
linked to a model of behaviour change and/or applicable to a broad range of behaviour.145 The 
BCW addresses previous limitations of behaviour change frameworks and is considered a 
comprehensive tool to aid in intervention development.145  
The BCW originated from the synthesis of 19 frameworks of behaviour change.145 At 
the core of the model, there are three components which represent sources of behaviour: 
capability (psychological and physical); opportunity (social and physical) and motivation 
(reflective and automatic) Figure 1:3. These components are directly related to behaviour, 
and it is stated that one or more of these components need to be altered for behaviour change 
to occur. The ring surrounding these sources of behaviour list intervention functions and the 
third (and final) ring surrounding the intervention functions list the seven policy categories 
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that one can use to deliver a certain intervention function. The final step in the BCW, which 
is not illustrated on the wheel, is the identification of behaviour change techniques (BCTs) 
and the mode of delivery included in an intervention. The APEASE criteria guides the 
movement between the stages in the BCW by encouraging informed decisions of an 
intervention’s Affordability, Practicability, Effectiveness and Cost-Effectiveness, 
Acceptability, Side-effects and Safety and Equity.145  
The BCW has been used in the development and evaluation of interventions to 
modify PA behaviour in COPD and there have been calls for further adoption of this 
framework within intervention development in the area.165,175 However, it has limited 
application in the development of interventions to promote PA following PR.176  
 
Figure 1:3: The BCW, illustrating the COM-B behaviour change model, Intervention 
Functions and Policy Categories.145 
 
1.8 Stakeholder involvement in research  
The MRC guidance reports that the inclusion of stakeholder interviews can also facilitate the 
identification and development of appropriate theory.159 The inclusion of patient and public in 
the research process, typically known as ‘patient and public involvement’ (PPI) or ‘lay 
involvement’ provides numerous benefits at different stages of the development and 
evaluation process. PPI is considered as a partnership between researchers and/or members of 
the public and patients177 and PPI may include individuals who are, or have, used health and 
social care services and those who are interested in a particular topic.  
1.8.1 Benefits of PPI in research 
PPI is gaining prevalence in grant applications and study protocols178 and has been widely 
recognised by those involved in the research process, for example including funders, 
regulators and publishers.177 PPI facilitates research at various stages of the development-
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evaluation-implementation process of complex interventions.159 For example, PPI can 
facilitate the identification and prioritisation of research topics such as study design, and PPI 
can contribute to writing patient information sheets, recruitment and the evaluation and 
dissemination of research results.178,179 PPI has had a positive impact on the quality and 
appropriateness of research.178,179 For example, in a systematic review of the role of PPI in 
clinical trials, authors found that PPI significantly increased the odds of participant 
enrolment.180 Evidence also suggests that involvement of individuals with personal 
experiences of the condition was associated with higher enrolment of participants.180   
1.8.2 PPI in COPD research  
The limited efficacy of previous interventions to promote PA following PR in COPD has 
been attributed to limited understanding of the determinants of PA behaviour.155 In a recent 
study to understand what matters for people with COPD181, researchers brought patients, 
carers and HCPs together in workshops to consider strategies to benefit patients. HCPs 
benefitted from witnessing the lived experiences of patients and gaining wisdom that can 
improve the efficacy of further interventions.182 This study highlighted the importance of PPI 
within research, particularly when new knowledge can be disseminated between different 
groups of stakeholders.  
There are various challenges involved in applying PPI across all processes involved in 
the development, evaluation, and implementation of interventions. For example, challenges 
include the time-consuming nature of PPI; potential clashes of opinions between stakeholder 
groups; and limited guidance and understanding on how to report PPI.178 However, evidence 
from previous studies which involve patients and HCPs in the development183,184 and 
delivery185–188 of interventions clearly supports the beneficial role of PPI in all process of 
research. The involvement of PPI is therefore a clear priority in further research.   
1.8.3 Lay volunteers in health research  
Inclusion of patients and the public within the delivery of health interventions also represents 
a potential strategy to improve the impact of an intervention. Evidence supports the inclusion 
of social support via HCPs to promote PA following PR in COPD.84,84,91,90,143 However, there 
has been limited investigation of the inclusion of peer support as an intervention component 
following PR, despite the perceived importance of peer support. One study has conducted 
focus groups and interviews with COPD patients to inform the development of a peer 
supported PR programme.189 Similar to previous research190,221,191,192, patients considered 
support after PR as critical to maintaining the beneficial effects of the programme.  
Recent evidence has provided support for the feasibility and acceptability of peer 
support in the PR pathway, specifically prior to and during the programme. White et al 
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(2019)185 recently tested the feasibility of recruiting and training PR graduates (COPD 
patients) to become lay health workers and support the uptake and completion of PR. The 
results of the study outlined that there was high engagement of PR graduates in the lay health 
worker scheme (almost 40%). Feedback from this study suggested that COPD patients and 
lay health workers found the intervention acceptable. A similar approach has also been 
adopted in non-COPD populations. For example, in the promotion of healthy behaviour in a 
smoking cessation intervention, whereby individuals received social support via WhatsApp 
and Facebook from a trained moderator, the intervention was effective in reducing relapse.193  
Training of lay volunteers in the delivery of health interventions is an approach which 
has previously been adopted185 and it is both recommended and adopted within intervention 
delivery for health management.185–188 It has been adopted in COPD management, for 
example, research into the acceptability of PR found that patients welcomed the support of 
patients who had already completed the treatment.185,189 In a recent study to investigate the 
impact of a peer educator in the maintenance of health and functional outcomes after PR, 
evidence supports the inclusion of lay volunteers in future research.189  
1.9 Summary 
Despite the importance of PA to patients’ physical and psychological health, PA in 
COPD is significantly lower than age matched healthy individuals. PR, a structured PA 
intervention, is an important treatment for COPD, and results in benefits such as improved 
exercise capacity, symptoms, and disease specific Quality of Life (QoL). However, this does 
not translate to an increase in long- term PA and previous interventions to promote PA 
following PR have had limited efficacy. There are currently a range of factors that contribute 
to gaps in our knowledge of how best to support individuals to stay active following PR. 
These factors include limited understanding of the determinants of PA following PR; limited 
understanding of the processes that contributed to the efficacy of interventions; limited 
application of theory and behaviour change frameworks in intervention development; and 
limited involvement of Patient and Public Involvement (PPI)  in previous interventions. 
There is a clear need for a step wise approach to the development of an intervention to 




2 Chapter 2: Facilitators and barriers to physical activity following 




Background: PR has short-term benefits on exercise capacity and QoL in COPD, but 
evidence suggests that this does not translate to increased daily PA on a patient level. This is 
attributed to a limited understanding of the determinants of PA maintenance following PR.  
Aim: This chapter reports the systematic review of qualitative research to understand COPD 
patients’ perceived facilitators and barriers to PA following PR.  
Methods: Electronic databases of published data, non-published data and trial registers were 
searched to identify qualitative studies (interviews, focus groups) reporting the facilitators 
and barriers to PA following PR for people with COPD. Thematic synthesis of qualitative 
data was adopted involving line-by-line coding of the findings of the included studies, 
development of descriptive themes and generation of analytical themes.  
Results: Fourteen studies including 167 COPD patients met the inclusion criteria. Seven sub-
themes were identified as influential to PA following PR. These included: intentions, self-
efficacy, feedback of capabilities and improvements, relationship with HCPs, peer 
interaction, opportunities following PR and routine. These encapsulated the facilitators and 
barriers to PA following PR and were identified as sub-themes within the three analytical 
themes, which were beliefs, social support, and the environment.  
Conclusion: The findings highlight the challenge of promoting PA following PR for patients 
with COPD, provide complementary evidence to aid evaluations of interventions already 
attempted in this area, but also adds insight into the future development of interventions 
targeting PA maintenance in COPD. 
2.2 Introduction   
As reported in the literature review (Chapter 1), PA is a complex behaviour137,140,188–193, but 
thus far, syntheses of the research surrounding PA following PR is predominantly based on 
randomised controlled trials (RCTs) using quantitative methods alone.197–199 These methods 
do not capture individuals’ insights on how and why interventions did, or did not promote 




understanding of the effectiveness of health interventions, providing complementary data to 
quantitative findings in RCTs. Systematic reviews of qualitative studies have provided 
evidence towards understanding COPD patients’ subjective view of the impact of PR137, and 
the barriers and enablers to participation in structured PA (i.e. exercise/PR programmes).140 
Such evidence does not address the factors which influence the maintenance of PA and long-
term behaviour change following PR, where the focus shifts to self-management of PA. 
Specific factors are proposed to be involved in maintenance of behaviour, different from 
those involved in behaviour initiation144, however, these factors have not been explored in 
this specific population.  
There is a need for a better insight into the patient subjective experience of PA 
following completion of PR to inform future practice and policies surrounding support of 
long-term adherence to health-enhancing behaviour in COPD. The aim of this systematic 
review was to therefore provide a comprehensive synthesis of the patient reported facilitators 
and barriers of PA following completion of PR, among individuals with COPD.  
2.3 Methods 
2.3.1 Protocol 
The Protocol for this review was registered on the international prospective register of 
systematic reviews (PROSPERO) (CRD42017058274). This review was reported in 
accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA)200 guidelines and Enhanced Transparency of Reporting the Synthesis of 
Qualitative Researchframework.201  
2.3.2 Eligibility criteria  
Study design: Qualitative studies (Interviews, focus groups) or mixed methods designs which 
included qualitative data.  




Exposure: Discussion of PA, which was defined as any bodily movement produced by 
skeletal muscles that results in energy expenditure48, for example experience of structured 
exercise such as fitness classes or walking groups, to activities of daily living such as 
shopping, meal preparing or housework following PR.  
Outcomes: Facilitators and barriers to PA following PR in COPD.   
2.3.3 Searching   
A comprehensive search strategy was used between February 2017 and October 2017 to 
identify all relevant available studies. DARE, PROSPERO, Cochrane Airways and Cochrane 
Database of Systematic Reviews (CDSR) were searched for ongoing and published reviews. 
For published original studies the following databases were searched: MEDLINE, Embase, 
Web of Science, CINAHL, ASSIA, PsycINFO and SPORTDiscus. An example of a full 
search strategy for one database (MEDLINE) is provided in Appendix A, (p285). Database 
searches were also supplemented with internet searches (e.g. Google Scholar) and contact 
with study authors and experts when required. Forward and backward citation tracking from 
included studies and review articles were also conducted to identify relevant papers. 
ClinicalTrials.gov, and Current Controlled Trials were searched for completed and ongoing 
trials. DART Europe E theses, EThOS, Open Grey, The New York Academy of Medicine, 
ProQuest Dissertations, theses.org and Conference Proceedings Citation Index (Web of 
Science) were searched for unpublished data. All references were exported and stored in 
EndNote.  
2.3.4 Study screening 
Two reviewers independently screened the titles and abstracts for inclusion against the 
defined eligibility criteria. Full text articles were retrieved for articles that were not excluded 
based on title or abstract. Further independent screening of full texts was performed to 




2.3.5 Data extraction 
Data from the included papers was extracted by two reviewers and was completed using a 
bespoke data collection form for qualitative research based on the UK National Institute for 
Health and Care Excellence (NICE) universal template.202 To facilitate synthesis of 
qualitative data, all studies were uploaded on to NVivo 11 Pro.203 
2.3.6 Critical appraisal  
Two reviewers independently performed a critical appraisal of each included study, through 
use of the Specialist Unit for Review Evidence (SURE) checklist (2015).204 This checklist is 
adapted and updated from the former Health Evidence Bulletins Wales checklist with 
reference to the NICE Public Health Methods Manual (2012) and previous versions of the 
Critical Appraisal Skills Programme checklists. Discrepancies were resolved through 
discussion between two reviewers. Studies were not excluded or weighted based on the 
quality assessment. 
2.3.7 Data synthesis  
Thematic analysis was the inductive approach used for synthesising the data from each study, 
an approach used to identify themes and patterns in qualitative research.205 This approach has 
previously been adopted to synthesise qualitative data in systematic reviews.200–205 Thematic 
synthesis was completed in three stages: the coding of text ‘line-by-line’, the generation of 
‘descriptive themes’ and the generation of ‘analytical themes’.210 Initially, the review 
question was put to one side to enable an analysis that was close to the data of the original 
studies and prevented reviewers imposing the data on to an existing framework. Participant 
quotations within the findings/results section of each included study were coded according to 
meaning and content. A ‘bank’ of codes were derived from the studies, and new codes were 
formed when necessary. Similarities and differences between the codes were explored, and 




The final stage of analysis involved engaging with the descriptive themes to answer the 
review question. This was an iterative process, which involved making inferences from the 
data about the facilitators and barriers to PA following PR, as well as considering 
implications regarding intervention development. To reduce bias, three reviewers 
independently coded the extracted data, produced descriptive themes, and reviewed and 
discussed analytical themes. 
2.4 Results 
2.4.1 Study selection 
Following removal of duplicates, searching identified 2392 records for eligibility assessment, 
of which 2340 were excluded based on title and abstract (Figure 2:1). Full text screening of 
the remaining records resulted in 18 records that were eligible for the review. A full list of 
excluded studies, together with reasons for exclusion can be found in Appendix B, p287. 
However, only 14 studies were included within the synthesis (n=12 published articles; n=2 
theses). In two cases, records referred to the same study214–216 and the remaining studies205,219 
  (n=2) were presented only as conference abstracts. These were identified as relevant to the 
research question of this review, but not eligible for inclusion within the synthesis of the 
results due to lack of availability of participant quotations.205 Authors of these studies were 





Figure 2:1: Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) flow chart representing the study screening process 
2.4.2 Study characteristics 
Twelve studies were of a qualitative study design only, and two studies were of a mixed-
method design214 (Appendix C, p290). Studies were conducted in Canada216,211,221, 
Norway214,213,224, Netherlands225, England187–230, USA230,187 and Sweden233 between 1998-
2017. All studies collected data using either semi-structured interviews211–215,219,230 ,235, open-
ended interviews232, or focus groups.214,216,216–235 The type of analysis ranged from thematic 
analysis214,216,221,213,217, template analysis235, qualitative content analysis233,225; analysis 
methods informed by grounded theory216,219,230, methods informed by phenomenology221,226, 
and one reported that their analysis adhered to “established guidelines”.215  
Overall, there were a total of 167 individuals diagnosed COPD across the studies 
(male = 92, female = 75). All participants had previously completed PR, but the treatment 
varied on setting and duration. The duration of the PR ranged from 4 -12 weeks and 
individuals attended either inpatient214,216,211,221,187 and outpatient PR venues213,215,216,235,230 or 




interventions219,187,235,227–231,233,225, however some were involved in post-rehabilitation 
programmes, such as a six-month community exercise maintenance programme216, a two-year 
tele-rehabilitation intervention221 and approximately half of individuals within one study192 
had received input regarding ongoing exercise programmes post-rehabilitation.192 The context 
of data collection after completion of PR also varied across studies. The data collection 
typically occurred at either the individuals’ home211,224,219, 187, the rehabilitation centre221,215, 
187, or a combination of both213,215,230,235 and data collection settings were not reported in some 
studies.216,217,235 All but two of the studies collected data just once following PR. One study 
conducted two semi-structured interviews222 and the other conducted three focus groups.221 
Data collection took place between 1-2 weeks and 42 months following completion of PR. 
2.4.3 Critical appraisal 
Critical appraisal of the studies was conducted by two reviewers, and the results are 
summarised in Table 2:1. All studies were interpreted as having a clearly focused research 
question or hypothesis, as having an appropriate research design, appropriate justification of 
sampling strategy, well described method of data collection and an explicit discussion of 
ethical issues. For each criterion, most studies were interpreted as good quality, with the 
exception of conflicts of interest and sponsorships, which were reported in eight 
studies.221,224,216,217,219–187 In four studies it was unclear how well the researchers knew the 
participants216, 221,213,230, and in two studies, no description of the relationship between 
participant and researcher was reported.227,233 In one study, the analytical method was not 
found to be clearly justified.225 Credibility of two studies were unclear, due to minimal 
quotations to support themes215,236 or discussion that was restricted to evaluation of 
theoretical models, without reference to previous studies.225 In two studies there was a lack of 




study. In three studies, authors did not identify limitations215,235, 187, and in two studies, there 



































Clearly focused question/ 
hypothesis? 
+ + + + + + + + + + + + + + 
Is the choice of qualitative 
method appropriate? 
+ + + + + + + + + + + + + + 
Is the sampling strategy 
clearly described and 
justified?  
+ + + + + + + + + + + + + + 
Is the method of data 
collection well described? 
+ + + + + + + + + + + + + + 
Is the relationship 
between the researcher(s) 
and participants explored? 
+ ? ? ? + + - ? + + + + + - 
Are ethical issues 
explicitly discussed? 
+ + + + + + + + + + + + + + 




+ + + + + + + + + + ? + + + 
Are the findings credible? - + + ? + + - + + + + ? + + 
Are there and 
sponsorships/ 
conflicts of interest 
reported? 
+ + - - + - - - - + + - - + 
Did the authors identify 
any limitations? 
+ + + + + + + + - - - + + + 
Are the conclusions the 
same in the abstract and 
discussion? 
+ + + + + + + + ? + + ? + + 




2.4.4 Data synthesis   
During the synthesis of the data from the fourteen studies included in this review, seven sub-
themes were identified as influential to PA following PR, which were organised into three 
analytical themes including beliefs, social support, and environment. The theme ‘beliefs’ has 
three sub-themes, including intentions, self-efficacy and feedback of capabilities and 
improvements. The theme ‘social support’ has two sub-themes, including relationship to 
HCPs and peer interaction and the final theme ‘environment’ also has two sub-themes, 
including opportunities following PR and routine (Figure 2:2). Facilitators and barriers to PA 
within these analytical themes are presented within Table 2:2, alongside a selection of 
participant quotes from included studies to reflect these themes. A line of argument, depicting 
the key analytical themes and sub-themes are reported.  
 
Figure 2:2: Concept map illustrating the key analytical and sub-themes of the facilitators and 




2.4.5 Theme: Beliefs  
Thoughts surrounding the importance of PA, previous experiences prior to PR, recognition of 
improvements following PR and confidence influence individuals’ intentions and motivation 
towards maintenance of PA following PR.  
Sub-theme: Intentions 
Many individuals held the belief that PA was enjoyable and important for their physical and 
psychological well-being.214,213,215,230,187 Individuals’ beliefs towards PA often manifested into 
intentions to be more physically active.214,213,215,230,187  These beliefs were often influenced by 
individuals’ lifestyles prior to COPD diagnosis. For example, regular engagement in PA prior 
to COPD diagnosis facilitated positive intentions towards maintaining PA following PR.231,225 
Information and education on PA was also identified as a facilitator to PA following PR, as it 
increased individuals’ understanding of the health benefits associated with PA.213–216,235,230, 235  
Intentions to be more physically active did not always translate into behaviour 
change. For example, in one study, individuals repeatedly indicated positive intentions 
towards PA following PR 232, however they were labelled as non-exercise compliant, 
highlighting an intention-behaviour gap in PA.   
Sub-theme: Self-efficacy 
Self-efficacy was a common theme throughout the data, referring to individuals’ beliefs in 
their ability to engage in PA. A barrier to PA maintenance was negative beliefs surrounding 
PA and health.224,216,235 These negative beliefs often stemmed from individuals’ previous 
experiences of PA that negatively affected their confidence and perceived capability of 
engaging in PA following PR. For example, individuals reported PA as too hard and that they 
were too restricted by symptoms such as breathlessness.192 Exacerbations and symptoms often 
led to psychological distress, for example individuals reported feeling overwhelmed, 




experiences negatively influenced individuals’ confidence to be active. Breathlessness and 
anxiety were repeatedly reported throughout the studies213,224,216,187, and this anxiety 
represented a barrier to PA after PR when individuals were attempting to maintain PA at 
home or by themselves, especially when individuals felt socially isolated.222,232 Avoidance 
was a strategy developed to manage anxiety associated with breathlessness221,187,226 and 
individuals did not want to draw attention to themselves by exercising outside of the house.221 
However, confidence to apply stress and breathing management techniques was often a 
reported facilitator to maintaining PA after PR.211,213,224,216,219,230 These skills were often learnt 
during PR, and were associated with feelings of increased self-efficacy and a sense of 
empowerment,221,230 and the newfound confidence also coincided with a more positive 
outlook on life.215  
Sub-theme: Feedback of capabilities and improvements  
Feedback refers to monitoring and providing informative or evaluative information on the 
performance of PA behaviour.145 When individuals noticed their personal improvements, or 
recognised their capabilities230, they were often more engaged or motivated by the outcomes, 
and felt empowered to maintain PA.214,216,215,216,219–235 
This motivation was facilitated by long-term feedback from health professionals, for 
example in a maintenance tele-rehabilitation study221, individuals reported that they had 
improved throughout the course, and felt a sense of accomplishment when discussing their 
progress, reporting that an upward feeling was important in motivating them to be active.221 
Those who had noticed improvements in health wanted these benefits to be maintained, and 
reported that they wanted the exercise classes to continue.192 Positive feedback therefore 
promoted beliefs of improvement and encouraged individuals to stay active following PR. 




individuals became unmotivated as they believed that the exercises were not worthwhile or 
helpful.221,226 
2.4.6 Theme: Social support  
Other people played a significant role in individuals’ journeys following PR. The perception 
of feeling cared for, valued, and assisted within the home and the community were important, 
in addition to relating to others who are in similar situations.    
Sub-theme: Relationship with health care professionals  
Individuals’ relationships with others had a large impact on their outlook and PA behaviour 
following PR, which extended beyond gaining feedback about their condition. Support from 
HCPs was commonly reported as being important for individuals, whereby their authority 
instilled a sense of trust, and individuals felt safe and comforted by their presence after 
PR.214,216,221,213,215,216,230–235 Individuals were less fearful of being overwhelmed by their 
symptoms, were comforted by the opportunity to ask questions, and were encouraged by their 
interest in their personal health.220 A barrier to PA was the lack of maintained support from 
HCPs, and individuals reported feeling unmotivated, for example by a lack of 
encouragement, incentive, and uncertainty regarding transferring these exercises to a different 
environment, such as their home.192  
Sub-theme: Peer interaction  
Interaction with peers was commonly reported as beneficial and it was considered a 
facilitator to the maintenance of PA, as it made PA more enjoyable and helped individuals 
conquer feelings of loneliness.214,216,221,213,215–,235,187,235 The opportunity to discuss symptoms 
and compare notes with others in similar situations also helped reduce distress associated 
with symptoms. However, individuals reported having a sense of loneliness that was difficult 
to manage following PR216,217,235, and a lack of peer interaction following PR was considered 




Individuals appreciated the ease of connecting with peers, even when in different 
countries.221 Throughout the studies, interest was expressed in the maintenance of interaction 
with peers with COPD after PR217,187,226, as well as socialising with individuals with mixed 
conditions and other members of the community.216 Despite this, peer interaction was also 
recognised as a barrier to PA, as it elicited fear in individuals as others’ conditions were an 
unwanted reminder of the progressive nature of COPD.222,227,232 This response motivated 
individuals to avoid peers in attempt to deny the illness and return to normality.227  
2.4.7 Theme: Environment  
Individuals’ surroundings influenced their opportunities to engage in PA following PR. In 
addition, individuals’ physical and social environment influenced their experiences and 
approach to maintaining a PA routine and successfully establishing habits following PR.   
Sub-theme: Opportunities to engage in PA following PR 
Individuals often expressed the importance of structured and unstructured PA sessions after 
PR215,187,235, in particular they would like access to PA maintenance.220,222 However, unclear 
information regarding maintenance sessions did not allow for individuals to consider 
alternative ways to be active, and this was a barrier to PA.235 Barriers to attendance in 
maintenance sessions also involved issues surrounding cost and proximity216 and restrictions 
imposed by family and work responsibilities.233 There were mixed views on home exercises, 
as some individuals responded positively to them221, whereas others did not feel like they 
would be helpful192, reflecting individual differences in preferences of PA. Walking and 
cycling225 were considered enjoyable activities, as well as simply being outside to enjoy the 
scenery.232 Individual differences regarding their preferred PA meant that having various 
opportunities to engage in a variety of activities was therefore considered a facilitator to PA, 
whereas restricted choice was considered a barrier to PA.   




Ongoing contact with HCPs and peers through maintenance groups also provided a sense of 
structure following PR and the expectation and pressure to conform to pre-set times and 
activities was appreciated and regarded as a facilitator to maintaining PA.221 However, 
without access to ongoing structured PA sessions, individuals largely reported that a barrier 
to maintaining PA was falling back into old habits.213,224,217,187 Routine was considered an 
important facilitator by individuals throughout the studies.213,216,230,235 However, this routine 
was influenced by individuals’ home life. For example, families’ understanding of COPD and 
their recognition of the importance of PA was identified as a facilitator to PA as they were 
able to provide support and encouragement225, whereas attention sometimes added too much 
pressure to individuals dealing with COPD.221,226 For example, individuals did not appreciate 
their family telling them to exercise.232 Social isolation due to restricted access to structured 
PA groups, lack of motivation192, as well as simply forgetting to be active232 were also all 
reasons why individuals fell back into their previous routines. In addition, establishing a 
successful routine was considered a long process which required patience224, placing 
emphasis on the challenge faced by many individuals to avoid falling back into old habits 





Table 2:2: Analytical themes and sub-categories with reference to quotations within primary studies 
Beliefs Social Support Environment 
Intentions 
- Information and 




“I became aware that I need 
not feel so frightened when out 
of breath and that was the most 
important. I felt that I got 
sufficient information to make 
me calm and less frightened 
when I lose my breath”233  
Beliefs surrounding PA and 
health influences intentions:  




“I have always enjoyed 
[exercising]. Only the cycling I 
don’t really enjoy, especially in 
the winter. But I realize now 
that particularly cycling means 
a lot to my physical condition 
and it would’ve been worse if I 
hadn’t cycled”225 
- PA is difficult/uncertainty 
regarding health benefits: 
224,216,235(-) 
“I went and bought a bike, it's 
downstairs. Bike is hard, bike 
is hard if you don't know how 
to do it and how much to do 
it.”192 
Self-efficacy  
- Previous experiences 
influence beliefs of 
capability and 
confidence: (+/-) 
- Exacerbations and 





Relationship with health care 
professionals 
- Contact regarding PA 
maintenance groups led 
to participation in weekly 
activities 222 (+) 
“The physiotherapist called 
me, and she asked me if I 
would like to continue with a 
group. Now I exercise with 
them every Thursday. I have 
planned to join other activities 
as well!” 222 
- Delivery of information 
via leaflets and the 
internet about PA was 
difficult to follow/not 
well accepted235(-) 
“But I do find leaflets what 
you’ve been given here or 
there they’re not exactly in 
plain English and they do take 
a lot of understanding”235 
- Provide a sense of 
security and comfort: 
helps overcome anxiety 
regarding symptoms214 
(+) 
“It meant, I like the fact that 
they allowed you to learn or go 




“One of the best things with 
the project has been to meet 
the [tele-]physiotherapist once 
a week, and get to ask 
questions about everything that 
is on your mind” 221 
- Continued support after 
PR regarded as 
beneficial216, 221,213,215,216,– 
235,230(+) 
“They give you confidence … 
to push yourself a bit, to 
PA opportunities  
- Individuals feel the need for clear 
information regarding exercise 
groups post PR 220 (+)  
“Just to know where these places are 
would be a big benefit and how to get 
into them.” 220 
- Individuals want and appreciate 
access to structured maintenance 
sessions after PR 220,226,227(+);  
“The best thing for me would be a 
mini-program, like we had in 
rehabilitation”225 
- Access to maintenance sessions 
affected individuals participation 
in PA: 216,221,216,187 (-) 
- Individuals were not motivated to 
exercise at home192 (-)  
“…it’s just difficult to get the 
motivation to do it at home” 192 
- Cost and proximity to sessions216  
(-) 
“... I have to go a little bit of a 
distance to get there, which I’m quite 
willing to do, if it isn’t going to cost 
me money. But I want something 
closer to home if I have to do this on a 
regular basis, which I do”.216 
- PA venue is important; hospital 
based programmes regarded as 
safe/supportive as they are 
associated with the health care 
system 220 (+) 
“Because you know that the 
healthcare system is interested in 
what’s going on with your exercise 
program” 220 
- Social environment of the PA 
venue is important. Public gyms 
can feel intimidating221 (-) 
“If I want to go to the gym, it is a 
60km drive from my house. Moreover, 
I would have felt weak in front of 
others. They would have looked at me, 





Table 2:2: Analytical themes and sub-categories with reference to quotations within primary studies 
Beliefs Social Support Environment 
“Come out of hospital and just 
feel and just feel sorry for 
yourself and not want to do 
anything” 227 
- Breathlessness is 
associated with anxiety 
213,224,216,221 (-) 
“…I don't want to go through 
things like that, if I can avoid 
it. I get nervous when I feel I 
can't breathe, it's scary, it gets 
very scary” 232 




“I saw the light one day. I was 
using the oximeter while 
cleaning the house, and I 
discovered that I was sooo low. 
I didn’t use the oxygen while 
doing housework before, but I 
do now” 221 
Feedback 
Awareness of change/self-
monitoring health influences 
motivation (+/-) 
- Recognition of 
improvements increased 
motivation to be active: 
214,216215,216,219–235 
“…I’m doing my own 
hoovering which I wasn’t 
doing because he did it, I’m 
cleaning windows, which he 
did, I do, you know there is, 
yeah, definitely sharing the 
jobs more” 
‘ … definitely doing more than 
I was …… (Williams) 
- Noticing health 
decline/lack of upward 
feeling negatively 
affected individuals 
outlook on PA:221,226 (-) 
“When you don't see results, 
you kinda say, ahhh... I don't 
know” 232  
 
try to do a bit more.”192 
- Support ends after PR 
negatively affects PA 
participation: 220,226,232 (-) 
“I don’t have the incentive and 
I don’t have anybody to kick 
my ass and tell me to get it 
done.” 220 
Peer interaction  
- Provide a sense of 
solidarity and support 
after PR:214,216,221,213,215–
235,221,235 (+) 
“The people that I know at the 
gym, we’ve all done pulmonary 
rehab and we all have a cup of 
tea after we exercise together 
and that encourages me to go, 
cos I think ‘Ooh if I don’t go 
today … they’ll wonder where 
I am’” 192 
- Peer interaction within 
PR affected individuals’ 
confidence following PR: 
Pre-PR: “[I do] nothing really, 
only stopping in the house 
really and listen to the radio 
and television’ (Pt4.1; 37-38) 
Post-PR: “…they have given 
me more confidence by being 
with people and going out 
twice a week for about 3/4 
hours, go there and come back 
you know, and meet people” 
229 
- Individuals struggle when 
peer interaction ends: 
222,226,232(-) 
“Exercises are all right in 
groups. However, to do it on 
your own.... I guess I don’t 
manage ” 222 
- Reminder of disease 
progression is 
uncomfortable/can lead to 
avoidance: 222,227,232 (-) 
“The meetings wouldn't do me 
any good right now. I would 
feel like that could be me, you 
 
 
-            Social isolation can be a barrier to 
managing negative emotions 216213,217,235 (-
) 
“Exercises are all right in groups. 
However, to do it on your own.... I 
guess I don’t manage.” 222  
- Access to preferred activity 
influences intentions and 
motivation to be active225 (+) 
“The cycling not so much, I do that 
because I have to, but the walking. I 
enjoy walking a lot. I don’t need 
motivation to do that.”225 
Routine 
- Establishing routine after PR 
facilitates PA maintenance: 
214,224,216,230,235(+) 
“It’s like I get up, I brush my teeth, I 
get dressed and I get on the treadmill 
before I even go downstairs . . . I know 
if I’m going to do it, I’ve got to get 
into a routine….”230 
- Family understanding of 
importance of PA:225 (+)  
“If my husband wouldn’t have been 
here, I would’ve needed help at home 
because I couldn’t manage alone. He 
also stimulates me to exercise.”225 
- Home responsibilities; caring for 
partner limits PA opportunities: 
233(-) 
“Now my husband is at home all the 
time, and since last winter when he 
fell ill he is too weak to go for walks 
so this winter there haven’t been any” 
233 
- Negative pressure from relatives 
and family leads to avoidance of 
PA221,226 (-) 
“They're always yelling at me, Ma, 
you know. And I say, Leave me alone, 
I don't tell you what to do, don't you 
tell me what to do." 232 
- Combination of both means 





Table 2:2: Analytical themes and sub-categories with reference to quotations within primary studies 
Beliefs Social Support Environment 
- Self-monitoring allowed 
individuals to 
acknowledge capabilities 
214,230  (+) 
“I have become more aware of 
what I do through registrations 
of my workouts. I am more 
engaged in my own health”221 
  
know, getting that bad— I 
don't want to give in, so I feel it 
would drag me down more” 227   
“Anyway, you will fall back to the old 
way of doing it. Because you have 
done so many times. It is difficult.”224 
 
 





2.5 Discussion  
2.5.1 Summary of the results 
The purpose of this review was to identify the patient reported facilitators and barriers of PA 
following PR. The analytical themes developed were beliefs, social support and environment 
that encapsulated the identified patient reported facilitators and barriers of PA following PA. 
Key facilitators identified within this review were the perception of continued support from 
HCPs, continued peer interaction, the sense of accomplishment gained through self-
monitoring and feedback, as well as opportunities to access PA maintenance groups 
following PR that enabled individuals to form routines and establish habits. Key barriers to 
PA were symptoms that evoked anxiety and fear, for example breathlessness upon exertion, 
restricted access to social support and structured maintenance sessions following PR and lack 
of positive feedback regarding health which led to individuals being less likely to establish 
routines incorporating PA, and were more likely to return to previous habits formed prior to 
PR.  
2.5.2 Strengths and limitations of this review  
Extensive searches for existing and ongoing systematic reviews suggest that there are no 
other systematic reviews to synthesise qualitative studies of COPD patients’ experiences of 
PA following PR. This systematic review followed a pre-specified protocol, conducting a 
comprehensive search strategy that yielded fourteen studies. Language, date and publication 
restrictions were not imposed in the search strategy, unlike previous qualitative systematic 
reviews in relevant areas, whereby inclusion criteria was either restricted to articles published 
in English140,143 or a selection of languages137 and included only peer reviewed articles.137,140,143 
Unpublished data proved valuable in this review, with a large amount of original qualitative 




Therefore, the inclusion of unpublished evidence was considered a key strength of this 
review. Systematic reviews of qualitative studies that do not adopt this approach are at risk of 
publication bias and excluding data relevant to their research question. The resulting context 
within the included studies was diverse in terms of individuals’ PR settings, PA experiences 
following PR and the cultural setting within each country, meaning that it was possible to 
achieve a higher level of abstraction in the synthesis.237 Two records retrieved in the search 
strategy were conference abstracts205, and based on the available information were deemed to 
meet the inclusion criteria. It may be considered a limitation that the data from these studies 
are not included in the synthesis, however, as findings largely reflected existing themes, it 
was unlikely that access to the full studies would change the conclusions drawn in this 
review.  
The approach to data (thematic) synthesis were in line with established methodology 
for systematic reviews of qualitative evidence210, an interpretative approach which enables a 
summary of the descriptive themes from the primary studies, with a subsequent production of 
analytical themes through applying a higher level theoretical framework to answer the 
research question. This approach was beneficial, as transparency between the developed 
themes within this review and the text from the primary studies was maintained. It has 
previously been suggested that qualitative synthesis such as meta-ethnography can de-
contextualise the findings from the primary studies.192 However, efforts to preserve context, 
in line with previous methods in thematic synthesis210, were taken to consistently refer to 
primary studies to check for contextual factors that could affect transferability. Additionally, 
by adoption of key principles of systematic reviews (extracting and tabulating study 
characteristics), facilitators and barriers reported in included studies can be considered 




Like quantitative research, there are no standardised criteria for assessing the quality 
of all qualitative research.201 This systematic review yielded studies with varied designs, 
methodological and analytical approaches, meaning that a key challenge was assessing the 
quality of research.204 This systematic review adopted an approach of appraising study quality 
by assessment of study conduct using a previously used critical appraisal tool.204 In 
accordance with approaches in systematic reviews of quantitative evidence, and with limited 
evidence to suggest that quality of reporting is associated with the credibility and 
transferability of the findings in qualitative studies240, we did not feel there was sufficient 
justification for exclusion or weighting of study data according to quality. For each criterion 
within the chosen critical appraisal tool204 the majority of the studies were appraised 
favourably, however the limitations in some of the included studies should be considered. For 
example, credibility was often jeopardised by the small amount of qualitative data provided 
throughout the studies and it was not possible to conclude whether selected quotes were 
biased towards researchers’ pre-existing views regarding their research question.  
2.5.3 Comparison to previous reviews  
No previous systematic review has synthesised qualitative data regarding facilitators and 
barriers to PA following PR. Meta-analyses of RCTs have provided limited success in 
demonstrating efficacy of interventions to improve PA in COPD, as the effects are typically 
modest and short-term.197,199 However, current proposals of the likely greater impact of 
longer duration PR programmes on modification of PA130 would support a key theme 
presented in the review, namely that ongoing support from both HCPs and peer interaction 
was a facilitator to PA maintenance. The importance of social support has previously been 
reported in systematic reviews researching individuals’ participation in PR128,143 and 
facilitators and barriers to PA in other lung conditions.140,143 Feeling supported by family 




study suggest that family, friends, partners and peers interaction are also important in the 
maintenance of PA.   During PR, it has previously been suggested that environmental and 
personal factors, in addition to social factors, have been recognised as influential to PA in 
patients with COPD.140  Environmental factors such as transportation and options regarding 
the type and intensity of PA were also considered influential factors to PA maintenance, as 
were personal factors associated with identity, for example previous experiences with PA and 
previous lifestyles which affected individuals’ PA beliefs. In this review, a larger emphasis 
was placed on access to information regarding opportunities to engage in PA following PR, 
likely due to the responsibility of PA maintenance being shifted from HCPs to patients after 
completing PR. Establishing a healthier routine is often reported to be a key benefit during 
PR137, however, the findings from this review identified both the importance and difficulty of 
maintaining these PA routines and forming habits following PR. Interestingly, the length of 
the PR programme has previously been recognised as a barrier to PA140, with less patients 
being likely to attend longer programmes, however the findings in this review suggest that a 
barrier to PA maintenance is the loss of structure and contact with other people.  
Unlike previous findings of key barriers to PR140, smoking status was not identified as 
a barrier to PA maintenance in this systematic review. It may be argued that a greater 
proportion of COPD patients included in the present review (i.e. who completed PR) were 
less likely to be smokers who are associated with poorer completion rates in PR and hence 
have other important personal factors. The findings suggest that COPD patients often reflect 
on their health. Positive feedback regarding PA and health was recognised as a facilitator to 
PA maintenance, whereas some became unmotivated if they did not recognise any 
improvements in their condition. This suggests that self-efficacy is an influential factor in PA 




achievement as a facilitator to PA during PR, and the benefits of adding pedometer-based 
counselling to multidisciplinary PR.140,193    
2.5.4 Conclusions 
This systematic review identified and synthesised the data referring to the patient reported 
facilitators and barriers to PA following PR, which provided an in-depth understanding and 
insight into patient experiences regarding the maintenance of PA behaviour. The results from 
this systematic review highlight the complexity of behaviour change, and the challenge of 
promoting PA following PR on a population level. The results provide clear guidance for 






3 Chapter 3: Use of the Behaviour Change Wheel to develop an 
intervention to promote physical activity following pulmonary 
rehabilitation in patients with COPD 
 
3.1 Abstract 
Background: Pulmonary rehabilitation (PR) is a programme of exercise and education that 
has benefits on breathlessness, exercise capacity and quality of life in COPD. However, these 
benefits do not necessarily translate to an increase in daily physical activity (PA) and long-
term behaviour change. Previous interventions to promote PA following PR have had limited 
efficacy.  
Aim: This chapter reports the systematic and comprehensive development of an intervention 
to promote PA following PR for patients with COPD, using the Behaviour Change Wheel 
(BCW).  
Methods: The eight steps outlined in the BCW were followed to develop an intervention.  
Stakeholder discussions facilitated the development of the intervention by considering and 
evaluating the intervention’s affordability, practicability, effectiveness and cost-effectiveness, 
acceptability, side-effects and safety and equity (APEASE).   
Results: The final intervention targeted patients’ capability, opportunity, and motivation, 
incorporating four intervention functions delivered via four policy categories and thirteen 
Behaviour Change Techniques (BCTs). The final intervention included 52 weeks of support 
through provision of a pedometer and step diary, and addition of patients to a WhatsApp 
group populated by fellow PR graduates and a ‘WhatsApp leader’. 
Conclusion: The BCW enabled a systematic and comprehensive development of a novel, 
multicomponent intervention to promote PA following a community PR programme in 
patients with COPD.  
3.2 Introduction 
As reported in previous chapters (Chapter 1 and 2), interventions to promote PA following 
PR have had limited efficacy and have only resulted in modest, short-term increases in 
PA.146,149 Behaviour change following PR is a complex phenomenon and it is therefore 




The results from the systematic review of the patient reported facilitators and barriers of PA 
following PR in COPD (Chapter 2), outlined various factors which impacted patients’ 
behaviour, and these were encompassed by patients’ beliefs, the environment and social 
support. The systematic review represented the first step in the development of a complex 
intervention, including the identification of the evidence base.159 The next step involves the 
identification of relevant theory to develop an intervention to target the promotion of PA 
following PR in patients with COPD.  
The Medical Research Council (MRC) framework for complex interventions states 
that intervention development should be a systematic process, based on coherent and relevant 
theory and the best available evidence.159 Though there are various intervention frameworks 
which can provide intervention development guidance172,173, the comprehensiveness of these 
frameworks are limited, for example they are not necessarily linked to a model of behaviour 
change and/or applicable to a broad range of behaviour.145 The BCW was developed to 
address these limitations. The BCW has been used in the development and evaluation of 
interventions including modifying PA behaviour in COPD and there have been calls for 
further adoption of this framework within intervention development in the area.165,175 The 
BCW has not yet been used to develop interventions for promoting PA in the post-PR setting. 
This chapter describes the application of the BCW in the development of an intervention to 
promote PA following PR in patients with COPD. 
3.3 Methods 
3.3.1 Settings  
PR service in Lincolnshire Community Health Services (LINCs) NHS Trust is an 8-week 
programme delivered to patients with chronic respiratory disorders who are symptomatic and 
functionally limited by their condition (MRC score 2 or more) or had a recent hospitalisation 




hour exercise and education sessions. The exercise component of the programme includes 
activities requiring minimal equipment (e.g. ‘sit to stand’ exercises using a chair) so that 
these can be performed at home during and following PR.  The educational component 
contains information on various topics, such as benefits of regular PA, management of 
exacerbations and breathlessness. Once patients’ complete PR, they are discharged and 
referred to primary care with no formal follow-up or support to maintain the benefits of PR.  
3.3.2 Design 
The BCW was applied to the development of an intervention to promote PA following PR in 
patients with COPD. The intervention was developed in accordance with three key stages of 
the BCW.145 Briefly, stage 1 includes understanding the behaviour; stage 2 includes the 
identification of intervention options, for example intervention functions and the policy 
categories which may deliver these and, finally, stage 3 includes the identification of content 
and implementation options.   
3.3.3 Stage 1 
Stage 1 included four steps, step 1: defining the problem in behavioural terms; step 2: 
selection of the target behaviour; step 3: specifying the target behaviour and step 4: 
identification of what needs changing via the model of behaviour that forms the core of the 
BCW, known as the COM-B.145 Specifically, based on the results of a qualitative systematic 
review (Chapter 2), step 4 involved conducting a behavioural analysis using the COM-B 
model. This model has three components which represent sources of behaviour: capability 
(psychological and physical); opportunity (social and physical) and motivation (reflective and 
automatic). This method identified the sources of behaviour that were involved in PA 




3.3.4 Stage 2  
Stage 2 included two steps, step 5 (the identification of intervention functions) and step 6 
(identification of policy categories). Decision making at steps 5 and 6 were informed by the 
matrix of links, which is a table within the BCW framework for moving between steps.145 For 
example, in stage 2, the matrix of links is a table that reports the intervention functions that 
are likely to bring about change to specific behavioural sources. In addition, similar to 
previous studies242, application of the APEASE criteria and discussions with stakeholders, 
including patient groups such as Lincoln Breathe Easy138, HCPs and academic experts in 
behaviour change, facilitated the development of an intervention that was acceptable to all in 
the local setting (Lincolnshire). Table 3:1 provides further details of the discussions with 
stakeholders. The Chief Investigator led discussions during each meeting and used the 
APPEASE to review the feasibility of the intervention strategies. Results and actions from the 
meetings were noted by the Chief Investigator. 
Identification of intervention functions in step 5, i.e. the functions that an effective 
intervention is likely to serve, were based on the behavioural sources (COM-B components) 
selected in Step 4 as needing to change. Intervention functions listed in the behaviour change 
wheel include education; persuasion; incentivisation; coercion; training; restriction; 
environmental restructuring; modelling and enablement. 
Identification of policy categories in step 6, i.e. how the intervention functions will be 
implemented, was based on the intervention functions selected in step 5. Policy categories 
listed in the behaviour change wheel include communications/marketing; guidelines; fiscal 
measures; regulation; legislation; environmental/social planning and service provision.145  
3.3.5 Stage 3 
Stage 3 included two steps, step 7: the identification of Behaviour Change Techniques 




delivery. Similar to stage 2, these steps were also informed by the matrix of links and 
discussions with stakeholders (Table 3:1 and Table 3:2) with application of the APEASE 
criteria.  
In step 7, the research team selected BCTs based on the intervention functions 
selected. For each intervention function, the BCW guide lists the most and less frequently 
used BCTs according to the Behaviour Change Taxonomy version 1 (BCTv1).243 This was 
used to facilitate the selection of relevant BCTs.  
For step 8, the research team selected modes of intervention delivery (e.g. individuals 
or groups of people, face to face or online) based on the previous steps (intervention 
functions and policy categories). The research team sourced and trialed specific intervention 





Table 3:1: Stakeholder discussions to inform intervention development in Steps 5-8 
 Methods Results Actions 
Attendees: Chief Investigator, 
Academic Supervisor and Breathe 




Communication: Face to face 
meeting 
 
Date: August 2017 
The Chief Investigator and their 
Academic Supervisor attended the 
Lincoln Breathe Easy Group to discuss 
the development of the intervention to 
promote physical activity. The results of 
the systematic review and proposed 
intervention strategies were shared with 
the group (Table 3.1).  
 
Breathe Easy Group members supported the 
addition of a pedometer to provide feedback 
regarding step counts. Individuals stated that they 
appreciated support from others who have similar 
conditions and reported their willingness to 
continue to meet with others following pulmonary 
rehabilitation. Some individuals stated that they 
would prefer meeting others face to face and 
wished to have more opportunities regarding 
social activities and options regarding physical 
activity classes after pulmonary rehabilitation. 
However, access to online forums or networks, 
where they could interact with others in similar 
situations, was considered favourably. 
 
To identify acceptable 
intervention strategies to 
build upon patients’ 
willingness to socialise 
with other patients 
following pulmonary 
rehabilitation and to have 
more opportunities 
regarding physical activity 





Attendees: Chief Investigator, 
Academic Supervisor and 
Lincolnshire Community Health 




Communication: Face to Face 
meeting 
 
Date: August 2017 
 
The Chief Investigator and their 
Academic Supervisor attended the 
Lincolnshire Community Health 
Services (Respiratory Team) monthly 
meeting to discuss the development of 
the intervention to promote physical 
activity. The results of the systematic 
review and the findings from the 
meeting with the Lincoln Breathe Easy 
group were shared to identify acceptable 
intervention strategies.  
The Respiratory Team provided support for the 
proposed intervention and identified social 
networking as a possible intervention strategy to 
promote social support following pulmonary 
rehabilitation.  
 
To explore the feasibility 
of using social networking 
applications in an 
intervention e.g. 
considering ethical issues.  
Attendees: Chief Investigator, 
Academic Supervisor and Health 




The Chief Investigator and their 
Academic Supervisor attended a 
meeting with an NHS Communications 
Officer in Lincolnshire to explore the 
possibility of promoting social support 
via social networking as an intervention 
All attendees concluded that there would not be a 
“one size fits all” approach to social networking. 
However, attendees agreed that WhatsApp may be 
the most accessible platform due to the popularity 
of the application e.g. it was agreed that many 
participants and/or family members may be 
To explore the target 
populations’ familiarity 
with online social 
networking applications 
such as WhatsApp. To 




Table 3:1: Stakeholder discussions to inform intervention development in Steps 5-8 
 Methods Results Actions 
 
Communication: Face to Face 
 
Date: September 2017 
 
strategy. The various social networking 
platforms (e.g. WhatsApp and 
Facebook) and practicalities of using 
these were discussed.  
 
familiar with the application. All attendees agreed 
that actions needed to be taken to address data 
privacy policies.   
 
policies in social 
networking applications.  
Attendees: Chief Investigator, 
Academic Supervisor and local 
respiratory support group members 
(Happy Breathers, Lincoln Breathe 
Easy and an informal pulmonary 
rehabilitation follow on group in 
Lincoln) (n< 30) 
 
Location: Lincoln and Spalding, 
Lincolnshire 
 
Communication: Face to Face 
 
Date: September – November 2017 
 
The Chief Investigator and their 
Academic Supervisor attended 
community respiratory patient groups to 
identify individuals’ level of familiarity 
and acceptability of Smartphones and 
Social media as an intervention strategy.  
Many individuals owned smartphones or were 
familiar with these due to family or friends’ 
influence. Nevertheless, many individuals in the 
patient follow-on groups were not familiar with 
WhatsApp and use of social media. Therefore, 
attendees agreed that education and information 
regarding the intervention was extremely 
important. 
To consider the delivery 
of education on the use of 
smartphones and social 
networking for the target 
population. To produce 
appropriate guidelines and 
instructions towards using 
social media applications.  
Attendees: Chief Investigator and 






Date: November 2017 
The Chief Investigator contacted two 
behaviour change experts (the 
Behaviour Change Lead at the British 
Lung Foundation and an expert in 
Behavioural Science based at University 
College London) to provide an overview 
of the intervention development project 
and to discuss collaboration.  
Both behaviour change experts agreed to 
collaborate in the project, and individually 
evaluated the steps undertaken to develop the 
intervention e.g. the relevance of the chosen 
intervention functions and BCTs to change 
physical activity. They also facilitated the 
production of the messages to be delivered within 
the WhatsApp group by providing suggestions for 
messages in the WhatsApp guidelines.   
To use the study materials 
(e.g. WhatsApp guidelines 
and booklet) in a pilot 
study to assess the clarity 
and acceptability of the 
study materials. 
*The Chief Investigator led discussions during each meeting and used the APPEASE to review the feasibility of the intervention strategies. Results and actions 






Table 3:2: Stakeholder discussions to inform intervention development in step 8 
 Methods Results Actions 
Attendees: Chief Investigator, 
Academic Supervisor and 





Communication: Face to face 
meeting 
 
Date: August 2017 
 
The Chief Investigator and their Academic 
Supervisor attended a Lincoln Breathe Easy 
meeting to identify the acceptability of pedometers. 
Samples of the pedometer (Yamax CW700/701 
model), were shared with the group and group 
members were encouraged to provide feedback on 
the acceptability in terms of size, user-friendliness, 
and comfort.   
 
The pedometer (Yamax CW700/701 




To trial the pedometer in a 
pilot study.  
 
Attendees: Chief Investigator, 
Academic Supervisor and 





Communication: Face to face 
 
Date: September 2017 
onwards 
 
The Chief Investigator purchased samples of the 
Alcatel Pixi 4 (Appendix D) and organised to meet 
with the Lincoln Breathe Easy Group Committee to 
identify the acceptability of the mobile phone, and 
to facilitate the development of the study materials. 
Attendees agreed that the mobile phone 
required pilot testing and agreed that it 
was important to provide clear 
instructions on how to use the pedometer, 
mobile phone, and WhatsApp.  
 
To use the study materials 
in a pilot study to assess the 
clarity and acceptability of 
the study materials. 
Attendees: Chief Investigator, 
Academic Supervisors (n=2) 
and PhD students (n=2) from 
the Lincolnshire Institute for 
Health. 
 
The pedometers and mobile phones were pilot 
tested by colleagues within the LIH (Lincoln 
Institute for Health) (n=4). Individuals were 
provided with an early version of the study manual 
and one person volunteered to act as a ‘WhatsApp 
leader’, which involved one person following an 
early version of the WhatsApp guidelines and 
Pilot study group members reported the 
poor functioning of the phone, though 
successfully used the phone to send and 
receive messages on WhatsApp. The 
WhatsApp leader volunteer adhered to the 
WhatsApp guidelines and manual.  
To identify and source 
other mobile phones which 





Table 3:2: Stakeholder discussions to inform intervention development in step 8 
 Methods Results Actions 
Location: The Lincolnshire 
Institute for Health 
Communication: Face to Face 
 
Date: February 2018 
sending daily messages to the group. This strategy 
enabled for the identification of any initial teething 
problems of the intervention strategies and 
intervention devices. 
 
Attendees: Chief Investigator, 
Academic Supervisor and 
group members of a 
Pulmonary Rehabilitation 




Communication: Face to face 
 
Date: February 2018 
The pedometer and mobile phones were pilot tested 
by a patient follow on group within Lincolnshire 
(n=4). Individuals’ were provided with an early 
version of the study manual, and one person 
volunteered to act as a ‘WhatsApp leader’, which 
involved following an early version of the 
WhatsApp guidelines, and sending daily messages 
to the group. This strategy enabled for the 
identification of any initial teething problems of the 
intervention strategies and intervention devices. 
 
Patients from the follow-on group were 
disappointed by the slow functioning of 
the phone, the short battery life (<1 day), 
the small screen and keypad and the 
number of updates it requires. 
Communication was limited by these 
barriers and the nominated WhatsApp 
leader volunteer did not adhere to the 
WhatsApp guidelines; however, this was 
attributed to the mobile device rather than 
the WhatsApp guidelines.  
 
To identify and source 
other mobile phones which 
are considered more user 
friendly. 
Attendees: Chief Investigator, 
Academic Supervisor and 
group members of a 
Pulmonary Rehabilitation 




Communication: Face to face 
 
Date: April 2018 
The Chief Investigator sourced Nokia 1 mobile 
phones (Appendix F). Individuals from the follow-
on group agreed to trial these devices and report 
their experiences.   
Individuals from the follow-on group 
considered the Nokia 1 more user-friendly 
and an acceptable device to provide to 
potential participants.  
It was agreed that the 
device would be used in the 







3.4.1 Stage 1 
PA was identified as the behaviour to target within this intervention. PA is important for the 
health and well-being of people with COPD following PR, and research suggests that 
individuals do not maintain PA after PR.109 Daily steps was chosen as the specific target 
behaviour.  
The behavioural diagnosis concluded that psychological capability, reflective 
motivation, automatic motivation, physical and social opportunity need to change for the 
target behaviour (PA maintenance) to occur (Table 3:3). The only behavioural source that was 
not deemed to require change was physical capability. Both previous literature and 
stakeholder discussions suggested that patients upon completion of PR would be in a position 








Barriers and facilitators to PA following PR in patients with COPD 
Psychological 
capability  
Information during PR is considered as important. Information can positively 
influence individuals’ intentions towards maintaining PA (+)  
Family understanding of the importance of PA affects the family’s attitudes to 
PA (+)     
Reflective 
motivation 
PA is associated with breathlessness, which leads to avoidance of PA (-) (due to 
the belief that they are not able to cope with breathlessness) 
Self-efficacy: exacerbations lead to distress and avoidance of PA (-) (due to the 
belief that they are not able to cope with PA 
However, recognition of improvements through self-monitoring and feedback 
leads individuals to recognise their capabilities and increase motivation for PA 
(+)  
Belief that PA is enjoyable and leads to health benefits (+)  
Information during PR influence intentions towards maintaining PA (+)  
Automatic 
motivation 
PA is associated with breathlessness, which leads to avoidance of PA (-) (due to 
negative emotions associated with breathlessness) 
Exacerbations lead to distress and avoidance of PA (-) (due to negative emotions 
associated with breathlessness)  
Establishing a routine after PR (+) and maintaining habits after PR (+) are 
important in the maintenance of PA 
Physical 
opportunity  
PA venue is important, e.g. access to a variety of structured maintenance 
sessions after PR (+)   




Hospital based programmes regarded as safe/supportive as they are associated 
with the health care system (+)   
Support and understanding from HCPs is important e.g. HCPs provide a sense of 
security/comfort (+)  
Maintenance of support from peers is important, e.g. peers provide a sense of 
solidarity/support following PR (+)  
Seeing other people with COPD can be reminder of the disease progression 
which is uncomfortable and can lead to avoidance of others in social situations  
(-)  
Social isolation is barrier to managing negative emotions (-)  
Home responsibilities; caring for partner limits PA opportunities (-)  
Negative pressure from family leads to avoidance of PA (-) 





3.4.2 Stage 2 
Based on the COM-B components that required targeting, all nine intervention functions 
were available for selection. However, only four intervention functions were considered 
acceptable and likely to serve the intervention, including education, environmental 
restructuring, enablement, and persuasion. Incentivisation, coercion and restriction were 
excluded as they were not considered suitable functions (i.e. did not meet APEASE criteria) 
for this intervention, e.g. there was uncertainty about the equity of incentivisation and its 
effectiveness for modifying PA in a COPD population.  
Based on the intervention functions selected, all seven policy categories were 
available for selection. However, only four policy categories were selected to implement 
these intervention functions and considered acceptable, including guidelines, service 
provision, communication, and environmental/social planning. The other four policy 
categories were excluded as they were not considered to meet the APEASE criteria, e.g. 
fiscal measures and legislation would not be possible, or appropriate, to use in this context.  
3.4.3 Stage 3 
Based on the four chosen intervention functions in step 5 (education, environment 
restructuring, enablement and persuasion), there were a total of 25 listed BCTs which were 
reported as frequently used, and a total of 63 BCTs reported as less frequently used BCTs. Of 
these BCTs, 13 were considered appropriate to stakeholders and selected to be included in the 
intervention (Table 3:4). These included social support (unspecified 3.1, practical 3.2, 
emotional 3.3), instruction on how to perform a behaviour 4.1, behavioural practice/rehearsal 
8.1, self-monitoring of behaviour 2.3, credible source 9.1, written persuasion about 
capabilities 15.1, focus on past successes 15.3, prompts and cues 7.1, restructuring the social 




excluded as they were not considered to meet the APEASE criteria. For example, goal 
setting: behaviour (1.1) and graded tasks (8.7) were not considered acceptable to stakeholders 
due to health and safety concerns i.e. the chance of patients over-exerting themselves and not 
having a HCP nearby.  
Based on the existing literature, stakeholder discussions and APEASE criteria, 
potential intervention components to utilise the selected BCTs included adding patients to a 
WhatsApp group populated by fellow PR graduates and a ‘WhatsApp leader’ (a volunteer 
from a patient support group), providing patients with a pedometer and, finally, providing 
patients with a step diary for 52 weeks following PR. Stakeholders considered 52 weeks as an 
appropriate intervention duration, as it was able to target long-term behaviour change and 
provide support to a population who suffer exacerbations and whose symptoms are likely to 
vary.1,31,52  
Stakeholders agreed that the intervention should be introduced to groups of patients, 
face to face, during PR. Stakeholders agreed that patients would benefit from the support of 
the research team and HCPs within in a familiar setting. This would also enable patients to 
meet the WhatsApp leader and to practice communicating with their peers (other COPD 
patients) via WhatsApp.  
Following PR, the WhatsApp leader would deliver WhatsApp messages via the 
internet to groups of individuals. The WhatsApp leader was considered a suitable person to 
deliver messages to the WhatsApp group, as they have experiences living with, or with 
someone, with COPD and therefore understand both the facilitators and barriers to PA.   
Social networking was considered an appropriate intervention strategy, as patients 
valued social support but were restricted by barriers such as transport and cost that limited 




these barriers. An outline of the final intervention, including the implementation of each BCT 




Table 3:4: Selection of behavioural sources, intervention functions, policy categories, BCTs, intervention strategies and mode of delivery for the intervention developed to 
promote PA following PR in COPD  
Behaviour source targeted 
in the intervention  
Intervention 
functions  
Policy category BCTs Intervention strategy  Mode of delivery 
Psychological capability  
 
(patients report they are 
not aware of PA 
opportunities) 
 
Education Service provision 
Guidelines  
Communication  
3.1 Social support 
(unspecified)/ 
4.1 Instruction on how 
to perform a behaviour/ 
behavioural practice 
  
WhatsApp messages provide 
information about local PA 
opportunities which provide support   
Distance. Group/Individual 
level (messages sent to the 
group, but individuals have 
the option to reply and 
receive tailored messages). 




(patients do not believe 
they are making progress 
after PR/do not believe 
they are capable)  
 
Education  Service provision  
Guidelines  
2.3 Self-monitoring of 
behaviour. 
Pedometer allows individuals to 
recognise potential progress in their 
PA following PR 
Distance. Individuals’ to be 
provided with the pedometer 
at the beginning of the 
intervention only 
 Education  Service provision 
Guidelines  
 
2.3 Self-monitoring of 
behaviour 
Daily diary of PA (step count from 
the pedometer educates/inform 
individuals about their PA 
capabilities) 
 
Distance. Individuals’ to be 
provided with the step diary 





Table 3:4: Selection of behavioural sources, intervention functions, policy categories, BCTs, intervention strategies and mode of delivery for the intervention developed to 
promote PA following PR in COPD  
Behaviour source targeted 
in the intervention  
Intervention 
functions  
Policy category BCTs Intervention strategy  Mode of delivery 
 Persuasion  
 






2.3 Self-monitoring of 
behaviour 
 
3.1. Credible source 
 
15.1 Written persuasion 
about capabilities 
 
15.3 Focus on past 
successes  
WhatsApp messages encourage 
group members to reflect on their 
step counts/activities. 
 
WhatsApp leader represents credible 
sources as they have completed PR 
and successfully maintained their 
physical activities.  
 
WhatsApp messages ask to list the 
previous performances of the 
behaviour  
Distance. See the first row 




Automatic motivation  
 
(Patients reported 
challenges of forming  












7.1 Prompts and cues  WhatsApp messages encouraging 
group members to form habits 
Distance. See the first row 








7.1 Prompts/cues  Pedometer and step diary provide 
reminders for the participants to be 
active 
  
Distance. Individuals’ to be 
provided with the pedometer 
and step diary at the 





Table 3:4: Selection of behavioural sources, intervention functions, policy categories, BCTs, intervention strategies and mode of delivery for the intervention developed to 
promote PA following PR in COPD  
Behaviour source targeted 
in the intervention  
Intervention 
functions  
Policy category BCTs Intervention strategy  Mode of delivery 
Social opportunity  
 
(Individuals feel self-
conscious being active by 
themselves. Some reported 
that they appreciate 
communicating with peers 
(as they can positively 
influence the way they 













planning   











12.2 Restructuring the 
social environment 
 
WhatsApp messages advise group 
members to seek company for PA. 
  
WhatsApp messages advise group 
members to seek company if they are 
worried/struggling to motivate 
themselves to engage in PA. 
 
WhatsApp group enables individuals 
to contact each other. This facilitates 
group support and removes 
distance/travel/social isolation 
barrier.  
Distance. See the first row 
for further detail.  
 
 Persuasion  Service provision 
Guidelines  
Communication 
10.4 Social reward/2.2 
feedback on behaviour 
WhatsApp messages to congratulate 
group members if PA effort/progress 
has been made.  
Distance. See the first row 
for further detail.  
 
Physical opportunity  
 
Time and location 
influence PA choice, 
affecting behaviour. 
Education  Service provision 
Guidelines  
Communication 
3.1 Social support 
(unspecified)/ 
4.1 Instruction on how 
to perform a behaviour/ 
behavioural practice 
 
WhatsApp messages provide 
information about local PA 
opportunities which provide support   
Distance. See the first row 





Table 3:5: Implementation of each BCT adopted within the developed intervention 
Intervention 
component  
BCT  Further description of BCT implementation (with mode of delivery) 
Addition of 
patients to a 
WhatsApp 
group 
Adding objects to the 
environment (12.5) 
Participants were provided with a mobile phone (Nokia 1) that had the Social Networking application ‘WhatsApp’. 
Restructuring the social 
environment (12.2) 
Participants were added to a WhatsApp chat, which was populated by other members of the PR they were enrolled on 
(only patients who enrolled onto the study) and a volunteer from a COPD patient support group (e.g. Breathe Easy). The 
WhatsApp group enabled individuals to contact each other, which facilitated group support and removed barriers caused 
by distance, travel and social isolation.  
 
Credible source (9.1) The volunteer was labelled as a ‘WhatsApp leader’. As the WhatsApp leader has successfully completed PR and 
maintained their physical activities, they may therefore be regarded as a credible source for participants. 
 
Feedback on behaviour 
(2.2) 
WhatsApp message are sent to WhatsApp group members to congratulate them if PA effort or progress has been made, 
for example ‘Congratulations on maintaining your step count (since… yesterday/last week/since you finished PR)’. 
Social Support, 
unspecified, practical 
and emotional (3.1; 3,2; 
3.3) 
and Instruction on how 
to perform a behaviour 
(4.1) 
Throughout the intervention, the WhatsApp leader followed a series of guidelines and checklists which outlined a 
minimum number of messages to send to the group every week, for example including information about: PA 
opportunities available to group members activities participants could complete at home; social support; health and 
relevant contacts; and also encouragement for participants to monitor their activity levels and to seek social support if 
needed (Appendix K, p333) for the guidelines and checklists). Throughout the 52-week period, WhatsApp leaders were 
asked to send a minimum of one weekly PA summary to the group, which included information about PA opportunities. 
Examples of these messages include: ‘it might help to meet up with other people in this WhatsApp group so that you can 
support each other to be active. Please let other group members know if you would be interested in meeting up and being 
active together’ (3.2) and ‘Friends, family, neighbours, colleagues etc. may provide you with emotional support/support 
if you are struggling to be active. Share your plans to be active with them so that they can support you.’ (3.3). The 
WhatsApp guidelines and Checklists provided information about the content and frequency of messages to send to the 
WhatsApp group (Appendix K, p333). 
Prompts/cues (7.1): WhatsApp leaders regularly sent participants messages to remind them of the importance of PA and encouraged 
participants to form habits and routine, for example ‘Some people find it easier to be active by sticking to a schedule. 
Try and do your daily activities every day at the same time (for example at 1pm).’ 
Social reward (10.4) WhatsApp messages were sent to congratulate group members if they reported being active, for example 
‘Congratulations of achieving a higher step count (than… yesterday/last week/since you finished PR).’  
Written persuasion 
about capabilities (15.1) 
WhatsApp messages were sent to ask participants to list their performances of previous PA, for example ‘Has anyone 











Adding objects to the 
environment (12.5) 
Participants were provided with a pedometer (Yamax CW700/701). This was a small device that attached to 
participants’ waist belts. It provided information/instant feedback regarding the number of steps that participants had 
done on that specific day. Daily step counts refreshed at midnight every day. Participants were asked to wear the 
pedometer every day, to put on when they wake up and to take off before bed. 




with a step 
diary  
 
Adding objects to the 
environment (12.5) 
Participants were provided with a paper step diary. This was a paper diary which had three columns (day of the 




Using the step diary, participants were asked to monitor and record their steps each day and to write any comments to 
explain their step count (e.g. ‘feeling motivated’, ‘tired’, ‘bad weather’ etc). 





3.5.1 Main findings 
This chapter described the development of an intervention to promote PA following PR in 
COPD. This included provision of a pedometer and step diary, and the addition of patients to 
a WhatsApp group populated by fellow PR graduates and a ‘WhatsApp leader’ for a duration 
of 52 weeks following PR.  
3.5.2 Comparison to previous literature  
Previous interventions to promote PA for people with COPD have utilised some of the 
intervention components adopted within this study and thus reflect the BCTs within this 
intervention. For example, pedometers and/or step diaries (adding objects to the environment 
12.5; Self-monitoring of behaviour 2.3) have been provided to COPD patients to increase 
their steps82,244,225 and patients have also been encouraged to use social media for social 
support (social support: unspecified 3.1; practical 3.2; emotional 3.3).246 However, many of 
those interventions were not specifically targeting long-term PA following PR (limited to 
three months post-PR).86,246 Therefore those interventions did not target the long-term 
facilitators and barriers of PA after PR, such as long-term social support and patient self-
efficacy241, which the developed intervention aims to address.  
Stakeholders considered WhatsApp as more appropriate than COPD web-based 
applications utilised in other interventions244,236 due to it being more accessible and familiar 
to patients and/or their friends and relatives, and it is an application which has been 
implemented in other interventions with a similar aim to help support health behaviour 
change.187,248 Use of WhatsApp as an intervention component addresses calls of previous 
research to explore the use of instant messaging as a strategy to facilitate long-term PA 




3.5.3 Strengths and limitations 
A clear strength of this study is the systematic development of an intervention which was 
based on a theoretical framework, a systematic review of the literature241 and stakeholder 
engagement. Intervention development was based on stakeholders within Lincolnshire and 
therefore it could be argued that the intervention may be context-specific, and not be as 
applicable to other areas. However, the prioritisation of patient and public involvement (PPI) 
enabled the research team to focus on the priorities of various COPD patient groups across 
Lincolnshire, thus considering the views of many individuals across different settings. 
Various meetings with stakeholders enabled further exploration of key issues such as the 
selection of acceptable pedometers, mobile handsets, WhatsApp, and WhatsApp guidelines. 
As reported in previous research242, application of the BCW was time consuming. However, 
it resulted in the selection of intervention components that were informed by usability tests as 
well as previous literature.252,91   
Whilst the BCW has been applied to the development and evaluation of interventions 
including modifying PA behaviour in COPD165,175, it has limited application in the 
development of interventions to promote PA following PR.176 Relatively few interventions 
have referred to theory92,90 and explicitly referred to the development of the intervention 
based on a behaviour change framework.253 There was therefore a need to utilise the BCW in 
the systematic development of this intervention.  
Understanding that it is not possible to design a ‘one-size fits all’ intervention 254, the 
intervention was multi-component, and thus incorporated many BCTs. The decision to 
implement the intervention for 52 weeks (long-term) enabled the research team to target 
long-term behaviour change for a population that may see a seasonal change in risk of 




3.5.4 Conclusion  
The BCW enabled a systematic and comprehensive development of a novel, multicomponent 
intervention to promote PA following PR in patients with COPD in an NHS PR service, 
facilitated by stakeholder involvement. The next steps are to conduct a feasibility study to 
assess acceptability and experiences of the intervention to a larger group of COPD patients 





4 Chapter 4: Methodology and general methods  
The development of the intervention adheres to the stages outlined in the Medical Research 
Council (MRC) framework: development, feasibility and piloting, evaluation and 
implementation.159 Chapter 3 reported the theoretically guided process of the development of 
this intervention. However, there are still unanswered questions regarding the intervention 
which need to be addressed prior to a full-scale definitive trial. The following steps in the 
MRC framework, the feasibility and piloting and evaluation, are the mechanisms in which to 
answer these questions, and these are reported in this chapter. Assessing the feasibility is a 
vital step in the development of a complex intervention and enables researchers to test the 
acceptability of an intervention, research procedures and the estimation of recruitment and 
attrition rates within a study.255 The outcome of this feasibility study informs the next step in 
the development of this complex intervention, and whether there is the need for further 
studies to refine this intervention design prior to its implementation.  
Both qualitative and quantitative methods are considered appropriate methods to 
address the overarching aim of the study and to address the uncertainties surrounding the 
acceptability of the intervention and research procedures. This chapter addresses the rationale 
for the methods chosen to test this intervention, and describes the methods used in the 
remainder of this thesis.  
4.1 Methodology 
4.1.1 Research design 
This intervention was tested in a mixed methods feasibility cluster randomised controlled trial 
(CRCT) with an embedded qualitative process evaluation, illustrated in Figure 4:2, Figure 




strengths and limitations of the available approaches, which are described in the following 
text.  
4.1.2 Quantitative and Qualitative approaches 
Qualitative and quantitative research methods have their unique strengths and limitations. 
Strengths of quantitative research include the ability to identify the relationships between 
variables, to control for confounding variables, the ability to replicate experimental trials and 
collect data that is generalisable.256 Quantitative research only has limited capacity to provide 
insight into participants experiences, for example those relating to the quality of their health 
care.257  
Qualitative research enables the researcher to gain insight into of how participants 
experience a phenomenon, as well as the meanings and interpretations participants attach to a 
phenomenon.258 Procedures within qualitative research are generally more flexible and 
responsive to the research participants.259 However, a limitation of qualitative research can be 
the time-consuming nature of data collection and analysis260 and the inability to objectively 
measure the relationship between variables. In this case, a solely qualitative study would not 
enable this thesis to measure the likely impact of the intervention on clinical outcomes such 
as PA.  
4.1.3 Mixed Method Research  
Mixed method research involves using both quantitative and qualitative approaches in the 
collection, analysis and integration of data to answer a research question within a single or 
longitudinal study.256  
4.1.3.1 Strengths and limitations of mixed methods research 
In principle, mixed method research is able to draw on the strengths of both qualitative and 
quantitative research and has the flexibility to use both methods in a creative and 




growing popularity reflects the increasing recognition of its benefits.264 Mixed methods is 
considered particularly powerful when addressing health service interventions and 
management of chronic conditions265–252 and there has been a growing interest in mixed 
method research in health research settings.265 Mixed method research has been used to gather 
insight into health care services and self-management for individuals with COPD268,254 and to 
test the feasibility and acceptability of health interventions.221–257 Mixed method research is 
supported by the MRC159 and use of qualitative and quantitative methods are often applied 
within process evaluations of complex interventions within RCTs and field observations are 
increasingly recognised as methods to understand patients’ experiences of trials, in attempt to 
understand health problems.272   
Insight into the intervention  
A mixed method design enables triangulation, complementarity, initiation, and expansion in 
this thesis. Objective quantitative measures enable an understanding of the likely effects of 
the intervention on PA and other health outcomes and qualitative measures can help gain an 
understanding into the reasons for PA patterns following PR but also participants experience 
following PR. In this thesis, it was important that the qualitative data could illustrate the 
quantitative findings and contribute to understanding the context and potential mechanisms of 
impact of the intervention. But it was also important that the qualitative methods could 
potentially challenge the quantitative results and offer possible explanations for any 
unexpected results. In this study, qualitative methods included interviews and focus groups, 
which aim to understand the views and experiences of various individuals (patients, HCPs 
and WhatsApp volunteers). As there were various components of the intervention, including 
provision of a pedometer, step diary and inclusion in a WhatsApp group (see Chapter 3 for a 
detailed description of these intervention components), it was particularly important to 




acceptable. As this was a feasibility study, a key aim was for the qualitative data to provide 
insight into the acceptability of the intervention and research procedures (such as participant 
recruitment and timings of the follow ups). Qualitative methods have the potential to offer 
multiple perspectives on the acceptability of the intervention273,274, thus potentially increasing 
the credibility and depth of the overarching study conclusions.  
Theoretical viewpoint  
Despite growing popularity, mixed method research has also been met with criticism. For 
example, it has been argued of there being theoretical hurdles to mixing paradigms associated 
with qualitative and quantitative research, due to the assumption that the two research 
methodologies are too separate in their underlying epistemology, meaning that they cannot be 
combined.275 However, this claim is based on arguments rooted in ontology and 
epistemology, including individuals’ perceptions of reality and their approach to 
understanding reality. This is traditionally an argument from a Constructivist and/or 
Positivist/Postpositivist viewpoint.  
Positivists believe that there is a single reality and therefore believe that reality can be 
measured with reliable and valid tools. Postpositivism stems from the positivism paradigm, 
though Postpositivists recognise that outcomes are a result of a complex interaction between 
various factors.276 Positivists and Postpositivists may likely adopt quantitative designs such 
as experimental designs and surveys to answer a research question. At the other end of the 
spectrum, Constructivist and Interpretivists believe that there is no single reality and that it is 
created by individuals in groups and therefore reality can only be interpreted by identifying 
individuals’ underlying meaning of the situations in question.  
The research contributing to this thesis was based on a pragmatic approach, with the 
assumption that reality is ‘constantly renegotiated, debated, interpreted in light of its 




method and design suited to answering a research question, and therefore refutes the 
assumption that qualitative and quantitative methods should not be combined. Pragmatism is 
less concerned about the questions relating to reality and instead focused on the practicalities 
involved in answering a research question.278,279 
Quality of Mixed Methods integration 
A commonly reported weakness of mixed method research is poor understanding and limited 
evidence of integrating quantitative and qualitative data.280 Integration of qualitative and 
quantitative data is an increasingly important criterion for mixed method research281, yet 
there are claims of low-quality data integration282 and lack of clarity in the rationale of 
collecting both qualitative and quantitative data. This may be attributed to mixed method 
research being a relatively new approach.262 There has been a surge of research using a mixed 
methods approach, yet there has been limited instruction in the integration of data. The 
development of clear, credible guidelines of systematic methods for conducting mixed 
method research has only been a relatively recent occurrence.272 To avoid low quality data 
integration, this mixed methods study was informed by recent mixed methods guidelines and 
recommendations.272,283  
Competence in using Mixed Methods 
Another reported pitfall in mixed method research is the lack of experience and expertise in 
conducting both quantitative and qualitative research methods. Mixed method designs can be 
a challenging and time-consuming approach, as it relies on conducting, analysing and 
integrating data from both qualitative and quantitative methods.265 The integration of the 
qualitative and quantitative data are reported in Chapter 6.  
4.1.3.2 Priority of qualitative and quantitative data  
Both qualitative and quantitative data were collected during the trial, as illustrated in Figure 




may suggest that priority was given to the quantitative data. However, as the aim of this study 
was to test the feasibility of a CRCT, equal priority was given to the qualitative and 
quantitative data. The qualitative data collected during the trial aimed to provide rich and 
valuable insight into participants’ perceived acceptability of the intervention and research 
procedures. Insight from patients, HCPs and WhatsApp leaders therefore contributed to 
understanding the feasibility of the trial. Equal priority to both quantitative and qualitative 
research is less common than prioritising either qualitative or quantitative research, but is 
justified when both methods are afforded equal status in answering the research question.270–
288  
4.1.3.3 Sequence of qualitative and quantitative data collection 
Qualitative and quantitative data were collected concurrently during the trial. To an extent, 
quantitative feasibility data, including consent and attrition rates, informed the selection and 
timing of the qualitative data collection. Qualitative interviews at the beginning of the trial 
aimed to understand and explore patients’ reasons for declining participation in the 
intervention. Interviews with participants who withdrew from the intervention were based on 
patient attrition rates and therefore were not planned. Interviews with those that adhered to 
the intervention were conducted after a minimum of 12 weeks of engagement in the 
intervention (inclusion in the first follow up). Other qualitative data, including focus groups 
with HCPs and WhatsApp leaders, occurred during the delivery of the intervention. Focus 
groups were conducted towards the end of the trial and enabled a reflection on the strengths 
and limitations of the intervention and research procedures. Qualitative research to address 
problems which potentially undermine the acceptability and delivery of an intervention 
and/or research procedures is a recognised strength of qualitative research within feasibility 




4.1.3.4 Integration of qualitative and quantitative data  
Reporting of the quantitative data and qualitative data were initially reported and analysed 
separately, through a contiguous approach.283 Chapter 5 first reports the quantitative 
outcomes (5.3, 5.5) of the feasibility study, followed by the qualitative outcomes. The results 
are then integrated to further explore patterns based on patients’ engagement in the 
intervention. The integration of the data included writing both qualitative and quantitative 
findings together on a theme-by-theme basis (Chapter 6).283  
4.1.4 Summary 
The previous section (4.1) outlined the methodology of the feasibility RCT with a qualitative 
embedded process evaluation and reported the rationale for the adoption of mixed methods. 
In summary, a mixed methods approach was chosen as an appropriate method to address the 
overarching aim of the thesis and identify the acceptability and feasibility of an intervention 
to promote PA following PR in patients with COPD. 
4.2 General methods 
The following text reports the general methods adopted in this study, starting with ethical 
approval (4.2.1), study setting (4.2.2), and clusters (4.2.4.1). Following this text, this section 
describes the research procedures included in the feasibility CRCT, outlined in Error! 
Reference source not found.- Figure 4:4, including the recruitment (4.2.4), consent (4.2.5), 
and quantitative and qualitative outcome measures adopted in this study (including HCPs, 
patients and patient volunteers) (4.4, 4.5). Error! Reference source not found. also 
illustrates the study arms which patient clusters were allocated, including the intervention 
group (IG) and control group (CG), but also the study procedures and timings of the patient 
follow ups (4.5.4). Description of the methods employed in this mixed methods study is 
separated into various sections, including a description of the methods employed in the 




data (4.5). Figure 4:6 illustrates how outcomes collected during this study provided insight 
into the context, implementation, mechanisms of impact and clinical outcomes of the 
intervention tested within this CRCT.160  
Reporting of the feasibility CRCT adhered to the Consolidated Standards of 
Reporting Trials (CONSORT) guidance for cluster trials and the extension for pilot and 
feasibility trials.290,291,292 Reporting of the qualitative research adhered to the Consolidated 
criteria for reporting qualitative research, a checklist guiding the explicit and comprehensive 
reporting of qualitative research.201  
4.2.1 Ethical approval  
Ethical approval for this study was obtained from South Central- Oxford B Research Ethics 
Committee and the Health Research Authority in May 2018. This study was also registered 
on ClinicalTrials.gov, NCT03660644.   
4.2.2 Study setting  
The setting for this study was LCHS NHS trust. The Countywide Respiratory service delivers 
PR for LCHS across the four regions of Lincolnshire including North West Lincolnshire 
(number 1), North East Lincolnshire (number 2), South West Lincolnshire (number 3) and 





Figure 4:1.  
All patients received PR. Within Lincolnshire, PR is delivered as a community 




a mixture of community halls and community hospital settings dependent on the region. PR 
programmes across Lincolnshire lasted for 8 weeks, divided in 2 x 2-hour sessions per week, 
resulting in a total of 16 sessions. PR programmes included group education and exercise 
classes. Each course delivered fifteen education sessions, which lasted one hour and included 
topics: introduction to rehab; benefits of exercise; how the lungs work; breathlessness; 
inhalers and devices; medications; inhalers, devices and oxygen; managing exacerbation; 
chest clearance; coping strategies; energy conservation/relaxation; planning for the future; 
nutrition; and finally, the open forum to discuss self-management after PR. Each course 
delivered sixteen exercise sessions which also lasted one hour and included activities which 
required minimal equipment so that these could be performed at home during and following 
PR. These exercises included get up and go; wall press; steps up; bent arm lateral raises; 
cross and reach; bicep curls and walking. PR included pre and post assessments on health-





























4.2.3 Clusters  
PR programmes were the unit of randomisation, and thus, patients followed the care 
pathways to which the programme (cluster) was randomised, Error! Reference source not 
found.. PR programmes (clusters) were randomly allocated to the Intervention or Control 
Group. Cluster randomisation was considered an appropriate method due to the nature of the 
intervention. For example, one component of the intervention was based on group 
involvement with fellow PR graduates. It was therefore not logical to randomise patients 
individually. Cluster randomisation was also used because it minimises treatment 
“contamination” between intervention and control patients.293 For example, groups of 
individuals were allocated to a specific programme, and they were in the same group for the 
duration of the programme. If individuals were aware of any differential treatment between 
each other within PR, contamination effects may have occurred. For example, individuals in 
the control condition might have adopted intervention strategies themselves or simply be 
affected by their awareness of the intervention.    
PR programmes were considered as eligible clusters if they were based within LCHS 
(NHS trust) and permission was provided from the lead HCPs of the PR programme to be 
involved in the study. PR programmes were not considered as eligible clusters if they were 
not within LCHS (NHS trust) and if the lead HCPs of the PR programmes were unwilling for 






Clusters (PR programmes) were screened by HCPs involved in PR to identify eligible 
participants. It was necessary to recruit from programmes with a minimum of two patients 
with COPD.  
4.2.4.2 Patients  
Prior to the start of the study, the research team contacted HCPs within LCHS who were 
involved in the delivery of PR, to provide patients information about the study. At least four 
weeks prior to discharge from PR (i.e. during the programme), HCPs provided eligible 
patients, within the allocated clusters, verbal and written information about the study, which 
included a brief script read by the HCPs prior to the research team attending PR, (Appendix 
E, p297) and a patient information sheet which outlined the aims and content of the study 
(including collection of data outcomes and telephone interviews). Patients then had at least 
one week to consider study involvement prior to being approached by the research team. The 
following week, the research team attended PR and individually asked eligible patients 
whether they had any questions about the study and/or whether they wanted to participate in 
the study.  
4.2.4.3 Health care professionals 
During the delivery of PR to patients in the intervention groups, at least three weeks prior to 
patients being discharged from PR, HCPs were invited to take part in a focus group (planned 
towards the final stages of intervention delivery). Verbal and written information about the 
study were provided, including an information sheet which outlined the aims and content of 
the study. HCPs then had at least one week to consider study involvement prior to providing 




4.2.4.4 WhatsApp leaders (patient volunteers) 
The Chief Investigator contacted COPD patient support groups to identify individuals who 
were interested in volunteering in this study. This included face to face visits and/or email 
contact with COPD patient groups based in Lincolnshire and surrounding areas (e.g. 
Sheffield, Nottingham, and Leicestershire). Email contact with some groups was facilitated 
by the British Lung Foundation (BLF). BLF advertised the aims of the study and provided the 
research team’s contact details for interested individuals to inquire about getting involved as 
a ‘WhatsApp leader’ in the study. When attending COPD patient support groups, the 
recruiting investigator explained the details of the study and individuals who raised interest in 
volunteering within the study were provided with the participant information sheet, ensuring 
that the individuals had enough time to consider participating or not. Opportunity was given 
to individuals to ask any questions they may have had concerning study participation. 
4.2.5 Consent  
Verbal and written informed consent were sought from all participants at the point of 
recruitment into the feasibility CRCT (including patients, HCPs and WhatsApp volunteers) 
(Error! Reference source not found. - Figure 4:4). Verbal consent was also verified prior 
to interviews and focus groups with all participants. In all cases, the research team collected 
consent from all participants.  
4.2.6 Population 
4.2.6.1 Patients 
Inclusion criteria: Patients within the clusters were considered as eligible if they were adults 
(age range: 30-100 years) with COPD294; were enrolled in PR within LCHS (NHS trust) and 
if they provided informed consent for their outcome data to be collected. 
Exclusion criteria: Patients within the clusters were not considered eligible if they were: not 




dropped out of PR following enrolment; were unable/unwilling to provide informed consent 
for their outcome data to be collected; and were involved in another study including the use 
of an intervention to promote PA. 
4.2.6.2 Patients (interviews) 
Inclusion criteria: Patients who participated or declined to participate in the feasibility CRCT; 
patients who provided informed consent to participate in a telephone or face to face 
interview.  
Exclusion criteria: Patients who were not approached to participate in the feasibility CRCT 
patients who are unable/unwilling to provide informed consent to participate in telephone or 
face to face interview.  
4.2.6.3 Health care professionals  
Inclusion criteria: HCPs who were involved in delivering the PR programmes allocated to the 
Intervention Group within LCHS (NHS trust) and those who were willing/able to provide 
informed consent to participate in a focus group. 
Exclusion criteria: HCPs who were not involved in delivering the PR programmes allocated 
to the Intervention Group within s (NHS trust) and/or those who were unable/unwilling to 
provide informed consent to participate in a focus group. 
4.2.6.4 WhatsApp leaders 
Inclusion criteria: Volunteers (who were members of local COPD support groups, whom held 
the position of Chair, Treasurer or Secretary, or were ordinary members, and in general, 
sufficiently stable to be a proactive and regular member of the group) and provided informed 
consent to lead the WhatsApp groups and participate in a focus group. 
Exclusion criteria: Not volunteers (and have not been involved in local COPD support 
groups, have not held the position of Chair, Treasurer or Secretary, have not been ordinary 




the group) and/or were unable/unwilling to provide informed consent to lead the WhatsApp 
groups and participate in a focus group. 
4.2.7 Randomisation and blinding 
PR programmes (clusters) were randomised (1:1) via a web based randomised system295 
according to a computer-generated random sequence, stratified by programme location 
(North West, North East, South East, and South West). Eligible programmes were informed 
by a researcher of their allocation verbally and in writing via email. The researcher was 
blinded to the randomisation sequence with allocations only made available one at a time. 
Patients were not directly informed that there was an alternative group (intervention or 
control) being studied.   
4.2.8 Sample size 
4.2.8.1 Clusters and patients 
Prior to patient recruitment, based on patient flow through PR service (LCHS) and data from 
previous research studies by the research team, 12 clusters (n= 6 per arm) were believed to 
provide a minimum of 30 patients in each arm. 30 patients in each arm was considered a 
sufficient number to meet the study objectives.296   
4.2.8.2 Patient interviews 
Interviews were conducted with up to 30 patients and sought to understand (at the relevant 
intervals) the views of subsets of patients in the intervention group, and included those who: 
refused to participate in the study; agreed to participate but withdrew; and agreed to 
participate and completed the study. Interview participants were purposefully sampled to 





4.2.8.3 Health care professionals  
Focus groups were conducted with a maximum of 10 HCPs who were involved in delivering 
PR to patients enrolled in the research study. Efforts were taken to ensure variation by 
recruiting HCPs who were involved in the delivery of the intervention to different clusters, 
i.e. different regions of Lincolnshire.297    
4.2.8.4 WhatsApp leaders 
A minimum of six volunteers were required to act as WhatsApp leaders throughout the study 
(one volunteer for each cluster allocation to the intervention group). However, due to the long 
intervention period of 52 weeks, ten volunteers were recruited, controlling for any potential 
withdrawals during the study. All WhatsApp leaders involved in the delivery of the 
intervention to participants were invited to participate in a focus group, ensuring variation 
across clusters.  
4.2.9 Interventions 
4.2.9.1 Intervention 
Clusters allocated to the intervention group received the intervention in addition to PR. The 
intervention was multi-component and aimed to increase individuals’ motivation to engage in 
PA upon completion of PR, including 1) inclusion in a WhatsApp group; 2) provision of a 
pedometer and 3) provision of a daily step diary (Appendix I, p309, for pictures of each 
intervention component). The development and underlying theory for this intervention has 
been previously described (Chapter 3).  
PR in the intervention clusters had an additional education session, 16 in total. Figure 
4:5 illustrates the study familiarity procedures for the intervention components. The research 
team and WhatsApp leader attended PR and introduced the intervention in the additional 
educational session on the 6th week (two weeks before the end of PR) (see Appendix F, p299, 




research team included the Chief Investigator (PhD student) and their Academic Supervisor 
from the University of Lincoln. The WhatsApp leader was a patient/lay volunteer who 
volunteered to take part in the study. The WhatsApp leader was allocated to ‘lead’ the 
WhatsApp group in their local region (or regions they were most familiar with) and to send 
regular messages to the WhatsApp group over the 52 week intervention period (see the 
WhatsApp guidelines and Checklists for further information on the messages sent by the 
WhatsApp leader, Appendix K). The education talk lasted approximately one-hour and 
participants were provided with the patient intervention manual (Appendix J, p312) and study 
mobile phones. Participants were encouraged to take the phones home with them, and to 
practice using the phones by communicating with peers and the ‘WhatsApp leader’. The 
research team provided participants with pedometers on the 7th week of PR (1 week before 
the end of the programme). Researchers and WhatsApp group leader attended the open forum 
session to allow participants to ask any remaining questions about the intervention. The 
intervention officially started following the final PR session (open forum). Patients were then 
encouraged to begin recording their steps and to communicate via WhatsApp to a level that 
suits them. The WhatsApp leader then began to send regular weekly messages to the 
WhatsApp group. These messages aimed to support patients to maintain PA and included 
information about local activities, social support, encouragement to reflect on step counts; to 
ask about previous performances of PA; to encouragement habit formation and routine and to 
congratulate PA. The intervention lasted 52 weeks and participants were encouraged to 
engage in the intervention to a level that suited them.  The development and underlying 
theory for this intervention has been previously described (Chapter 3).145 Figure 4:6 outlines 
how the intervention components related to the behavioural sources which were targeted 






Figure 4:5: Illustration of the intervention familiarity procedures during pulmonary 
rehabilitation for the intervention group
 
4.2.9.2 Control (usual care)  
Following completion of PR, all patients were discharged and referred to their primary care 
provider with no formal follow-up or support to maintain the benefits of PR.  
4.2.10 WhatsApp leader training 
Prior to starting the intervention, it was necessary to familiarise the patient volunteers with 
the aims and procedures of the intervention. The following text describes the steps taken to 
introduce the intervention and WhatsApp leaders’ role throughout the study (4.2.10.1).  
The Chief Investigator met with the WhatsApp leaders individually for approximately 
1-2 hours to discuss the study procedures and their role in the intervention. However, timing 
was flexible as it was expected that there would be individual differences in the level of 




During these meetings, the Chief Investigator provided volunteers with the study 
phone (Nokia 1) and were given the option of receiving the pedometer (Yamax CW700/701 
model) and step diary that other members of the WhatsApp group were to be provided. The 
WhatsApp leader was also provided with WhatsApp guidelines and checklists (Appendix K, 
p333). The WhatsApp guidelines provided an overview of the research procedures and 
instructions for WhatsApp volunteers. These were informed by previous literature and 
stakeholder discussions193 and were an attempt to provide structure to the delivery of the 
intervention i.e. facilitate the consistent delivery between WhatsApp volunteers.  
4.2.10.1 WhatsApp leader guidelines 
The guidelines included information and instructions to WhatsApp Leaders. For example, 
this included: suggestions that the WhatsApp leaders become familiar with the list of 
example messages; instructions about timings, for example to send a reply to the messages 
from individuals in two time slots; instructions about WhatsApp security, for example to not 
change the security setting on their phone; instructions on WhatsApp behaviour, for example 
to be the role model for the group and to not post offensive statements; information about the 
end of the study i.e. that the research team will collect the mobile phones used in the study, 
and finally, information about contacting the research team, for example to contact the 
research team if the WhatsApp leaders’ encountered any problems during the study. 
There were eight distinct categories of WhatsApp messages, including a total of 74 example 
messages, which were based on the BCTs outlined in the BCTTv1145 (see Chapter 3 for more 
information). Categories included: Active Lincolnshire (n=13); vitality exercise classes 
(n=12); activities at home (n=6); social support (n=8); monitor activity levels (n=14); 





WhatsApp leaders were also provided with a list of the current PA opportunities in the 
local area, (according to their WhatsApp groups location). For example, details about local 
health walks, COPD exercise classes etc.  
4.2.10.2 WhatsApp Checklists  
WhatsApp leaders were also provided with WhatsApp Checklists (Appendix K, p333), which 
provided instructions about specific messages to send to the WhatsApp group on a weekly or 
monthly basis. There were three checklists, including Checklist Week 1, Checklist 1, and 
Checklist 2. 
Checklist Week 1 informed the WhatsApp leader what to send to the WhatsApp 
group on the first week of patient-participant enrolment. These messages included 
introductory statements to familiarise the group with the WhatsApp group and the types of 
messages to be sent to the group, for example ‘Hello and welcome to the WhatsApp group. 
My name is XXX and I am your WhatsApp leader. My role is to motivate you to keep active 
now you have finished PR’ and ‘next week I will start sending you information about the 
local PA opportunities in your area. Make a note of any activities that you would be 
interested in attending’.     
Checklist 1 informed the WhatsApp leader what type of messages to send to the 
WhatsApp group each week, for example to send a message from the category ‘social 
support’ on a Tuesday and to send a message from the category ‘monitor activity levels’ on a 
Wednesday, etc. The message categories listed on Checklist 1 represented different 
Behaviour Change Techniques (BCTs), as discussed in further detail in Chapter 3.  
Checklist 2 was provided to WhatsApp leaders as a blank template, to be filled in when they 
send any additional messages to the WhatsApp group i.e. not outlined in Checklist 1.  




Further face to face meetings were arranged with WhatsApp leaders if they felt they 
required further information or guidance in their role as a WhatsApp leader. Furthermore, 
volunteers were encouraged to contact the research team if they had any questions about their 
role in the study.   
4.3 Quantitative data (procedures) 
The following text describes the quantitative procedures for all patients, which is illustrated 
in Table 4:1. 
4.3.1 Baseline 
As illustrated in Table 4:1, following written consent and at least 3 weeks before the 
intervention began (patient discharge), the Chief Investigator or other member of the research 
team attended PR to collect information about patient demographics. A detailed form was 
used to collect information including patient demographics (age, race, ethnicity, gender), 
body measurements (stature, body mass, Body Mass Index) other comorbid chronic diseases 
(e.g. hypertension, cardiac illness, hypercholesterolemia, and/or stroke), medication use, 
smoking history and number of exacerbations in the previous 12 months. Smoking status was 
validated by measuring exhaled carbon monoxide (MicroCO, CareFusion Ltd.UK) 
(Appendix L, p348).  
Participants were then provided with an accelerometer (Actigraph wGT3X-BT). 
Patients wore the accelerometer on the dominant side of their waist (dependent on them being 
right or left hand sided). Participants were instructed to wear the USB port facing towards the 
ceiling (vertical side), on axis 1= -1G. Participants were instructed to wear the accelerometer 
on a continuous basis (i.e. over 24 hours) for 7 days. At PR, (at the end of the 7-day period), 
the Chief Investigator instructed patients to complete the weekly version of the PROactive 
tool73. As part of standard care, the patient assessment at the end of PR within LCHS 




Anxiety and Depression Scale (HADS)118, the Incremental Shuttle Walk Test (ISWT)115 and 
the Endurance Shuttle Walk Test (ESWT).116 To collect the baseline measures for these 
outcome measures, the responses to these questionnaires and the results from the ISWT and 
ESWT were shared in a pseudonymised form between the LCHS and Lincoln Institute for 
Health.  
4.3.2 Follow up visits (12 and 52 weeks) 
There were a further two study follow ups. The Chief Investigator contacted patients (at 
approximately 10 and 50 weeks after patient discharge from PR) to arrange a convenient 
day/time/location to provide the accelerometer (Actigraph wGT3X-BT). A convenient 
day/time to attend a follow-up visit 7 days after this was also arranged. Patients were asked to 
undergo the same 7-day accelerometer and data collection periods as the baseline timepoint at 
both 12 and 52 weeks. After the 7-day periods at 12 and 52 weeks timepoints, the Chief 
Investigator instructed the patients to complete the CRQ, HADS and the weekly version of 
the PROactive tool. These measures were not collected as part of standard care. The Chief 
Investigator asked patients to return their step diary when attending the 52-week study follow 
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Age; race; ethnicity; gender; body measurements; other comorbid chronic diseases; 
medication use, smoking history; number of exacerbations in the previous 12 months; 
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4.4 Quantitative data (outcome measures) 
4.4.1 Feasibility outcomes 
4.4.1.1 Consent, recruitment, and attrition rates 
The primary outcome of this trial was the number of patients who consented and complied 
with the intervention for 52 weeks. Secondary feasibility outcomes included consent, 
recruitment, and attrition rates.  
Consent rates referred to the number of eligible individuals who received a participant 
information sheet that were willing to consent and participate in the study. Recruitment rates 
referred to the time taken to achieve planned sample size of participants. Withdrawal rates 
referred to the number of individuals who enrolled (signed a consent form) and subsequently 
dropped out of the study prior to the end. These measures enabled the research team to 
measure individuals’ acceptability of study, help inform the time taken for recruitment for a 
definitive trial and provide a measure of compliance in the study.   
Consent, recruitment, and attrition rates were collected for all participants in the 
study, including patients, HCPs, and WhatsApp leaders.  
4.4.1.2 Step diary 
Though the initial aim of the step diary was to promote PA (intervention component), the step 
diary also provided a measure of subjective PA and enabled a verification of the primary 
outcome measure (Actigraph wGT3X-BT). They were also another measure of adherence to 
the intervention.  
4.4.1.3 WhatsApp checklists  
WhatsApp leaders were asked to send copies of WhatsApp checklists to the research team 
every 4 weeks. The WhatsApp checklists enabled the research team to measure the 




4.4.1.4 WhatsApp chat exports 
WhatsApp chat exports provided a copy of the conversation on WhatsApp between group 
members. These exports were beneficial as they enabled a verification of the WhatsApp 
checklists. They were also another measure of fidelity when the WhatsApp checklists were 
not completed. For example, the research team could measure the frequency and content of 
the message types sent to the WhatsApp group. WhatsApp leaders were also instructed to 
export a copy of the conversation on WhatsApp between group members every 4 weeks.  
4.4.2 Clinical outcomes 
4.4.2.1 Physical activity (Actigraph wGT3X-BT) 
The proposed primary outcome for a future definite trial was daily steps. Hence, the primary 
clinical outcome in the feasibility study was average daily steps at 12 months. Daily steps 
was connected to the intervention component (pedometer) and supported by previous 
research which states that steps are a common outcome measure which is readily 
interpretable.53 Daily steps provided an indication of how physically active individuals are. 
Average daily steps at 12 months reflect whether PA has been maintained long-term upon 
completion of PR. Daily steps have been collected in various recent studies which have 
aimed to determine COPD patients’ PA levels.84,252,285  
A wGT3X-BT triaxial accelerometer was used to measure daily steps. This 
Accelerometer has access to raw data and can capture and record continuous, high resolution 
PA information. This wGT3X-BT triaxial accelerometer was chosen as it is the preferred and 
recommended activity monitor model as reported in recent guidelines53 and it has been used 
in previous studies.299,300 The Accelerometer wGT3X-BT has also been validated for use in 
COPD populations.301 Data was sampled in 10 second epochs as research suggests that 
shorter epoch lengths are suited for estimation of sedentary behaviour (SB). Data were 




zero counts, up to two 1-minute epochs of up to 100cpm. The data was considered valid if the 
patients had worn the accelerometer for a minimum of 600 minutes (10 hours) in one day, 
which is supported by recommendations.53 Patients were asked to wear the accelerometer for 
a minimum of seven days which meant that patients had a high chance of accumulating valid 
data. Half days were excluded from the analysis, as the data did not necessarily reflect true 
activity levels of patients. For example, the accelerometer may have recorded data before 
participants started wearing the accelerometer and after the participants returned the 
accelerometer. Guidelines suggest that a minimum of five days of data is a valid interval of 
data.53 However, researchers included all valid days of data from patients, irrelevant of how 
many valid days they achieved throughout the wear time interval. This decision was made 
based on the conclusion that previous literature does not report a weekday/weekend effect in 
this population who are older and less active.53 Placement of the activity monitor on the waist 
enabled accurate assessment of sedentary and postural transitions.53 
Data collected from PR and non-PR days were analysed separately, as it has 
previously been suggested that days where patients completed PR were often higher in PA 
than non-PR days128, and therefore not representative of their usual daily PA. 
4.4.3 Secondary outcomes (clinical) 
4.4.3.1 Activity (Accelerometer wGT3X-BT) 
In addition to average daily steps, the accelerometer was used to record a range of secondary 
outcomes, which included: daily and weekly vector magnitude units; and time spent: 
sedentary behaviour (SB); in light physical activity (LPA); moderate to vigorous physical 
activity (MVPA). PA data (time spent in different PA intensities) was based on METS 
(metabolic equivalent of task). Thresholds were informed by MET thresholds used in 
previous literature302 set as the following: SB (<1.5 metabolic equivalents of task), LPA 




4.4.3.2 PROactive tool (weekly tool) 
This tool was used in conjunction with the accelerometer. A working group of international 
experts developed this patient reported outcome (PRO) tool to measure patients’ experience 
of PA in terms of ‘amount’ and ‘difficulty’. PROactive is a hybrid tool which combines a 
short patient-reported outcome questionnaire with activity monitor variables (daily and 
weekly steps, daily and weekly vector magnitude units) which provides valid and reliable 
measures of PA in COPD patients.73 This tool is useful as it is possible that the accelerometer 
will not completely capture activities of low intensity. Additionally, questionnaires do not 
always accurately measure PA as patients can have errors in recall. The weekly PROactive 
instrument includes 14 items, including the domains ‘amount of physical activity’ and 
‘difficulty with physical activity’, and is quick to administer. Each question is rated on a 
numerical, 5-point modified Likert Scale.  
4.4.3.3 Chronic Respiratory Disease Questionnaire (CRQ-SR) 
This is a self-reported measure of disease specific QoL for people with chronic lung 
disease.117 It is made up of four dimensions relating to dyspnoea (breathlessness), emotional 
function, fatigue, and mastery, with 20 questions in total. Each question is rated on a 
numerical, 7-point modified Likert Scale and a higher score indicates better disease specific 
QoL. This questionnaire has been found to be a reliable measure of health status 
(reproducibility and internal consistency), and valid (content and concurrent validity)117,303 
and is currently used in pre and post PR across LCHS.  
4.4.3.4 Hospital Anxiety and Depression Scale (HADS) 
HADS118 is a widely used instrument to assess symptoms of depression and anxiety in 
patients with COPD, with evidence to suggest that it is sensitive to detect symptoms in 
COPD patients.306,307 The questionnaire asks how patients have felt in the previous week and 




reported questionnaire which comprises of 14 items. Each question is rated on a numerical, 4-
point modified Likert Scale and a higher score indicates higher levels of anxiety/depression. 
This questionnaire is currently used pre- and post- PR across LCHS.  
4.5 Qualitative data (outcome measures) 
4.5.1 Semi-structured Interviews with patients  
Qualitative interviews were chosen as a method of data collection. Interviews facilitate the 
exploration of patients’ perceptions and meaning of a specific phenomenon, thus increasing 
understanding of the research in question.308,309 There are a variety of interview techniques 
which vary in their level of rigidness, for example structured, semi-structured and open 
ended, each associated with their own strengths and limitations.310 Semi-structured interviews 
are among the most popular in qualitive research310 and they generally centre around a set of 
predetermined open-ended questions and potentially generate other questions based on the 
interaction between the interviewer and interviewee.311 A strength of semi-structured 
interviews involves the flexibility of the process, for example the researcher has the freedom 
to deviate from the topic guide and probe on a line of questioning.312 This method prioritises 
understanding the perceptions and meaning of the patients’ and provide opportunities for the 
researcher to ask probing questions to explore topics that patients’ find particularly important. 
An element of structure was required for this research, as it was necessary to explore specific 
processes of the study e.g. participant recruitment and experiences of the intervention 
components. However, it was also important to identify and understand the processes that 
influenced patient acceptability and experience of the research procedures and intervention, 
hence semi-structured interviews were the chosen method of data collection. To enable the 
interview data to reflect patient acceptability throughout different stages of the study, the 




4.5.2 Focus groups with Health Care Professionals and WhatsApp leaders 
A focus group was chosen as the method to gain insight into HCPs’ and WhatsApp leaders’ 
experience of the intervention and research procedures. A focus group is a semi-structured 
discussion with a small group of people (for example ranging from 4-12 people), which aims 
to explore and understand a topic of interest, and use open questions to gather rich and 
meaningful data.313 Focus groups enable the identification of potential issues within research 
and generate impressions/insight of the service and the direct interaction with HCPs and 
WhatsApp leaders, and therefore the possibility to observe non-verbal cues.314 The main 
benefit of Focus Groups over semi-structured interviews is that data collection is both 
situated in and facilitated by a group setting and the complex and dynamic social context 
influences the results. Social interactions within focus groups enable discussion around the 
topics of interest and enables individuals to offer their opinions regarding the research. The 
group format enabled individuals to react and build upon each other’s opinions.315  
The Focus Groups were planned towards the end of the research study, meaning the 
preliminary findings of the wider study (both short and long term feasibility and clinical 
results, Chapter 5) could be discussed and interpreted by the HCPs and WhatsApp leaders.   
As the validity of focus groups were reliant on individuals’ level of comfort when 
sharing their views about the research, which is potentially affected by group dynamics, 
careful consideration of intrapersonal factors, interpersonal factors and environmental factors 
was considered important prior to the start of qualitative research.314 For example, there were 
different roles within the PR team, including: the lead Clinical Specialist Physiotherapist, 
Physiotherapists and Physiotherapist Assistant’s, and therefore there was a clear hierarchical 
structure within the team. However, HCPs within LCHS regularly work together, have 
regular monthly meetings, and the Chief Investigator judged their interactions as comfortable 




Chief Investigator had met all HCPs prior to conducting the focus groups and obtained 
informed consent for their potential participation in the focus group. Arguably, all HCPs were 
motivated to take part in the focus groups, implicating their co-operation within a focus 
group. The research team did not consider there to be any hierarchical structure between the 
WhatsApp leaders. 
4.5.3 Topic guide development and structure 
All topic guides (Appendix M - Y, p349- 358) were informed by previous literature and 
stakeholder discussions. To increase the validity of the topic guides, they were initially 
reviewed by the Chief Investigator’s academic supervisors and patient volunteers (individuals 
within COPD patient groups). Final versions were then pilot tested with colleagues.   
As all topic guides were semi-structured, the questions within the interview/focus 
groups remained the same, but the order of the questions were flexible. These questions 
enabled Chief Investigator to identify participants’ views on how the intervention and 
research procedures could be improved during the feasibility study (e.g. early interviews 
could have enabled the research team to improve upon their recruitment technique) and for 
the development of a future trial. 
The topic guides included open questions to invite participants to describe and explain 
their experiences and prompts were used to further explore participants’ responses, and 
verbal and non-verbal prompts included statements to remind participants of the phenomena 
included in the question, in addition to open questions to further explore participants’ 
experience. For example, when patients were asked ‘can you tell me how did you first hear 
about this research?’ the prompt for patients included the reminder ‘information sheet from 
the lead health care professional, spoke to the research team.’ When HCPs were asked ‘could 
you tell us about your relationship with other WhatsApp group members?’ the prompt 




Non-verbal prompts such as head nodding and silences were also used to encourage 
participants, in addition to techniques such as reflective listening and summary reflections to 
check that interviewer/moderator had understood what the participants meant to convey.316 
The prompts were important during the interviews, as they lead the participants to further 
consider factors they may have forgotten or not explored during the interviews/focus groups.  
4.5.3.1 Topic guides for patient interviews 
Topic guides for all patient interviews (intervention and control group) (Appendix M, p349) 
were tailored due to patients’ level of inclusion in the study, meaning there were several 
variations of the topic guide. The number of questions varied for each subset of patients. For 
example, patients who refused to participate were asked for their reason/s for deciding not to 
take part, and patients who withdrew from the study were asked for their reason/s for 
deciding to withdraw from the research. However, topic guides for all subsets of patients 
included the following groups of questions: recruitment: how patients first heard about the 
research, their initial reaction to receiving the invitation to take part, their thoughts on the 
invitation technique and the written information about the research (n=4); Capability, 
Opportunity and Motivation (COM-B) (n=3); Data collection (including accelerometer) and 
measurement time points: follow-up visits; patients thoughts on the activity monitor; 
PROactive; CRQ and HADS questionnaires; the ISWT (n=6); Plans to keep active (n=1); 
End of interview (n=1). The Topic Guide included additional questions for the Intervention 
group: Experiences of using the devices: their thoughts on the pedometer, step diary, mobile 
phone and WhatsApp group (=4); Patient training (n=2); Familiarisation period (n=2); Impact 
of the Intervention on PA (n=11); Plan to keep active (use of intervention components) (n=1). 
Overall, the topic guide for the IG included 35 questions, and usual care included 15 
questions. Questions about patients’ capability, opportunity and motivation enabled the Chief 




4.5.3.2 Topic guides for focus groups with health care professionals 
Topic guides with HCPs (Appendix N, p355) included the following components: PR 
programme recruitment (n=3); Patient recruitment (n=2); patient training (n=2); phone and 
pedometer familiarisation period (n=2); impact of the study on the programme (n=1); impact 
of the study on HCPs (n=1); Impact of the intervention of PA (n=1); feasibility questions 
(n=3); end of the interview (n=1). Overall, there were 16 questions included in the topic 
guide. The topic guide included open questions to invite HCPs to describe and explain their 
experiences.  
4.5.3.3 Topic guides for focus groups with WhatsApp leaders 
The topic guide (Appendix O, p358) included 8 groups of questions, including the following: 
introductions (n=2); recruitment (n=2); training (n=2); experience of using the intervention 
components (n=5); experience of messaging the WhatsApp group (n=2); messages (n=5); 
support (n=3) and future involvement (n=1). Overall, there were 22 questions included in the 
topic guide.  
4.5.4 Procedures 
4.5.4.1 Patient interviews 
The Chief Investigator contacted subsets of patients during the study and asked them to 
reconfirm their decision to participate in an interview (face to face or telephone). The time 
and day were based on patients’ convenience. Patients who opted for a face to face interview 
were given the opportunity for it to be conducted at their homes, the University of Lincoln, or 
the local PR community centre, subject to the setting being free of distractions. Patients were 
informed that they could be joined by a relative or friend if this made them feel more 
comfortable and that the interview was predicted to last approximately 60 minutes. 
The interviewer (Chief Investigator) had previously met all patients on numerous 




before the interview and therefore every effort was made to construct an environment which 
made the participant feel at ease. This enabled an effortless conversation style approach to the 
interview and allowing the interviewer the possibility of clarification when making sense of 
patients’ answers.311 Prior to starting the interview, the interviewer summarised the purpose 
of the interview and asked patients to reconfirm their agreement for the interview to be 
recorded. If patients did not feel comfortable answering specific questions during the 
interview, the interviewer moved the interview onto the next component.  
A Dictaphone (Btopllc digital voice recorder) was used to record the interview, 
meaning that the Chief Investigator did not need to make notes during the interview, as this 
would have interrupted the flow of the interviews. However, field notes were recorded after 
the interviews to capture contextual factors such as setting, time of day and interruptions 
during the interview. The duration of the interview was also recorded.  
At the end of the interview, patients were reminded that they could contact the 
research team with any questions about the study. Participants were asked to take part in a 
maximum of one interview. However, in the unlikely event of technical failure (for example, 
inadequate Dictaphone recordings), repeat interviews were re-scheduled. 
4.5.4.2 Focus groups with Health Care Professionals and WhatsApp leaders 
Two separate focus groups were organised. One with HCPs and the other with WhatsApp 
leaders. Prior to the focus groups, HCPs and WhatsApp leaders involved in the study were 
contacted by the Chief Investigator and asked for their permission to participate in a Focus 
Group. Participants were informed that the focus groups were predicted to last approximately 
90 minutes, and they were organised at a time and place of convenience for participants, 
dependent on the room being comfortable and free of distractions. Prior to conducting the 
focus group, the Chief Investigator summarised the purpose of the focus group and asked 




The Chief Investigator moderated the focus group and was facilitated by their 
Academic Supervisor to assist with practicalities such as note taking and summarising the 
main discussion points to the group. The participants were familiar with the research team as 
they had met the Chief Investigator and their Academic Supervisor during recruitment and 
data collection procedures.  
Notes were taken to record participants’ non-verbal aspects of the focus groups314, 
such as emotional cues such as smiles, body position and raising of voice. These cues may 
have been in response to topic guide questions and comments from other group members and 
therefore important data. In addition, the moderator recorded contextual factors such as 
setting, time of day and the flow of discussion e.g. duration and frequency of silences within 
the group, individuals talking at the same time, potential interruptions or leadership 
tendencies and conflicts between group members. A Dictaphone was used to record the focus 
group, meaning that the research team were not reliant on field notes.  
At the end of the focus groups, participants were reminded that they could contact the 
research team with any questions about the study. The moderator summarised the main 
discussion points to the groups at the end of the focus group, which enabled participants to 
offer any further information that they considered relevant. Participants were asked to take 
part in a maximum of one focus group. However, in the unlikely event of technical failure 





Figure 4:6: An edited MRC illustration, outlining the intervention components which relate to behavioural sources, and the key components of 






The analysis of all data was performed by the Chief Investigator. As this was a feasibility 
study, analyses of quantitative data were treated as exploratory and mainly reported 
descriptively. Quantitative data was presented using numbers and proportions for categorical 
data, and means and standard deviations (SDs), medians and effect sizes for continuous data. 
Estimates of effect size and their 95% confidence intervals were also reported. The data 
provided information on the potential efficacy of the intervention and hence suitable 
parameters to inform a sample size calculation for a future, definitive CRCT. 
The WhatsApp exports were exported onto NVivo 12 Pro.203 A deductive approach 
was then used to analyse the data referring to type of messages sent to the WhatsApp groups 
(based on the categories of messages which reflect the BCTs used in the intervention). There 
are 93 codes, referring to the Behaviour Change Techniques (BCTs) outlined in the 
Behaviour Change Technique Taxonomy 1 (BCTTv1) that were applied to the data, enabling 
an identification of the types of messages that the WhatsApp leader sent, to the intervention 
framework applied in the development the intervention.145  
All interviews and focus groups were audio recorded and data was transcribed 
verbatim. In some cases, automatic transcription software ‘Transcribe’ (audio to text)317 was 
used to facilitate transcription. Personal identifiers were removed, and participants were 
pseudonymised where necessary.  
NVivo Pro 12203 was used to facilitate the analysis of the anonymised transcripts.  
A thematic analysis of the patient interviews and focus groups was conducted. Thematic 
analysis was informed by stages outlined by Braun and Clarke.205 An inductive approach was 
used to analyse the data referring the patients’, HCPs’ and WhatsApp leaders’ acceptability 




data-driven and not driven by the researcher’s analytic preconceptions.205 This approach 
enabled the identification of patterns or themes within the data.205  
The Chief Investigator also adopted a deductive approach to thematic analysis to 
identify the behavioural sources that related to PA following PR for participants. The 
intervention was informed by the steps outlined in the Behaviour Change Wheel (BCW)145, 
which outlines that behaviour is driven by Capability, Opportunity and Motivation (COM-B) 
(Chapter 3). A deductive approach to thematic analysis enabled the Chief Investigator to map 
the factors referring to individuals’ COM-B components.145 Six deductive codes referring to 
the behavioural sources outlined in the Behavioural Change Wheel145 were applied to the 
data. These included physical and psychological capability; social and physical opportunity 
and automatic and reflective motivation (discussed in Chapter 3).  
Interviews were transcribed and coded throughout the study, an iterative process, 
meaning that emerging themes were apparent to the Chief Investigator. Data saturation 
signalled the end of data collection and no more interviews were arranged with subsets of 
patients.  
Identified themes were discussed between the research team and presented to key 
stakeholders, including individuals in Breathe Easy138 groups across Lincolnshire and 
physiotherapists involved in PR across Lincolnshire, with the aim to enhance credibility and 









Background: Despite PR’s beneficial impact on exercise capacity and quality of life in 
COPD, these improvements do not translate to an increase in long-term PA. Previous 
interventions to promote PA following PR have had limited efficacy. Chapter 3 outlined the 
development of a complex, multicomponent intervention to support patients’ maintenance of 
long-term PA following PR, which included provision of a pedometer and step diary, and 
addition of patients to a WhatsApp group populated by fellow PR graduates and a ‘WhatsApp 
leader’ for 52 weeks.  
Aim: This chapter reports the quantitative and qualitative results from the cluster randomised 
controlled trial (CRCT) and process evaluation.  
Methods: This was a mixed-methods study including a feasibility CRCT and a qualitative 
process evaluation. Clusters were PR programmes across LCHS, NHS Trust (n=12), 
randomly allocated to the Intervention Group (IG) or Control Group (CG). The primary 
outcome was the acceptability of the intervention. Secondary outcomes included: recruitment, 
consent and attrition rates, intervention fidelity, and the proposed clinical measures for a 
definitive trial, including: daily steps and PA intensity (Actigraph wGT3X-BT), PA Amount 
and Difficulty (PROactive), Anxiety and Depression (HADS), and disease specific quality of 
life (CRDQ). Semi-structured interviews with participants and focus groups with HCPs and 
WhatsApp leaders assessed individuals’ experiences and perceived acceptability of the 
intervention and research procedures.  
Results: The study was successful in recruiting the target number of patients, and the consent 
rate was 55%. Most patients in the IG engaged in the intervention components. By 52 weeks, 
49% had engaged in the step diary, and 58% of participants who had consented to use 
WhatsApp had sent at least one WhatsApp message to the group. Participants who engaged 
in the step diary had a smaller decline in their daily steps at 52 weeks compared to those who 
did not engage in the step diary, MD, 45.5 (-1796, 1889), although this did not exceed d = 
0.2. Participants who engaged in WhatsApp had a smaller decline in daily steps at 52 weeks 





However, results also suggest there was a larger detrimental decline in breathlessness, 
emotion (CRQ) and depression (HADS) in the IG than the CG. WhatsApp leaders adhered to 
sending a minimum of weekly PA messages throughout the 52 weeks period. Common 
themes from interviews and focus groups were that patients would benefit from more 
familiarity with the intervention components, and that the convenience of the intervention 
components and research procedures could be improved. Rapport between the patients and 
WhatsApp leaders was considered important and face to face support should complement 
social networking following PR.   
Conclusion: The results highlighted that the intervention is feasible for a definitive trial. The 
clinical results outlined a beneficial impact of the intervention on patients’ PA. All groups 
considered the intervention and research procedures to be acceptable and feasible, based on 
specific modifications, which require further testing prior to a definite trial.  
 
5.2 Introduction  
Chapter 1 and 2 reported the evidence base surrounding PA following PR in patients with 
COPD. This informed the development of the complex, multicomponent intervention to 
support patients’ maintenance of long-term PA following PR, which included provision of a 
pedometer and step diary, and addition of patients to a WhatsApp group populated by fellow 
PR graduates and a ‘WhatsApp leader’ for 52 weeks, (Chapter 3). This intervention was 
tested in a mixed-methods study including a feasibility CRCT and a qualitative process 
evaluation (Chapter 4). The feasibility testing of the intervention and research procedures 
adheres to the stages outlined in the MRC framework.159  
This Chapter reports both the quantitative and qualitative results from this study. The 
following text reports the quantitative results, starting with the feasibility outcomes (5.3.1), 
followed by the clinical outcomes (5.3.5), the qualitative results (5.5), including the results 
from the interviews with patients (5.5.1) and focus groups with WhatsApp leaders (5.5.2) and 
HCPs (5.5.3). As previously reported in Chapter 4, the outcomes from the feasibility study 




and determines whether there is the need for further studies to refine this intervention design 
prior to its implementation. However, the main aim of this chapter is to report the 
acceptability and feasibility of the intervention and research procedures. 
5.3 Quantitative results  
5.3.1 Feasibility outcomes 
5.3.1.1 Consent, recruitment, and attrition rates  
5.3.1.1.1 Patients  
Participants flow through the study is illustrated in Figure 5:1. Twelve PR programmes 
(clusters) were invited to the study and were randomised to the intervention group (IG) or 
control group (CG). Overall, there were a total of 134 patients eligible for the study, with an 
overall consent rate of 55%, between June 2018 and January 2019. There was an overall 
attrition rate of 35% over the 52-week period, which was higher in the IG (41%) compared to 
the CG (30%), Figure 5:1. 
5.3.1.1.2 WhatsApp leaders 
Eight volunteers from COPD patient groups consented to become a WhatsApp leader, but 
only seven proceeded to deliver the intervention by sending messages to the WhatsApp 
groups (one individual volunteered to be the WhatsApp Leader for two WhatsApp groups). 
Two WhatsApp leaders withdrew from the Intervention. Five WhatsApp Leaders sent 
messages to the six WhatsApp groups. There was therefore an attrition rate of 29%.  
5.3.1.2 Completeness of follow-ups 
Of those participants who consented to the study, fewer participants provided data at all three 
study visits (baseline, 12 and 52 weeks), including; valid wGT3X-BT triaxial accelerometer 
(wGT3X-BT) data (IG = 14; CG = 13); HADS data (IG = 14; CG = 21), CRQ data (IG = 18; 
CG = 23), and finally, PROactive data (IG = 10; CG = 15). Reasons for missing 





















5.3.2 Clinical Characteristics 
5.3.2.1 Baseline characteristics of the Intervention and Control group 
Of the 74 participants enrolled onto the study, there were an equal number of participants in 
both groups (IG, n=37; CG, n=37). Overall, 58% of participants were male and 97% were 
White British. The mean (± SD) age was 70.2 years, (8.19), BMI 28.2 (7.13) (kg/m2) and the 
FEV1% predicted was 55.3 (19.2). Overall, 17% were current smokers, 77% were former 
smokers and 6% of participants had never smoked. All participants who were current or 
former smokers had a mean (± SD) pack history of 39.6 (34.3). The median MRC score was 
3 and there was a median number of 2 comorbidities and 1 exacerbation per year. The CG 
had a larger mean age, with a mean difference (MD) of 4.11 years, (95% Confidence Interval 
(CI), -7.81, -0.41). The CG had a larger reported: BMI (kg/m2), MD, 1.65, (-4.93, 1.63); 
FEV1 % pred, MD, 3.83, (-13.7, 6.02); ISWT, MD, 37.3m, (-110, 35.5); and ESWT, MD, 
181m, (-468, 106). However, the CG had a lower reported score in: CRQ Emotion, MD, -
0.25 (-0.24, 0.75); Depression (HADS-D), MD, -0.81, (-2.66, 1.04); and fewer exacerbations 
per year, MD, -1.14, (-0.66, 2.93), Table 5:2  
5.3.2.2 Baseline post-PR outcomes of patients who declined vs. patients who consented to 
the study 
The intervention aimed to promote PA for patients following PR. To understand if there were 
differences in the groups which consented and those who declined the study, their PR 
outcomes were collected and examined. Overall, 74 patients consented to the study and 60 
patients declined the study (55% of eligible patients).There were few differences detected 
between the clinical characteristics (post PR outcome data) of patients who consented to the 
study compared to those who declined the study (Table 5:1), suggesting that those who 




(HADS). Those who consented had smaller mean scores in: CRQ Emotion, MD, -0.56, (-
0.96, -0.16), and CRQ Mastery, MD, 0.27 (-0.72, 0.18). Those who consented also had a 
larger mean score in Anxiety (HADS-A), MD, 1.16 (-0.36, 2.69); and Depression (HADS-D), 
























  Consent Decline Consent Decline 
  





ISWT (m) 67 48 274 (281) 234 (142) 39.4 
 
-39.9 119 0.17 
 ESWT (m) 55 46 586 (524) 575 (495) 10.4  -192 213 0.02 
CRQ Dyspnoea       65     58 3.46 (1.15) 3.69 (1.21) -0.22  -0.65 0.2 0.19 
 Emotion 65 57 4.7 (1) 5.26 (1.25) -0.56     -0.96 -0.16 0.49* 
 Fatigue 65 58 4.04 (1.15) 3.95 (1.28) 0.09  -0.35 0.52 0.07 
 Mastery 65 57 5.01 (1.24) 5.28 (1.26) -0.27  -0.72 0.18 0.22* 
HADS Anxiety 65 58 7.09 (3.78) 5.93 (4.61) 1.16  -0.36 2.69 0.28* 
 Depression 65 58 6.4 (3.73) 5.19 (3.39) 1.21  -0.07 2.4 0.34* 
*Effect size is >0.2 (exceeded Cohen’s d convention for a small, medium or large effect size), M: Mean, SD: standard deviation , SE: standard 
error, CI: confidence interval, d: Cohen’s d, ISWT: Incremental Shuttle Walk Test, ESWT: Endurance Shuttle Walk Test, CRQ: Chronic 
Respiratory Questionnaire, HADS: Hospital Anxiety and Depression Scale, SB: Sedentary Behaviour, LPA: Light Physical Activity, MVPA: 




Table 5:2: Baseline characteristics of the Intervention and Control group   
  N M (SD)     
 
  IG CG IG CG 
  MD  
(IG- CG)   
        95% CI 
(Lower, Upper)  
Effect size (d) 





 Gender (m/%) 19 (51) 24 (65)          
 BMI (kg/m2)
  










 MRC Mean    3.47 (0.72) 3.08 (1.02) -.39     








































 Depression 33 32 5.97 (3.43) 6.78 (4.01) -0.81 
 
(-2.66, 1.04)  
 
0.22* 
PROactive Amount 22 32 7.67 (2.94) 7.73 (3.37) -.06   (-1.84, 1.72)  0.02 
 Difficulty 22 32 23.1 (7.69) 23.5 (5.66) -.44  (-4.08, 3.2)  0.07 
 Sum 22 32 30.8 (9.61) 31.3 (7.45) -.5  (-5.16, 4.16)  0.06 
Physical activity Daily steps  26 32 3397 2217 3220 (2181) 176  (-986, 1339)  0.08 
METS (minutes) SB 26 32 1076 (206) 1039 (201) 36.3  (-71.1, 144)  0.18 
 LPA 26 32 11.7 (13.1) 12.4 (13) -.729  (-7.63, 6.17)  .05 
 MVPA 26 32 5.47 (14.7) 6.23 (8.03) -77  (-6.84, 5.3)  .06 
Adverse events  Hospitalisations 
(per year) 












Effect size is >0.2 (exceeded Cohen’s d convention for a small, medium or large effect size), IG: Intervention Group, CG: Control Group, M: Mean, SD: standard deviation, SE: standard error, 
CI: confidence interval, d: Cohen’s d, ISWT: Incremental Shuttle Walk Test, ESWT: Endurance Shuttle Walk Test, CRQ: Chronic Respiratory Questionnaire, HADS: Hospital Anxiety and 




5.3.3 Level of intervention engagement  
Overall, 31 participants consented to the full intervention (WhatsApp, Pedometer and Step 
Diary), and 6 participants partially consented to the intervention (Pedometer and Step Diary 
only).  
5.3.3.1 WhatsApp 
Participant engagement in WhatsApp varied between individuals and across the WhatsApp 
groups (clusters). The number of participants involved in each WhatsApp group ranged from 
2-6. However, only 18 (58%) of the 31 participants who originally consented to use 
WhatsApp were engaged in WhatsApp (sent at least one WhatsApp message to the group). In 
one WhatsApp group, no participants sent any WhatsApp messages. In another, only 1 
participant sent a WhatsApp message. Participants sent a mean (± SD) of 18.3 (35.6) 
WhatsApp messages to the group over the 52-week period (365 days). The mean (± SD) 
duration that participants stayed in the WhatsApp group was 222 (141) days out of 365 (61% 
duration of the study). 
5.3.3.2 Step diary 
Overall, 19 participants (51% of those who originally consented) in the IG engaged with the 
step diary and returned this to the Chief Investigator at the end of the intervention. The 
remaining 49% of participants did not return the step diary and it was therefore not possible 
to calculate their engagement in the step diary.  
5.3.3.3 Step diary engagement at 12 weeks 
At 12 weeks, 17 participants had engaged in the step diary (49% of the total participants) and 
the median number of people in each cluster who engaged with the step diary was 3. The 
mean (± SD) number of days that participants engaged with the step diary (recorded their 
steps from the Yamax CW700/701 pedometer and/or commented about their steps) was 65.8 




5.3.3.4 Step diary engagement at 52 weeks 
At 52 weeks, the mean (± SD) number of days that participants engaged with the step diary 
was 177 (132) and the mean engagement for participants was 25% (percentage that 
participants recorded their mean daily steps). The mean (± SD) number of daily steps for 
participants was 3803 (1671).  
At 52 weeks, 14 participants engaged with the step diary beyond 12 weeks (43% of 
the total participants who had engaged at 12 weeks) and the median number of people in each 
cluster was engaged was 3. Of these participants, their mean engagement in the step diary 
was 61% and their mean daily step counts were 3962 (1675). Two participants started 
recording their step counts after 12 weeks, and their mean engagement was 19%, and their 
mean daily step counts were 2054 (56.4).  
5.3.4 Intervention fidelity  
5.3.4.1 WhatsApp checklists 
WhatsApp leaders did not complete the WhatsApp checklists during the intervention as they 
considered it too time consuming. However, WhatsApp leaders did base most (57%) of their 
messages on those outlined in the WhatsApp guidelines (Appendix K, p333) to select the 
type of messages they sent to the WhatsApp groups. The WhatsApp guidelines provided 
examples of messages that the WhatsApp leader could send to the WhatsApp group. These 
messages were divided into  nine categories which included messages to introduce 
participants to the WhatsApp groups; messages to summarise PA opportunities (including 
information from Active Lincolnshire and about Vitality exercise classes); information and 
encouragement for completing activities at home; encouragement for group members to seek 
social support; encouragement for group members to record their PA and share this in the 
group; encouragement for group members to form habits and routines; messages to 




members to seek support if they notice a decline in their health.  The type of messages the 
WhatsApp leader sent to the WhatsApp groups were identified in the WhatsApp chat exports 
(see WhatsApp chat exports below).     
5.3.4.2 WhatsApp chat exports 
All WhatsApp leaders (n=5) sent the Chief Investigator WhatsApp exports at the end of the 
intervention (after 52 weeks). The WhatsApp leaders sent a mean (± SD) of 92.5 (68.5) 
messages to the WhatsApp groups over the 52-week period. Of these messages, 36% were 
weekly PA summaries, which included messages about activities offered by local 
organisations (e.g. Active Lincolnshire and Vitality). The other 67% of these messages were 
messages based on: Introduction messages to WhatsApp (3%); Activities at home (<1%); 
Social support (3%); Monitor activity levels; (8%); Habits and routines (1%); Congratulatory 
messages (4%); and Health (<1%); and other (43%). ‘Other’ included a broad range of 




Table 5:3: Type of WhatsApp Leader messages to participants 
 Total (%) M (SD) (per WhatsApp group) 
Total messages 569 (100) 92.5 (68.5) 
Physical activity summaries 177 (36) 33 (13) 
Introduction to WhatsApp 17 (3) 2.83 (2.71) 
Activities at home  3(<1) .5 (.84) 
Social Support 14 (3) 2.33 (2.73) 
Monitor activity levels 45 (8) 7.5 (5.75) 
Habits and routines 7 (1) 1.17 (.98) 
Congratulatory messages 21 (4) 3.5 (4.04) 
Health 3 (<1) .5 (.55) 
Other 282 (43) 47 (49.8) 





5.3.5 Clinical outcomes 
5.3.5.1 Primary clinical outcome: daily steps at 52 weeks (Accelerometer wGT3X-BT) 
The proposed clinical outcome for a definite trial was mean daily steps at 52 weeks. A total 
of 35 participants (IG, n=18, CG, n=17) had valid Accelerometer data at 52 weeks. However, 
only, 34 participants (IG, n=14; CG, n=20) had valid Accelerometer data at both baseline 
(non-PR days) and 52 weeks, where it was possible to calculate the mean difference (MD) 
between the two time points. Of the participants who had both data sets, the duration of the 
data sets at 52 weeks ranged from 1-6 days, with a mean of 5.6 (1.76) days. Both groups 
declined in mean daily steps at 52 weeks, with a larger decrease in the CG than the IG 
(Error! Reference source not found.), MD, 180, (-765, 1126), Table 5:4.  
Secondary clinical outcomes 
5.3.5.2 Daily steps at 12 weeks (Accelerometer wGT3X-BT) 
There were a total of 49 participants (IG, n=23, CG, n=26) who had valid Accelerometer data 
at 12 weeks, however, only 43 participants (IG, n=18; CG, n=25) had valid data at both 
baseline and 12 weeks. Of these participants, the duration of the data sets at 12 weeks ranged 
from 1-6 days, with a mean (± SD) of 5.09 (1.39) days. Both groups declined in mean daily 
steps from baseline to 12 weeks, with a larger decrease in the IG, however there were no 
effects of the groups which exceeded d = 0.2, Table 5:4.  
5.3.5.3 Physical activity intensity (METS) (Accelerometer wGT3X-BT)  
There was a decline in daily Sedentary Behaviour (SB) from baseline to 12 weeks in both the 
IG and CG. This decline was larger in the IG (MD, -86.6, (183, 9.93). SB in both groups 
declined from baseline to 52 weeks, but the effect size did not exceed d = 0.2. Both groups 
decreased in LPA at 12 weeks, but the decrease was higher in the CG (MD, 5.17, (-1.12, 




the CG, (MD, 19.18, (-49.3, 6.97). Both groups decreased in mean daily MVPA from 
baseline to 12 weeks and 52 weeks. There were no effects of the groups at 12 weeks, and 52 
weeks which exceeded d = 0.2, but the line chart (Error! Reference source not found.) 
illustrates that the CG had a larger decrease in MVPA than the IG at 52 weeks a, MD, 2.14 (-
3.95, 8.24), Table 5:4. See Error! Reference source not found. which illustrates the 





 Table 5:4: Between groups differences in physical activity outcomes from baseline to 12 and 52 weeks 
    Allocation N  M (SD) MD (from baseline) MD (IG-CG) 95% CI (Lower, Upper) Effect size (d) 
Physical activity                  
Mean daily steps 12 weeks IG 18 3122 (1836) -689 -159 (-854, 536) 0.13 
  CG 25 2887 (1777) -529       
  52 weeks IG 14 3198 (2210) -794 180 (-765, 1126) 0.11 
 
  CG 20 2980 (1581) -974       
METS (minutes)         
SB 12 weeks IG 18  942 (180) -148 -87 (-183, 9.93) 0.11 
  CG 25 960 (139) -61.12    
  52 weeks IG 14 872 (130) -202 -2.57 (-112, 107) 0.05 
  CG 20 879 (134) -200    
LPA 12 weeks IG 18 13.5 (15.3) -0.47 5.17 (-1.12, 11.5) 0.51* 
  CG 25 8.38 (7.81) -5.63    
  52 weeks IG 14 14.9 (18.4) -.276 -19.18 (-49.3, 6.97) 0.53* 
  CG 20 36.81 (55.5) 19.5    
MVPA 12 weeks IG 18 5.15 (9.03) -6.72 -0.19 (-7.67, 7.3) 0.01 
  CG 25 4.78 (7.35) -6.54    
  52 weeks IG 14 8.5 (15.7) -.066 2.14 (-3.95, 8.24) 0.16 
    CG 20 6.65 (5.3) -2.21    
PROactive          
Amount 12 weeks IG 15 7.8 (3.23) -.21 (1.7) 0.39 (-1.09, 1.86) 0.08 
  CG 24 7.53 (3.5) -.6 (2.48)    
 52 weeks IG 13 7.24 (2.41) -.57 (2.54) 0.25 (-2.09, 1.59) 0.27* 
  CG 20 7.99 (3.19) -.32 (2.52)    
Difficulty 12 weeks IG 15 21.2 (9.01) -4.07 (4.61) 2.28 (-5.81, 1.26) 0.04 
  CG 24 21.5 (6.93) -1.79 (5.69)    
 52 weeks IG 13 20.6 (7.21) -.57 (2.54) 2.48 (-6.85, 1.9) 0.13 
  CG 20 21.6 (7.05) -.32 (2.52)    
Sum 12 weeks IG 15 29 (11.5) -4.28 (5.4) 1.89 (-6.02, 2.24) 0.01 
  CG 24 29.1 (8.6) -2.39 (6.64)    
 52 weeks IG 13 27.8 (8.32) -4.64 (6.71) 2.73 (-7.87, 2.42) 0.19 
*Effect size is >0.2 (exceeded Cohen’s d convention for a small, medium or large effect size),  METS: metabolic equivalent of task; IG: Intervention Group, CG: Control Group, M: Mean, SD: 
standard deviation, MD: Mean Difference, SE: standard error, CI: confidence interval, d: Cohen’s d, SB: sedentary behaviour, LPA: light physical activity, MVPA: moderate vigorous physical 




Table 5:5: Between groups differences in Clinical Outcomes from baseline to 12 and 52 weeks 
    Allocation N  M (SD) MD (from baseline) MD (IG-CG) 95% CI (Lower, Upper) Effect size (d) 
CRQ domains                 
Dyspnoea 12 weeks IG 21 2.49 (0.88) -1.01 -0.23 (-0.92, 0.45) 0.20* 
  CG 26 2.75 (0.80) -0.78    
  52 weeks IG 18 2.89 (1) -1.12 -0.47 (-1.40, 0.47) 0.33* 
  CG 23 2.9 (1.23) -0.65    
Emotion 12 weeks IG 21 4.04 (1.24) -0.84 -0.67 (-1.34, 0.01) 0.58* 
  CG 26 4.43 (1.19) -0.17    
  52 weeks IG 19 4.23 (1.26) -0.58 -0.26 (-0.89, 0.36) 0.27* 
  CG 23 4.2 (1.26) -0.31    
Fatigue 12 weeks IG 22 3.52 (1.39) -0.5 -0.09 (-0.79, 0.6) 0.08 
  CG 26 3.65 (1.27) -0.41    
  52 weeks IG 19 2.96 (1.31) -0.91 -0.09 (-0.81, 0.63) 0.08 
  CG 23 3.32 (1.11) -0.82    
Mastery 12 weeks IG 22 4.67 (1.64) -0.44 0.05 (-0.79, 0.88) 0.03 
  CG 26 4.54 (1.4) -0.48    
  52 weeks IG 19 4.55 (1.59) -0.54 -0.11 (-0.83, 0.61) 0.1 
  CG 24 4.61 (1.21) -0.43    
HADS                 
Anxiety 12 weeks IG 18 8 (4.89) 0.44 0.21 (-1.87, 2.3) 0.13 
  CG 26 7.12 (4.31) 0.23    
  52 weeks IG 18 7.56 (5.24) 0.67 0.35 (-1.77, 2.47) 0.11 
  CG 22 7.68 (4.6) 0.32    
Depression 12 weeks IG 18 7.06 (4.37) 1.11 0.15 (-1.79, 2.08) 0.05 
  CG 26 7.81 (4.08) 0.96    
  52 weeks IG 18 8.33 (4.6) 2.33 1.11 (-1.24, 3.45) 0.30* 
  CG 22 8.14 (4.04) 1.23    
*Effect size is >0.2 (exceeded Cohen’s d convention for a small, medium or large effect size),  IG: Intervention Group, CG: Control Group, M: Mean, SD: standard deviation, MD: Mean 





Table 5:6: Between and within group differences in mean daily steps in Non-PR and PR days 
  Between group differences Within Group differences 
 
 
N M (SD) MD 




N MD 95% CI (Lower, 
Upper) 
























 CG 32 3221 (2181)        
PR days IG 25 4223 (2944) 311 (-1387, 2008) 0.1 31 692 (-715, 2098) 0.98* 
 CG 31 3912 (3305)        
*Effect size is >0.2 (exceeded Cohen’s d convention for a small, medium or large effect size),  IG: Intervention Group, CG: Control Group, M: Mean, SD: 




5.3.5.3.1 PR vs non-PR days (baseline) 
Prior to a definitive trial, it was important to identify if the baseline PA should include 
both PR and non-PR days, and whether PR days impacted the mean daily steps. The duration 
of the baseline data sets ranged from 1-7 days, with a mean (± SD) of 5.48 (1.06) days (non-
PR days: 4.5(1); PR days: 1(.23)). There was a difference between PR and non-PR days on 
mean daily steps in both groups, and there were more steps recorded in PR days (IG, MD, 
826, (-637, 2289); CG (MD, 692, (-715, 2098), Table 5:6. In this study, baseline PA data 
during PR was based on non-PR days only, as the results from this study supported the 
suggestion that days where patients completed PR were often higher in PA than non-PR days, 
and therefore not representative of their usual daily PA.128  
5.3.5.4 PROactive 
There was a decrease in the mean scores in the Amount and Difficulty domains of the 
PROactive in both the IG and CG at 12 and 52 weeks, suggesting that both groups decreased 
spent time in PA, but also found PA more difficult throughout the study. However, there was 
a larger decline in the scores in the IG across 12 and 52 weeks in both domains. The only 
notable difference between the IG and CG (effect size > 0.2) was the mean change in the 
amount of PA at 52 weeks, MD, .25 (-2.09, 1.59), which was lower in the IG, Table 5:4. 
5.3.5.5 Hospital Anxiety and Depression Scale (HADS) 
There was an increase in the mean scores in the Anxiety and Depression domains (HADS) in 
both groups at both 12 and 52 weeks. Though the mean increase in scores appeared higher in 
the IG, there was only a notable difference between the groups in the mean increase in 
Depression from baseline to 52 weeks, which was higher in the IG (MD, 1.11, (-1.24, 3.45) 




5.3.5.6 Chronic Respiratory Questionnaire (CRQ) 
There was a mean decrease in all CRQ domains from baseline to 12 and 52 weeks in the IG 
and CG. The decrease appeared to be larger in the IG than the CG for all but one measure 
(mean change in Mastery at 12 weeks). However, the only difference that exceeded d = 0.2 
was the mean change in Dyspnoea, with a larger decrease in the IG at 12 weeks (MD, -0.23, 
(-0.92, 0.45) and 52 weeks (MD, -0.47, (-1.40, 0.47), Emotion at 12 weeks (MD, -0.67, (-
1.34, 0.01), and finally, Emotion at 52 weeks (MD, -0.26, (-0.89, 0.36), Table 5:5.  
5.3.6 Comparison of the Feasibility and Clinical outcomes 
5.3.6.1 Intervention engagement (Step diary) and daily steps (Accelerometer wGT3X-BT) 
For IG participants who provided valid Accelerometer data at baseline and 52 weeks (n=14), 
daily step counts (from the Accelerometer) was compared between those who engaged in the 
step diary (n=9), with those who did not (n=5). Participants who engaged in the step diary 
had a smaller decline in their daily steps at 52 weeks compared to those who did not engage 
in the step diary, MD, 45.5 (-1796, 1889), although this did not exceed d = 0.2. Nevertheless, 
this result requires further exploration to identify if the intervention had any impact on 
patients’ PA.  
5.3.6.2 WhatsApp engagement and daily steps (Accelerometer wGT3X-BT) 
For IG participants who provided valid Accelerometer data at baseline and 52 weeks, and 
engaged in WhatsApp (n=18), daily step counts (from the Accelerometer) was compared 
between those who engaged in WhatsApp (n=11), with those who did not (n=6). Participants 
who engaged in WhatsApp had a smaller decline in daily steps at 52 weeks compared to 




5.3.6.3 Comparison of the Accelerometer wGT3X-BT and step diary (Yamax Digi-walker 
CW-700) data 
Daily steps from the Accelerometer were compared with daily steps from the pedometer to 
validate the accuracy of the devices. PA data from 14 datasets, across 68 days was compared. 
The mean (± SD) daily steps the Accelerometer recorded was 3648 (1966), which were 




5.4 Discussion (quantitative results) 
5.4.1 Summary 
The aim of this study was to report the feasibility of intervention and to identify the likely 
effects of the developed intervention on PA and other health outcomes following PR. The 
study was successful in recruiting the target number of patients and WhatsApp leaders.148 
Over half of the participants engaged in the intervention components, and the majority 
continued to record their daily steps past the first follow up (12 weeks). The mean (± SD) 
duration that participants stayed in the WhatsApp group was 222 (141) days out of 365 (61% 
duration of the study). The mean (± SD) number of days that participants engaged with the 
step diary was 177 (132). WhatsApp leaders adhered to sending weekly messages to the 
WhatsApp groups, and based most of the messages on those outlined in the WhatsApp 
guidelines. Although there were no improvements in daily steps and secondary health 
outcomes for the IG and CG, there was a larger decline in mean daily steps and MVPA in the 
CG at 52 weeks, suggesting that there was a beneficial impact of the Intervention on the rate 
of decline in PA. Unexpectedly, there was a larger increase in the LPA at 52 weeks in the CG 
compared to the IG. Within the IG, daily steps of those who engaged in WhatsApp and the 
Step Diary was higher than those who did not engage with the intervention components. 
However, results also suggest there was a larger detrimental decline in dyspnoea, emotion 
(CRQ) and depression (HADS) in the IG than the CG.     
5.4.2  Comparison to previous literature 
The consent rates were lower compared to previous trials which have aimed to promote PA 
following PR.3–8 However, these studies were full scale trials, and may have undergone 
feasibility studies or pilot trials to optimise patient engagement, therefore it is expected that 
recruitment rates in this trial would be higher in a definitive trial. All cluster sites in this study 




compared to a previous cluster RCT which aimed to promote PA via mobile and web-based 
monitoring and feedback, where only 10% of practices agreed to participate in the trial.318  
There are only a limited number of studies with similar intervention components delivered 
over 52 weeks, and attrition rates in this study are similar to a previous study.148 Similarly, 
attrition rates at 12 weeks in this study were similar to attrition rates in previous 
studies85,88,319, and these rates reflect the various factors that this population encounter, such 
as illness, appointments with HCPs and family and social responsibilties.241,136,320  
Of the studies reporting COPD patients’ engagement with the pedometer, figures are 
higher in previous studies than those reported in this study.246,319 However, these studies were 
conducted over a much smaller time frame, and were therefore less demanding of patients, 
hence it is not surprising that engagement is lower in this study. In this study, it is possible 
that participants lost their step diary and/or did not return their step diary, or engaged in 
WhatsApp without recording their engagement, hence the engagement rates may be 
underestimated. However, one of the previous studies involved asking participants to upload 
their weekly step counts online, which added a level of accountability to participants’ 
intervention adherence.246 The other study involved participants wearing their pedometer 
during PR, meaning that participants were likely supported and reminded by HCPs to adhere 
to the intervention.319 These factors may explain the differences in intervention engagement. 
Although step diary engagement was higher at 12 weeks compared to 52 weeks, it should 
also be noted that the majority of participants who did engage in the step diary recorded their 
steps beyond the 12 week mark, and the adherence of those who started recording their steps 
reflects a much higher intervention engagement figure.  
There are a limited number of studies which reported participants engagement in 
social networking applications as part of a behaviour change intervention.193,321 One study 




their study had higher participant engagement rates.193 However, the average number of 
messages sent in this study was higher than this previous study193, suggesting that those who 
were engaged in WhatsApp were likely to send more messages. The other study recorded 
participant engagement by reporting the number of participants who read the weekly 
feedback, rather than the number of posts from participants.321 In this study, it was not 
possible to count the number of messages that WhatsApp members read, and therefore it was 
possible that WhatsApp engagement was underestimated in this study. Also, many studies 
have not reported participants’ level of intervention engagement83,91,92,90,84,137,178,306 so it is 
difficult to discern the relative acceptability of the intervention to other studies.   
Recruitment and retention of WhatsApp leader volunteers in this intervention was 
challenging. There are few studies which have recruited lay volunteers to deliver a social 
networking intervention in people with COPD185. The results from this feasibility study were 
similar to a peer support intervention which had 40% withdrawal of volunteers prior to the 
intervention, and volunteers who provided inconsistent support to patients.185 This highlights 
the need to identify how researchers can provide extended support to lay volunteers in 
research.  
More than half of the messages were based on categories outlined in the WhatsApp 
guidelines (Appendix K, p333) and WhatsApp leaders were consistent in sending a weekly 
PA message to the WhatsApp group members, despite many participants not replying to their 
messages. This suggests that WhatsApp guidelines were considered acceptable to the 
WhatsApp leaders. However, the other messages sent by WhatsApp leaders were not related 
to the WhatsApp guidelines, which is similar to the results of another study in which trained 
counsellors sent messages to encourage participants to encourage smoking cessation. For 
example, most of the posts via social networking applications were not based on the protocol, 




are most comfortable in sending conversational messages, rather than structured posts, 
however this requires exploring in further research.      
WhatsApp leaders did not adhere to the WhatsApp checklists, as they were 
considered too time consuming. This did not adversely impact the analysis of the results, as 
messages were coded based on the export of the WhatsApp chat. As the WhatsApp checklist 
was not considered a necessary or helpful resource in the trial, this should not be provided to 
lay volunteers in a future definitive trial, and researchers should ensure that all study 
procedures for lay volunteers are as simple as possible.  
This intervention did not result in an increase in mean daily steps in the IG. These 
results contradict findings from various studies with similar intervention components, which 
reported an increase in PA91,90,137 though few studies have reported that there were no 
difference between the IG and CG.91,84,  However, the IG had a smaller mean reduction in 
daily steps than the CG at 52 weeks, and the rate of decline in MVPA was lower in the IG 
compared to the CG, which suggests a potential beneficial impact of the intervention. These 
results reflect previous studies which show a beneficial impact of the intervention on 
MVPA85,244, yet contradict another.91  
The time spent in SB decreased at a similar amount and rate between both groups. 
There are a limited number of interventions which have previously reported the impact of PA 
interventions on patients’ SB in COPD.89 However, a study which did report a reduction in 
SB was also accompanied with improvements in daily steps.89 Nevertheless, previous 
literature has outlined the need to understand PA patterns in COPD across the whole day, 
which include SB and LPA82,78,127,310,311, particularly as the government guidelines for older 
adults focus on the reduction of SB.77 As the result highlights interesting long-term patterns in 





Participants in the IG who engaged in the intervention components (WhatsApp and Step 
Diary) had higher mean daily steps at 52 weeks than those who did not engage in the 
intervention. Furthermore, the mean difference in daily steps between the IG and CG 
increased from 12 weeks to 52 weeks, further supporting the suggestion that intervention 
engagement was associated with a lower decline in mean daily steps. This is a novel finding 
as previous research had not reported any positive associations in intervention engagement 
and PA.321 This result points towards a positive impact of the intervention on PA, though the 
difference did not exceed the most recent reported MCID in daily steps in COPD of 300-
1100.99  These results require further exploration to understand if, how and why the 
intervention was beneficial, or whether low adherence to the intervention was related to 
barriers of PA such as poor health and competing demands, hence impacting PA levels. 
The PROactive results are novel as there is limited research combining objective and 
subjective outcome measures for PA.155 Interestingly, the results from the PROactive 
measure outlined that the IG reported a larger decline in the amount of PA at both 12 and 52 
weeks compared to the CG. Similarly, the IG reported more difficulty in performing PA 
across the 52-week period compared to the CG. These results were surprising, as the results 
from the Accelerometer (Actigraph wGT3X-BT) reported that the IG had a smaller decline in 
daily steps compared to the CG. The questions about the amount of PA in the PROactive 
refer to how much walking outside and daily chores patients did. These questions may not 
capture other daily activities that patients complete, for example walking around the house 
and/or gardening, which may explain the discrepancies between the trend in daily steps and 
the ‘amount’ domain in PROactive.    
Literature has outlined that PA is associated with beneficial health outcomes.1,77  It 
was therefore unexpected that the IG had a larger decline in their disease specific quality of 




Based on the results from the CRQ, HADS and PROactive, it could be suggested that the 
IGs’ well-being was associated with the difficulty they had in being active and maintaining 
their daily routine.326 It could also be suggested that LPA is more important to patients than 
the number of daily steps they complete. However, this requires further investigation, 
possible by gaining insight from patients involved in the intervention. 
The mixed results in PA and other health outcomes in previous literature may reflect 
heterogeneity between the studies, including sample sizes, type of intervention components 
and BCTs and the length of follow ups, and therefore it is challenging to understand the 
reasons for the different outcomes between studies.130  
The Actigraph (wGT3X-BT) was the accelerometer used due to recommendations in 
recent literature.53 However, there were various occasions when the accelerometer data was 
invalid, and some patients refused to wear the activity monitor during the study due to 
discomfort, which has been previously reported.91 The accelerometer provided similar step 
count readings to the pedometer, which contradicts previous findings91, therefore raising the 
possibility of these pedometers as a suitable outcome measure in further studies. Use of a 
pedometer as an outcome measure in future trials could resolve issues faced in this study, 
extend the datasets of PA, and potentially reduce the costs for researchers. However, more 
research is required to identify the consistency of these results, as well as the adherence of 
patients to wearing the pedometer and reporting their steps.  
5.4.3 Strengths and limitations  
A limitation in this study was the method by which intervention engagement was assessed. In 
this study, WhatsApp engagement was measured by the number of messages that patients 
sent to the WhatsApp group. This meant that patients who viewed the messages, but did not 
send replies, were not accounted for. Measurement of Step Diary engagement was only 




account for patients who lost or forgot to return their step diary. Furthermore, a limitation of 
this study was that the number of participants reading the messages sent to the WhatsApp 
groups were not identified during the study. However, engagement in the step diary and use 
of the pedometer and WhatsApp are explored in the next chapter via patient interviews, 
which can help to understand the reasons for limited engagement from patients. As these 
factors contribute to understanding the acceptability of the intervention, it is important to 
consider how these could be measured in a further trial.  
A potential limitation of the study is the small sample size of patients involved in the 
feasibility CRCT, as it the study was not powered for statistical data analyses. However, this 
was a feasibility study, with a primary aim in understanding the acceptability of the 
intervention and research procedures.159,296 The feasibility study was valuable in outlining the 
likely impact of the intervention on patients’ PA and other health outcomes and successful in 
recruiting the target number of patients. This feasibility study is therefore valuable in 
informing the definitive trial.   
The decision to conduct a feasibility study prior to a larger scale trial is a clear 
strength, as it has enabled researchers to assess the feasibility and overarching acceptability 
of this intervention prior to a future larger scale trial. Though the impact of the intervention 
on clinical outcomes appear limited compared to previous studies, this feasibility study has 
outlined potential benefits of the intervention.  
It could be argued that the sample is not representative of the ethnic profile of the 
wider population and therefore acceptability of the intervention cannot be generalised to other 
areas with different ethnicity profiles. However, the study sample was relative to the 
population in Lincolnshire.327 Another limitation was that the mean age in the IG was higher 
than the CG as older age is generally associated with reduced PA328, anxiety and 




of the study. However, this was not considered likely, as both groups were over 65 and 
therefore both categorised as ‘older adults’ who receive the same PA recommendations.77 
Differences in age such as these should be statistically controlled for in further research. 
There were incomplete data sets from those participants who withdrew from the IG, 
meaning that results do not include data from those who found the intervention the least 
acceptable. However, as most patients, from both study arms, withdrew for similar reasons, 
such as health issues, it is unlikely that the results are impacted by bias.    
A strength of this study was the decision to compare the clinical characteristics of 
those who declined the study with those who consented, as previous studies have not reported 
this.331,84,91,90,137 This enabled researchers to explore the characteristics of people who found 
the study acceptable. In this study, the results for those who declined the study suggested that 
they had better psychological well-being and disease specific QoL, but little is understood 
whether worse anxiety and depression and disease specific QoL predicts involvement in the 
intervention. Furthermore, patients who declined the interviews also had lower functional 
capacity, possibly suggesting that those with lower functional capacity may be more 
interested in structured PA interventions following PR. Interviews with patients who declined 
the study may provide insight into the factors that prevent participants from engaging in the 
intervention, therefore discussing how the intervention could be improved to be acceptable 
for the wider population.    
The cluster design of the intervention was successful in proving balanced groups, and 
participants did not report being aware of separate groups. This was considered a strength of 
the study. Though there were small differences in the baseline characteristics of the IG and 
CG, for example, age and functional capacity, cluster randomisation was deemed successful 




Factors which impacted the fidelity of the intervention included withdrawals and 
replacements of WhatsApp leader volunteers in the early stages of the intervention, meaning 
that some WhatsApp groups had limited engagement with the WhatsApp leaders throughout 
the intervention. This could have impacted patients’ acceptability of the intervention. This is 
a limitation, as social support has been identified as an important factor that impacts PA  
following PR.241 Prior to the delivery of the intervention, more than six WhatsApp leaders 
were recruited for the study. This was in recognition that COPD is a complex condition, 
which is associated with health concerns, and that many individuals with COPD have 
competing demands such as family and volunteering responsibilities (Chapter 2). 
Recruitment of a ‘bank’ of WhatsApp leaders enabled a smooth transition when replacing 
WhatsApp leaders who withdrew. This was considered a strength of the study.  
Some of the WhatsApp messages that WhatsApp leaders sent were not based on those 
provided in the WhatsApp guidelines, meaning that the content of the messages was not 
controlled for across the WhatsApp groups. This is important, as the WhatsApp guidelines 
were initially categorised according to the Behaviour Change Techniques145 to focus on the 
facilitators to PA following PR in COPD, which were identified in the systematic review 
reported in Chapter 2.241 However, all WhatsApp leaders sent a minimum of one weekly PA 
message to the WhatsApp groups, which suggests that some aspects of the guidelines were 
acceptable.   
Another limitation of this study was the missing data among the three study visits, 
which may have therefore impacted the conclusions drawn from this study. However, most 
who refused to wear the accelerometer agreed to provide questionnaire data, and some 
participants who were ‘lost to follow up’ during the 12-week follow up were later contacted 
for the 52-week follow up, hence many participants contributed at least two sets of 




A strength of this study was the collection of patient-reported outcomes in measuring 
PA (PROactive) which provided further insight than the traditional one-dimensional objective 
measurement.73 The results indicated that patients in the IG found PA more difficult and were 
participating in less PA at 52 weeks compared to the CG. These results contradicted the 
results from the Accelerometer, which indicated that the IG had a lower rate of decline in 
daily steps and MVPA. These unexpected results support the importance of further research 
to identify the reasons for these differences, and for a conclusive outcome on the potential 
impact of the intervention on patients’ PA.  
5.4.4 Conclusion 
This study addressed the feasibility of a complex intervention, the second stage outlined in 
the MRC guidance in the development and evaluation of a complex intervention.159 The 
results of this study addressed the acceptability, feasibility, and likely impact of this 
intervention on patients’ PA and other health outcomes. Recruitment of participants was 
considered successful. As WhatsApp leaders based most of their messages on the WhatsApp 
guidelines, the results suggest there was high intervention fidelity. There was a decline in PA 
and other health outcomes in both groups, which could suggest that there was limited 
acceptability of the intervention. However, participation in the IG was associated with a 
smaller decline in daily steps and MVPA compared to the CG. Also, engagement in the 
intervention components was associated with a smaller decline in daily steps than those who 
did not engage. Stakeholders’ acceptability of the intervention and research procedures 
should therefore be explored to consider if and how the intervention should and could be 
improved for a future definitive trial. This was explored in the next section which reports the 
qualitative findings from the interviews with patients (5.5.1) and focus groups with 





5.5 Qualitative results  
An objective of this thesis was to conduct a process evaluation to assess the acceptability of 
the intervention and research procedures for patients, patient volunteers, and HCPs. An 
inductive thematic analysis was conducted to explore the acceptability and feasibility of the 
intervention and research procedures, in line with the guidance from the Medical Research 
Council (MRC) for process evaluations of complex interventions.160 The following section 
describes the results from the interviews with patients and focus groups with WhatsApp 
leaders and HCPs. The results will help identify any changes to be made prior to a definitive 
trial, for example whether the intervention requires further refinement and/or whether the 
research procedures are acceptable and feasible.  
5.5.1 Patients 
Sixteen patients from the feasibility CRCT engaged in a semi-structured interview to discuss 
the acceptability and feasibility of the intervention and the research procedures. These 
included patients who: declined to take part in the intervention; enrolled in the intervention 
and subsequently withdrew; initially opted for some intervention components but declined 
others, and patients who opted for all intervention components. Full demographic information 
and clinical characteristics are presented for patients in Table 5:7, except for patients who 
declined the intervention (demographic information was not recorded for these patients). 
The overarching themes included the ‘facilitators’ and ‘barriers’ of the acceptability 




















P1 full   7  51 male WB  29.5 4 0 1 ex-smoker 22.5 
P2  full   10  69 female WB  43.6 MD 1 2 ex-smoker 48 
P3  full   7  70 male WB 24.3 3 7; 0 3 ex-smoker 60 
P4  full   6  58 female WB  17.8 4 0 2 ex-smoker 46 
P5  full  8  63 female WB  35.5 3 10; 10 2 smoker 141 
P6  full   7  73 male WB  28.7 3 8; 1 0 ex-smoker MD 
P7  full   8  63 female WB  19.5 3 0 2 ex-smoker 4.5 
P8 full   3  67 female WB  21.6 3 1; 0 1 ex-smoker 60 
P9 full   11  65 female WB  31.7 3 1; 1 4 ex-smoker 30 
P10  full 
(withdrawn) 
11  80 male BI  20.45 4 1; 1 3 ex-smoker MD 
P11  partial 4 69 male WB  23.3 3 1; 0  0 ex-smoker 30 
P12  partial 4 75 female WB  21.2 4 1; 0  3 never 
smoked 
0 
P13  decline x 
 
male WB  x x x x x x 
P14 decline x x female WB  x x x x x x 
P15  decline x x female WB  x x x x x x 
P16 decline x x male WB  x x x x x x 
full = received all study components (WhatsApp, pedometer, step diary) ; partial = received pedometer and step diary only; decline = decline to be involved in the 
intervention but provided permission to be interviewed; withdraw = enrolled in the intervention and subsequently withdrew; x = no data available:  
P: Person; WB: White British; BI: British Indian; MD: Missing Data; MRC: Medical Research Council Dyspnoea Scale 
*Previous 12 months number of courses of antibiotics/oral steroids; hospitalisations; †the number of months that patients had been involved in the study, from the time that 






Figure 5:3: A concept map illustrating patients’ acceptability and feasibility of an 
intervention, and associated research procedures, to promote PA following PR in COPD 
5.5.1.1 Barriers to the acceptability and feasibility of the intervention and research 
procedures 
The most common barriers to the acceptability and feasibility of the intervention and research 
procedures were limited familiarity and confidence in using technology, competing demands 
and convenience, negative perception and experience of social interaction and, finally, the 
comfort and convenience of the data collection procedures.  
Limited familiarity and confidence 
Limited familiarity and understanding of the intervention components impacted patients’ 
experience of the intervention. Patients who had limited support from family and friends were 
less able to reach out to others for support in dealing with potential issues with the 
intervention components. For example, a patient who struggled to engage in WhatsApp said: 
P7 (full): And it’s not as if I could go to my partner and say, ‘do you know what the 
devil this is all about?’ I mean he knew about WhatsApp, he put it on my phone, but I 




Experience in using the WhatsApp was often associated with patients’ confidence in using 
the smartphones. One patient declined to participate in the research because they did not 
believe they were good at using a smartphone and suggested that their age was a reason for 
this:  
P15 (decline): well I’m just not very good at. Well, I don’t know really. The 
 phone and what have  you…. 
I’m getting a bit too old for it duck.  
Those enrolled in the study, who did not engage in WhatsApp, reflected on their limited 
experience with technology and often suggested that they were not skilled in using 
technology. Patients’ reported how they have previously struggled to navigate their own 
mobile device and phones at their previous places of work: 
P5 (full): So, it was like they introduced the phones and they started introducing the 
phones when I was at work… 
And what I did I had no idea, I used to do all sorts to it… 
Before going off it was ‘not again what have you been doing to it this time?’ 
Lack of interest in using technology was the reason one patient had never tried learning how 
to navigate a smartphone: 
P3 (full): well I can’t speak for other people but for myself, no well it can’t have done 
any…I don’t know if you have a mental block with these things, you know if you’re 
not interested then you don't have to pick things up as quickly. 
Technical difficulties impacted on the ability to use WhatsApp, and sometimes left patients 




I: so, there was some technical difficulties there.  
P7 (full): Yes. I hadn’t got a clue what to do about it so. I did see somebody, and they 
said ‘ohh it doesn’t matter, it doesn’t matter’ but then after a little while I thought it 
does because you feel something is going on that you don’t know about... 
Outstanding questions about the intervention devices suggested that not all information was 
covered in the study resources, hence impacting their familiarity and confidence with the 
intervention components: 
 P1 (full): Does it go back on its own, to where it was? (the time on the pedometer) 
One patient, who reported having limited engagement in the intervention, struggled to recall 
receiving study resources. For example, when they were asked if they had received an 
intervention manual, they replied: 
P2 (full): don’t think so. 
This could be a result of the patient either forgetting that they received an intervention 
manual, or that they did not receive one during PR. It also possible that patients did not 
receive the information as there was a high number of people who missed PR sessions for 
various reasons, such as illness and family responsibilities.  
Competing demands and convenience 
Most patients led busy lives and reported that they had to manage their schedule to 
accommodate responsibilities such as work, family support and volunteering roles. For some 
patients, their existing schedule impacted on their decision to be involved in the intervention, 
and their engagement in WhatsApp. Busy lives, particularly in combination with other factors 
such as personal issues and health concerns, impacted patients’ engagement in the 




who declined the study reported that they already had a busy schedule, which included family 
responsibilities and days spent driving. Though they reported having intentions to keep active 
following PR, their ability to engage in PA had been affected by a family bereavement and 
their responsibilities involved with the funeral. Other patients’ who enrolled in the study 
report being busy with volunteering roles and hobbies: 
P6 (full): I do the auctioneering for them. Then I get roped into doing other jobs. 
Saturday its bingo, I run that. But it’s like, not for profit. 
Due to patients leading busy lives, some report forgetting to record their steps or have 
stopped using the step diary: 
P7 (full): So, I’d quite often forget over this short period (to record steps). 
WhatsApp could feel restrictive, as it required more maintenance than the other intervention 
components. For example, patients needed to charge the smartphone and connect the 
smartphone to a Wi-Fi connection. Patients would particularly struggle to engage in 
WhatsApp when also dealing with work or health concerns: 
P1 (full): I've only used it [WhatsApp] for the first, I sort of work in the day, long 
hours, and I’m not really a texty…I don’t do a lot… 
It got to a point where I didn’t have the time of the energy to use it. So, I mean I 
haven’t used it in months.  
One patient reported that their PA since PR had been limited by their health concerns and 
caring responsibilities for their family. This meant that they had limited time to engage in the 
intervention, despite believing that WhatsApp was easy for them to use: 
P2 (full): So, I don’t walk very far at all.  




P2 (full): It’s hard to say really because I feel like I have been stuck indoors more. 
But that’s basically because of this thyroid thing and because of keeping a watch on 
my X (family member) … 
So, but yeah. It is really hard to say, because I’ve been stuck at home for months.  
Health concerns, alone, were enough to prevent participant’s engagement in PA: 
P6 (full): and after a couple of weeks it goes back down again but I’m gonna have to 
start the steroids again… 
So, it’s like up and down, up and down. So physically and mentally, it’s like driving 
me mad... 
So, I’ve got to go back to the exercise sessions but it’s just trying to fit in when. 
The pedometer (Digi-walker CW-700) was not convenient for all patients, and many patients 
could not use the pedometer in their daily activities due to issues clipping the pedometer onto 
their clothing, particularly on certain items of clothing, such as smart clothing or elasticated 
waist belts. One suggestion was to wear the pedometer on a belt, rather than clipping directly 
onto clothing: 
P12 (partial): I notice that if I left it off for a day or two that the time on it was totally 
different to what it should be... 
And the steps sometimes it only showed six steps and I’d been all around time and 
that. I mean it seemed to catch up eventually, but I wonder if that was because it had 
been left off.’… 
The only thing is, it’s a pity you can’t, use a belt or something. Well I suppose you can 




Patients also reported difficulties using the pedometer, such as faulty step count displays and 
often worried about losing their pedometer. For example, though another patient reported not 
having any problems with the pedometer falling off, they continued to worry about the 
pedometer falling off: 
P8 (full): But I get, when I’m out, I keep going (moves hand to hip to check the 
pedometer is there), keep going like that to make sure… 
But it doesn’t even work my way up my trousers or nothing... 
It’s really good. 
With regards to a future trial, training to familiarise patients with the smartphone and 
WhatsApp may boost their confidence to integrate the intervention components into their 
busy lives. As the pedometer was difficult for many patients to wear on certain clothing, 
other step counter devices could be integrated in a future trial, potentially enabling patients to 
wear their personal device or a wrist worn device. 
Negative perception and experience of social interaction 
An element of face to face contact and support was considered important, as this enabled 
patients to become familiar with each other. At times, talking to others on the telephone felt 
impersonal for participants: 
P10 (full, withdrawn): I wasn’t particularly keen on using that. I was never kind of 
keen on using any sort of telephone cos I always felt like I was talking to a machine 
rather than a human being... 
And would have been my…(inaudible)…when I talk with other people. Even if I could 




Information from the WhatsApp leader was considered beneficial; however, most patients 
had not met the WhatsApp leader. They suggested that this may have been off-putting for 
group members: 
P9 (full): But obviously…And I think it is hard for people to sort of talk to a phone, 
when they, you know when they’re talking to somebody, they know it’s different isn’t 
it... 
But when they’re just talking to…and I thought that the information thing was good. 
The bloke from X, it was good to tell everybody what was going on and that… 
Though patients had completed PR with other group members, they often did not feel 
comfortable when messaging them on WhatsApp: 
P7 (full): Yeah. It’s another means of support, but I found it hard to(long pause) to 
talk to anyone really. Cos, I didn’t really know them.  
Another patient reported limited engagement with WhatsApp, and they were not confident 
that it was beneficial, unless they had some element of face to face support with the other 
WhatsApp group members: 
P6 (full)…I’ve only used it once or twice when you gave it back to me. But I don’t 
think, in my opinion, it’s going to serve us a lot of good…to me, unless I was going 
back to the group, on a Monday (PA follow on group), it would be ok. 
Some patients were opposed to staying in touch with others via WhatsApp. Those who 
declined the intervention suggested that it felt intrusive and were not interested in the social 
aspect of the PA groups. There were individual differences in the amount of social interaction 




P14 (decline): I’m not a sort of crowd person. So, like, if I go to it, I’d go to the 
exercise part and probably stay for 5 or 10 minutes but I won’t stay there, sort of tea 
and caking it. 
Another patient who enrolled in the intervention but declined the WhatsApp component 
because they did not want to join a group discussion, suggested that others’ experiences after 
PR was not their concern: 
P11 (partial): Well basically I mean that was all I was really interested in, the fact 
that how I got on with that, I wasn’t really interested in joining a group discussion 
and things like that about it, I mean how everyone else manages, that was totally up to 
them.  
Complex and interacting factors influenced patients’ experience of WhatsApp, for example 
group members’ levels of WhatsApp engagement, the number of group members, leadership 
qualities, feelings of belonging, and gender were factors that impacted participants’ 
experiences of WhatsApp. The number of patients involved in the WhatsApp groups ranged 
from two to six. Such small numbers reduced the likelihood of WhatsApp engagement 
between group members.    
Patients were discouraged from using the smartphone and engaging in WhatsApp 
because there was limited communication from those involved in the group: 
P8 (full): No, I don’t use the phone… 
I had one message from XXX (another WhatsApp member) and I replied back and 




No, I don't think it's about people needed. I think what you've done you've been a 
great benefit to all the people in the group. Maybe if there were more people in the 
group then that might have helped. (WhatsApp group) 
Though one participant’s daughter believed WhatsApp was a positive idea, they believed that 
it would be beneficial if more people were included and engaged in the group: 
P8 (full)_Daughter: Yeah but the WhatsApp. If I don't go (to the house) then Mum can 
WhatsApp somebody. If there’s more people in the group then she could WhatsApp 
more people to say, ‘having a bad day’, and then hopefully somebody can reply back 
and pick her up, if that make sense? … 
It’s brilliant, I just wish more people would do it.  
Another patient believed that there were gender differences in the way that WhatsApp group 
members communicated with each other and believed that women may communicate with 
each other more than men: 
P6 (full): So, I think it might be the ladies that do a lot more of the communicating 
between each other. So, this is number 4 talking to number 2 blah blah blah. With the 
guys it's hardly anything at all.  
A lack of communication from the WhatsApp leader also discouraged WhatsApp use. One 
patient recalls a time they attended a PR exercise follow on group, which was led by the 
WhatsApp leader. They felt that it was important that the leader should take responsibility for 
the whole group. However, they believed that the leader only communicated with their 




P7 (full): And with the groups in the halls, if the “leader” is not, is only taking notice 
of the friend she chats to on an everyday basis or is going shopping with then that 
isn’t helpful for, or isn’t a motivation for you to do anything, you know... 
When discussing PA abilities and accomplishments, patients often compared themselves to 
others, for example, patients on the PR programme, ‘normal people’ (people without lung 
conditions) and to their family. One patient who declined the intervention felt that they were 
at earlier stages of COPD to others on the course and felt that the intervention was more 
appropriate for people at later stages of COPD: 
P13 (decline): So to be absolutely honest, I think on the course I was on that I was 
one of the fittest ones there and I felt it wasn’t really necessary for me at the early 
stages of the COPD that I have. So I thought it would of benefitted someone more 
that…I know you didn’t sign up as many people as you wishes but I don’t think I was 
a great candidate for that period of time, and I certainly didn’t want to do it for 
nearly a year. 
Those who compared themselves to ‘normal people’ reported that they could not do as much 
PA, nor keep up, with others: 
P9 (full): And you just you know, think, you know I don’t do loads of steps, like 
normal people. But if you just look at it, sometimes you think ‘oh my god’, you know 
and ‘all these steps’ and it just keeps you thinking about doing exercise and things 
like that. 
P8 (full): Yeah. See I’d never do that in one go, would I?  
Step counters are popular devices, and many of the patients’ family members owned one. 
Some patients compared themselves to family members, who reported doing more steps than 




P3 (full): my Granddaughter has got, what do you call it, a Fitbit? … 
Well it is cos, her mum you see, she takes the dogs out and she’ll do. I said to her 
‘how many you doing?’ and she said ‘like a very, very quiet day is 10,000 plus’… 
And I thought ‘oh my god’. 
Overall, social interaction had different meaning for different patients. Some patients felt they 
would benefit from more face to face contact with the fellow patients and WhatsApp leaders, 
and would perhaps benefit from having more people in the WhatsApp groups. However, for 
some patients, social interaction was perceived as negative and they didn’t want to 
communicate with others following PR. Negative comparison to family members or feeling 
‘left out’ of the WhatsApp group negatively impacted patients’ experiences of the 
intervention.  
When considering a future definitive trial, patients may benefit from face to face 
support interaction from the WhatsApp leader and other group members. This could be 
improved by inviting the WhatsApp leader to PR sessions and encouraging the WhatsApp 
group to meet outside of PR. As some of the WhatsApp groups were low in numbers, 
researchers should ensure that WhatsApp groups have more group members, potentially 
joining multiple PR WhatsApp groups together.  
Though the education talk during PR (delivered by the research team) emphasised that 
all patients have different capabilities, some patients compared their PA capabilities to other 
people, such as their family, and reported feeling demotivated. This barrier could be 
addressed in a future trial by incorporating further education surrounding individuals’ PA 
capabilities, and for potential ‘WhatsApp leaders’ (or someone with an equivalent role) to 




For example, HCPs could emphasise that they should only compared their achievements to 
their personal goals.    
Discomfort and inconvenience surrounding the data collection procedures 
All patients were contacted a minimum of two weeks before each study visit, to provide them 
with enough time to arrange a meeting with the research team. Patients had the option of 
meeting with the researcher at a place of convenience, for example at a community centre 
venue or at home. Although most patients believed that the study visits were convenient for 
them, one patient did not think they had enough time to prepare:  
P10 (full, withdrawn): Er a bit of more notice would be useful because there are 
various other things.  
Patients were asked to complete three questionnaires and a diary at three intervals during the 
study. The only negative associated with the questionnaires was that they sometimes felt 
slightly repetitive: 
P11 (partial): you know, no example like, I would sit there and think ‘I’ve just 
answered that’, maybe in a different format but it’s the same answer. If you’re with 
me. 
One patient did report struggling to remember details of the study when they were being 
interviewed about their experiences of the intervention and research procedures. They 
believed that they may have benefitted from receiving information prior to the interview 
which lists the type of questions that would be asked. They believe that this would have 
provided them time to reflect on the intervention and research procedures: 





Then I could have a think. 
Overall, patients would benefit from more time to prepare for the study visits and more 
information about the sleep diary and the content of the interviews. The questionnaires 
sometimes felt repetitive, and patients may benefit from having less paperwork to complete.   
Patients were asked to wear an accelerometer (Actigraph 3GTX) around their waist 
for seven days, at three intervals during the intervention. For some patients, the accelerometer 
was uncomfortable for a number of reasons, for example it was itchy, or dug into patients’ 
abdomen or back when they slept. One patient had difficulty undoing the activity monitor 
strap because of their arthritis and needed assistance from their partner. Others were worried 
that the activity monitor slipped, meaning that their data would become invalid.  
P2 (full): I didn’t have to do anything with it, I just wore it. So that’s ok, except it 
made me feel a bit itchy but the material. I may have been slightly sensitive to the 
material it was made of. 
Although most patients did not believe the activity monitor was inconvenient, they did note 
that it sometimes it felt unnatural to wear it, simply because they were not used to wearing 
the activity monitor around their waist. 
P10 (full, withdrawn): but it was not particularly inconvenient. Again, it is something 
that we are not normally used to, so that makes you feel uneasy when it’s happening. 
As various patients felt uncomfortable when wearing the activity monitor on their waist, they 
felt they may benefit from having the choice of wearing the monitor on their wrist. As the 
activity monitor strap and buckle was uncomfortable for some patients, they also suggested 
that they would benefit from using a different strap material, or even to remove the buckle 




5.5.1.2 Facilitators to the acceptability and feasibility of the intervention and research 
procedures 
The most common facilitators to the acceptability and feasibility of the intervention and 
research procedures were benefits of support, recognition of progress, convenience, and 
preference of the intervention components, and finally, convenience of the study visits.  
Benefits of support 
Although patients identified various barriers associated with WhatsApp and the social 
support element of the intervention, some patients considered WhatsApp an important 
element of the intervention. For example, WhatsApp enabled another means of support, and 
patients and their families recognised that WhatsApp had the potential for patients get out and 
meet people. 
P8 (full): I think it's brilliant. It gets you out. You meet people because if not, I know 
my daughter is brilliant. She comes every day and takes me. But a lot of them just sit 
their own. 
Family and friends took interest in the study and often supported them with the intervention 
components. Some patients’ family or partners supported them by being present during the 
interview and often expressed interest in the study.  
 Patients made references to their family members also owning a pedometer, and 
suggested that their family were interested in their progress: 
P3 (full): my Granddaughter has got, what do you call it, a Fitbit?  
Right and she came the other day because she knows I’ve got, I’ve got one and she 
says ‘how many have you done? 




the pedometer was a way to engage with their family and to compete to gain more steps. 
Their daughter was enthusiastic about the positive impact of the pedometer on their PA levels 
and suggested that their Mother had significantly increased their steps: 
P8 (full): I’ve even brought my daughter one. 
I: Yeah, so I remember you saying that. Did you buy the same make in the end or was 
it a different one? 
P8 (Daughter): A different one. Yeah, but the kids have got the same one as what my 
mum's got. 
P8 (full): They’ve all got them now. It's competition… 
Daughter: So you was like only doing 300 and now... 
P8 (full): 3 thou (thousand)  
Daughter: To start off with and now she's doing 3,000… 
And sometimes I'm over 4, way over 4.  
Recognition of progress 
The intervention components, particularly the pedometer and step diary, impacted patients’ 
motivation to be physically active. Patients felt positive when they had completed many 
steps, as they could attribute it to their own PA achievement. Recognition of progress 
encouraged patients to do more steps, hence highlighting a virtuous circle: 
P6 (full); I’m happier when I know there’s a lot on there…Cos, I think ‘great, I’ve 
been doing a lot of walking that day’. 
Patients found it important to track their progress and identify if they had a low step count. 




P9 (full): yeah that was a good idea because you’re keeping track aren’t you… 
So, some days I was only doing a thousand and was thinking that I must improve 
(laughs) you know I’ve had a lazy day today and yeah… 
So, it does give you an incentive, definitely.  
P8 (full)_(Daughter): it causes you to walk more, doesn’t it? 
P8 (full): Yes, it does. Cos I’ll sit here and think I haven’t done many steps, I better 
get going.  
Convenience and preference of the intervention components 
Patients considered it easier to engage with the intervention components if they were able to 
develop a habit in wearing the pedometer and recording their daily steps. Some patients 
reported problems in wearing the pedometer and preferred the option of using an alternative 
device, such as a Fitbit. 
P12 (partial): No, I just thought it might restrict me a bit. With the pedometer I can 
just go out and about and do what I usually do, so I prefer that.  
One patient who struggled to wear the pedometer due to skin sensitivities decided to 
improvise by using their Fitbit and recording their steps from this device instead of the study 
pedometer: 
P2 (full): I mean I’ve got a Fitbit. I could always take the daily steps off that. 
Once patients got used to the pedometer, wearing the pedometer became habitual: 
P6 (full): But that's the activity I've been doing. Most of the time I forget it's there... 
And then I go to bed and that's it. You don't think about it in the daytime, it's been that 




Patients appreciated the simplicity of the step diary and reported being in a habit of recording 
their steps: 
P4 (full); Yeah so, the paperwork is on the bedside cabinet With a pen, Just unclip it 
at night time, write it down and that's it… 
The automatic, you forget after a while, but you still do it automatically (step diary). 
When patients were asked about their preferences of how to report their steps, they suggested 
that the paper step diary suited them: 
P9 (full): I quite like the paper diary, cos yeah. I mean, I probably could record it on 
my phone but that’s alright for me really, a paper diary cos it’s something to write 
everyday (laughs). 
Overall, the convenience of the intervention components was important to patients, as most 
patients reported leading busy lives. If patients perceived the intervention components as 
simple and easy to use, the more likely they were to integrate them into their daily lives.  
Convenience of the study visits 
Most patients were satisfied with the study visits from the research team. For example, most 
patients believed that two weeks to prepare for the study visits provided them with plenty of 
notice. For those that could not travel to a local community venue to meet the researcher, they 
were happy to receive a home visit from a member of the research team: 
P12 (partial): Yeah, they’re fine (research visits).  
Although it took many patients a few days to adjust to wearing the accelerometer around their 
waist during the three intervals throughout the study, most patients did not consider the 
activity monitor as disruptive in their daily activities:  




P12 (partial): Oh yes it was, yeah. Even wearing it at night it was quite alright. Mm 
yeah. 
Patients also accepted that completing questionnaires and the sleep diary at three intervals 
throughout 12 months was part of the study, and that these were not too time consuming or 
tedious: 
P6 (full): No trouble at all (completing the questionnaires and sleep diary).  
P1 (full): It was easy enough, wasn't it? (completing the questionnaires and sleep 
diary).  
Overall, most patients were satisfied with the study visits. If they had competing demands, 
for example hospital visits or health concerns, they were able to rearrange the study visit to 
suit them. As the research team had direct contact with all patients, they were able to help if 
patients had questions about the activity monitor or the questionnaires.  
           Prior to a future definitive trial, patients should have the necessary knowledge about 
the study and receive both oral and written information about the intervention during PR. 
Researchers should consider giving patients more time to prepare for the study visits. As 
some patients felt the questionnaires were slightly repetitive, the research team should 
consider methods to make these easier to complete. Patients should also be further prepared 
for the interviews and reminded about the intervention and research procedures prior the 
interview. The accelerometer should be comfortable for all patients and researchers should 





5.5.2 WhatsApp Leaders 
Five WhatsApp Leaders participated in a focus group to discuss their acceptability of the 
intervention and research procedures, in line with guidance from the MRC for process 
evaluations.160 WhatsApp leaders were volunteers from COPD patient groups based in 
Lincolnshire and Sheffield who had received face to face training from the Chief Investigator 
(see the Methodology for more information, Chapter 4). Of these five WhatsApp leaders, 
three WhatsApp leaders had been involved in the WhatsApp groups since the beginning of 
the intervention. Two WhatsApp leaders had replaced previous volunteers who had 
withdrawn from the study.  
As the WhatsApp leader’s role was to communicate with patients via WhatsApp, the 
results are focused on the acceptability and feasibility of the WhatsApp component of the 
intervention, as well as the accompanying research procedures such as the recruitment of the 
WhatsApp leaders and exporting the WhatsApp chat to the Chief Investigator.   
A thematic analysis was conducted to explore the acceptability and feasibility of the 
intervention and research procedures from the perspective of the WhatsApp leaders. The 
overarching themes were the ‘facilitators’ and ‘barriers’ of the acceptability and feasibility of 





Figure 5:4: A concept map illustrating WhatsApp leaders’ acceptability and feasibility of an 
intervention, and associated research procedures, to promote PA following PR in COPD
5.5.2.1 Barriers to the acceptability and feasibility of the intervention and research 
procedures 
The most common barriers to the acceptability and feasibility of the intervention and research 
procedures were familiarity and convenience of the intervention components, limited rapport 
with the WhatsApp group and, finally, the recruitment of the WhatsApp leaders.  
Familiarity and convenience of the intervention components 
WhatsApp leaders suggested that patients were not familiar or confident with using 
technology. Age was given as a reason that some may not be as familiar with technology.   
WL1: Are the people in the group given the phone as well? … 
I think. I don’t know whether…I think you told me one was quite elderly…. 
And I think if they’re not…with tech (in audible) 
WL2: Familiar with technology. 
In this study, only one WhatsApp leader was able to attend two PR groups prior to becoming 
involved in the WhatsApp groups with patients. For a future definitive trial, WhatsApp 




familiar with the smartphone during PR. For example, WhatsApp leaders, or other volunteers, 
should attend PR in a future study to help patients practice using the smartphone. Asking the 
WhatsApp group to practice using WhatsApp and enabling the group to ask questions at a 
later follow up session was a method that was suggested for the future definitive trial: 
WL1: Get them to do the messages to each other just for a practice.  
WL3: Yeah and when you…that’s what I was thinking. And when you go back…the 
WhatsApp leader could go in maybe the last 6 sessions.  
WhatsApp leaders were provided with a pedometer and a step diary prior to the intervention. 
Though WhatsApp leaders enjoyed reflecting on their daily steps and felt the pedometer and 
step diary were important to incentivise themselves and patients to do more activity, the 
pedometer was not always comfortable and convenient for WhatsApp leaders. For example, 
the pedometer was not comfortable for one WhatsApp leader, it did not stay attached to their 
clothing and was easily misplaced. Pedometers and step diaries were considered old 
fashioned, and devices such as Fitbits and activity trackers on people’s mobile phones were 
considered more convenient. WhatsApp leaders considered themselves reliant on technology, 
and one individual preferred to record their daily steps on an excel spreadsheet:    
WL1: I didn’t mind using it, in fact I thought it was quite good to look and ‘Oo’ 
WL5: it is.  
WL1: Cos if you’re near to. Or near to like 8000 steps, well you think ‘oh ill just 
do…I’ll just go over there…I’ll just do that to get to 8000’ 
WL3: yeah 
WL1: well I think that’s pleased me but I was just so frightened of losing it and saying 




WL5: so was I.  
WL1: I’ve not kept up with the step diary cos it was something to do…to write down 
and record it and I relied too much on technology and other things so if I’m honest… 
Though WhatsApp leaders agreed that pedometer sometimes provided feedback which 
motivated them to be more active, they did report various issues when using these 
components. WhatsApp leaders did not explicitly state that the pedometer and step diary were 
necessary for their involvement in the intervention. As WhatsApp leaders were already 
motivated to remain active following PR, this raises the question of whether they should be 
provided with the step diary and pedometer in a future trial.  
 WhatsApp leaders considered the smartphone simple to use when sending messages 
to the WhatsApp groups. However, WhatsApp leaders reported practical issues such as low 
battery and problems maintaining a Wi-Fi connection: 
WL5: It’s fine, I’m quite happy with it.  
WL1: it’s fit for purpose.  
WL2: it does “the job”. It eats the battery.  
WL5: Because I didn’t have a problem with the phone. The only problem I had with 
the phone is that my Wi-Fi kept dropping out and I didn’t realise that it wasn’t going 
to automatically connect again when it came back in because I thought that’s what it 
would do. But it didn’t. I had to keep putting it back in so we had an awful lot of 
trouble with our Wi-Fi and we’ve changed it three times, the code. So it’s alright now, 
so that wasn’t a problem with the phone. That was just a connectivity problem.  
WhatsApp leaders believed some patients may have had limited understanding of the 




smartphone and pedometer were often fit for purpose, WhatsApp leaders often preferred 
using alternative devices, for example their personal smartphone and step counters such as 
‘Fitbit’, which were considered more convenient for them.  
Limited rapport with the WhatsApp group 
The WhatsApp guidelines provided a set of example messages for WhatsApp leaders to send 
to the groups. The guidelines also outlined instructions for WhatsApp leaders to send, for 
example, they instructed the WhatsApp leaders to send a weekly PA reports to the WhatsApp 
groups. Despite trying to connect with the WhatsApp groups, WhatsApp leaders reported that 
they had received limited responses from the group. Though WhatsApp leaders understood 
the reasoning behind the structure of the WhatsApp messages, WhatsApp leaders avoided 
some of the messages outlined in the WhatsApp guidelines, as they did not feel appropriate 
and considered them as patronising.  
WL3: Cos I felt. I must…I never put in ‘if you like, you can use a fridge magnet and 
put the step diary on your fridge!’ 
WL5: No 
WL3: Or ‘if you put it next to you, where you can see it’…No I thought… 
WL5: It’s a bit too much isn’t it.  
In attempt to engage patients in conversation in the WhatsApp groups, one WhatsApp leader 
reported trying to be more social and another WhatsApp leader often sent messages about 
their experiences of PA:  
WL5: Cos I think if they know how I find doing that, then that might encourage them 
to have a go. Because there’s more than one Tai Chi class around the area around 




to them about their steps – ‘have you done your steps?’ and ‘have you been recording 
them?’ and ‘how are you doing?’ But nothing. And I’ve not stuck to the script in here, 
but I’ve tried to be more social with them to try and engage them, but that doesn’t 
work either. (laughs) 
WL3: yeah with my lot I’ve got photographs where I went to Blackpool illumination, 
so I send and say ‘this is what I’ve been doing. I always connect it, saying I’ve walked 
up and down Blackpool prom which was 8000 steps, how you getting on? You know. I 
didn’t do much this week because, you know, I was breathless or you know, I did 
something, cut my finger. So, I’m…so I’ve only done 3000 steps, how many have you 
done?  
Low engagement of patients was also attributed to the group not knowing the WhatsApp 
leaders. Though patients in two PR groups met the WhatsApp in person leader during PR, the 
other patients had not met the WhatsApp leader prior to the intervention: 
WL3: So, I’m XXX (name) and I’m from Lincoln and I’m WhatsApp leader for 
Gainsborough and Skegness. And I met the Skegness people briefly, but I didn’t meet 
the Gainsborough people. 
WL4: Haven’t met any of them. I think at the moment it’s dwindled down to two 
people. And I’ve not had any responses from anybody. 
Despite WhatsApp leader’s efforts to engage the WhatsApp group in conversation, there was 
limited communication between patients and the WhatsApp leaders. WhatsApp leaders 
suggested that patients would be more likely to engage in the conversation if they had met the 





WL1: That was, that was the plan. But I think it’s. The opportunity is if in the 
beginning of that programme you’ve got phones that you can send messages to and 
people get used to it. And it’s also then people are then motivated cos they like. I 
mean it becomes a little like…like the group I started in…people got on. We got on. 
To move forward with a future definitive trial, face to face support was considered important 
in maintaining contact with the group and keeping patients connected. Regular meetings with 
group members could be a way to draw people 'out of their shells and help build a rapport 
with patients. Being familiar with the group enables them to follow up with patients who 
might be struggling, in a way that does not feel intrusive.  
WL5: I think they do and then obviously the groups that we have are fairly local to 
each of us as individuals so once you’ve met face to face, once twice then you get 
everyone as an individual. Some people take two or three meetings before they sort of 
come out of themselves. But I think that…I think that would give them more, through 
this… 
So, we would probably message more to them because we would have a communicate 
interaction... 
Built on the grounds of the face to face contact.  
WL3: But at the moment I can’t phone round anybody because I think its intrusive, 
isn’t it.  
WL5: Yes exactly. Exactly. I don’t know these people or anything about them. So, I 
wouldn’t know what to say to them.  
WL3: Mm 




WhatsApp leaders also felt that regular face to face meetings with patients in the WhatsApp 
groups could lead to the development of a larger network of patients who could meet. Face to 
face meetings were a way that group members could discuss their issues and motivate each 
other to stay active: 
WL3: Or as the main thing. But is that part of the, is that what you want? To end up 
with this network of…cos of course once we get. Cos if it’s us 5 in here for instance 
and we’ve all got our groups. Once we’ve got to know them really well, we could say 
‘do you want to meet up all together?’ so you’d end up with 50 or 60 people all going 
across the 5 groups and countywide and then nationwide. We could all be talking 
and… 
Though face to face support was considered important, there were practicalities that needed 
to be overcome. For example, finding a date that suits everyone would be challenging, and it 
would be important for the WhatsApp leaders to live near other group members:  
WL3: Yeah, I think yeah so, I think it would have to be quite local wouldn’t it.  
Connection with other volunteers was also considered important for a further trial. This 
would enable volunteers to share their experiences and potentially alleviate any worry that 
group members have not responded to their messages. Contact with other volunteers would 
also enable volunteers to offer advice for engaging with the group: 
I: So, there was a bit of interest in getting a WhatsApp group together for all the 
WhatsApp leaders. Would this be something that we could do in the future, just to get 
a sort of group together with all the volunteers to carry on? As WhatsApp leaders or 
the equivalent? 




WL1: I’d like to have known early, that you weren’t getting a response (laughs).  
WL2: It’s exactly what I was going to say.  
Further research should focus on the development of an intervention which enables 
WhatsApp leaders and patients to maintain face to face support following PR. Though there 
are challenges involved in the organisation of these meetings, face to face support was 
perceived as a necessary step which would benefit both WhatsApp leaders and patients.    
Recruitment of WhatsApp leaders 
The research team recruited WhatsApp leader volunteers by attending COPD patient support 
groups and introducing the study. All WhatsApp leaders who volunteered to take part in the 
study were provided more information about the research procedures from the Chief 
Investigator. WhatsApp leaders had no issues with the way that they were recruited to the 
study but reflected on how there was only a limited number of people who were interested in 
becoming a WhatsApp leader.   
WL3: No, I felt recruiting us was fine but…X (WL1), how many of your PR group 
went on to do this social group? Was it all of them? Some of them? 
WL1: Some guys are on a Thursday and a Tuesday, so you know, not all together but 
I’d say in my group there was 15.  
WL3: So. But, out of the group when you went to see us, I think I was the only 
enthusiastic one about becoming a WhatsApp leader.  
As there were only a limited number of WhatsApp leader volunteers for this study, this has 
implications on the feasibility of a further intervention. Changing the way that WhatsApp 
leaders are recruited for the study, for example by recruiting patients at PR, may improve the 




 Despite WhatsApp leaders’ willingness to be involved in the intervention, some 
believed that a social support network led by patients from PR was the most feasible way to 
continue social support in the long-term. One WhatsApp leader sending messages to many 
PR group may not be possible. Volunteers suggested that they attend PR to discuss the 
benefits of maintaining PA and to suggest that PR members create their own social 
networking groups. This would also mean that the groups would already be familiar with all 
the group members and would not have an ‘outsider’ sending messages.  
WL3: As WL1 said, say if I went along to a Lincoln group then the best outcome 
would be if someone else wanted to be a WhatsApp leader. Because if I went to this 
group and I get some from another group then… 
WL5: Yeah 
WL3: …You think well I’m sending messages to 15 groups now.  
5.5.2.2 Facilitators to the acceptability and feasibility of the intervention  
Although there were various barriers to the acceptability and feasibility of the intervention 
and research procedures, there were several factors that facilitated WhatsApp leaders’ 
acceptability of the intervention. The facilitators to the acceptability and feasibility of the 
intervention included the following subthemes: commitment to the WhatsApp leader role, 
connection with patients and fellow volunteers, and goal setting as an important element for 
patients.    
Commitment to the WhatsApp leader role 
WhatsApp leaders considered the intervention important. When asked if the WhatsApp 
leaders would like to have further involvement in shaping the intervention for the future, 
WhatsApp leaders outwardly expressed interest. They felt passionate and that there was a 




WL3: No, I’d be very interested yeah. You know cos you get involved in something 
and you feel passionate. Well, not passionate…that sounds like it’s coming off the 
telly doesn’t it ‘I’m so passionate… 
WL5: There is a sense of purpose to it. 
Two WhatsApp leaders based in Lincolnshire believed they could commit to becoming a 
WhatsApp leader in a further intervention. For example, one WhatsApp leader said they 
could attend all the PR sessions to meet with potential WhatsApp group members, whereas 
another felt they could attend at least a couple of the sessions. WhatsApp leaders were willing 
to help in a further study, but reported time restrictions due to prior responsibilities and 
limited ability to travel: 
WL3: And we wouldn’t have to go to 12 sessions would you, you know, but I would.  
WL5: I could go to the odd one, you see. 
Not all WhatsApp leaders were based in Lincolnshire and considered that a local WhatsApp 
leader could be more appropriate in a further study. WhatsApp leaders’ passion for research 
and development was clear in their commitment to the research procedures. Despite limited 
engagement, and sometimes no response at all from the WhatsApp members, the WhatsApp 
leaders all reported that they regularly sent messages to the WhatsApp groups in line with the 
protocol for the study. WhatsApp leaders had therefore been sending out a minimum of one 
weekly message.  
WL4: although I do find it. I don’t have difficulty sending the messages out, that’s 
fine, that’s not been a problem at all. So, I’ll keep going and hope that there’s 
somebody out there.  




WhatsApp leaders did not find it difficult to send out the messages, and reported that they 
formed a routine of sending the messages out: 
WL1: I just got a thing where I put it on Monday night and then that’s it.  
WL5: I do mine on Monday or Tuesday. And I do Tai Chi and I tell them sometimes. 
There’s only two but I tell them sometimes how I’m finding that.  
WhatsApp leaders rarely forgot to send out the WhatsApp messages, and when they did, it 
was only occasional: 
WL3: …It’s been quite good. But I did lapse last week. 7th of July, 7th of June was the 
last time. So, I missed one. So, it’s been, been ok. 
Connection with patients and fellow volunteers 
WhatsApp Leaders considered sending messages based on their personal experiences as more 
natural and they believed other group members would relate to their experiences and sense of 
humour. Relating the messages to their own experiences, by using anecdotes, was considered 
more acceptable. This was an approach that felt more natural and avoided them feeling as if 
they were patronising the group. Sending a joke to the group was a method to engage with the 
group, as one member hoped that humour would lighten the mood, and perhaps help the 
group start thinking about PA, or even trigger a response: 
WL5: I haven’t said that. I’ve said to them, ah what was it, when it was raining so 
much, I said ‘has you got webbed feet yet? It’s very difficult to get your steps on a day 
like this’. Things like that.  
Because that I think is…whilst there is a serious side to what we’re doing, someone 
reading that message will say ‘ahh that’s really funny’…. 




WhatsApp leaders shared their experiences and one individual commented how they liked the 
idea of sending more personal messages. They compared the messages to information that 
they would hand out to strangers.  
WL3: Of when I went to Blackpool, of the illuminations, and you know, just all sort of 
quite friendly things.  
WL1: That’s quite nice. I just send very small like ‘hi, you know, I’ve not done this, or 
I’ve done this or I’ve been at home, had to give it a miss this week because…’ but no 
response you know, you feel maybe they’re not…you know why would they be 
interested in someone they’ve never met, and somewhere they haven’t been (laughs).  
WhatsApp leaders reflected on the importance of social support in motivating themselves to 
maintain PA, and therefore believe it could help others. WhatsApp leaders recognise the 
value of social support and how this motivates them to stay active following PR: 
WL5: And because there’s two of us doing it, we make it continue (physical activity).  
WL2: It’s very difficult to do anything on your own, even if you’re surround by people 
that you don’t know, it’s very difficult to do anything on your own. Whereas the group 
that came from the NHS PR to continue at the gym has struck together.  
WhatsApp leaders suggested that an alternative social networking application to WhatsApp, 
such as Facebook, may be more beneficial in building a connection with patients and other 
WhatsApp leaders. For example, it would be possible to have a private group, yet more 
freedom to chat with other WhatsApp leaders. WhatsApp leaders considered Facebook as 
more personable, as it enables group members to upload their own profile picture and 
potentially share other pictures. Facebook was also considered less formal and a more user-




WL1: Facebook. Mm, Facebook group… 
You can have a private Facebook, can’t you, where people can join.  
WL4: Yeah cos ive wondered sometimes whether the actual format of the WhatsApp 
message, it’s not really very easy to read, is it? It’s a lot of scrolling down and… 
Goal setting as an important element for patients 
WhatsApp leaders considered goal setting as key in motivating patients to stay active. 
However, goal setting as part of an intervention was considered tricky due to variations in 
patients’ exercise capabilities. The inclusion of physiotherapists could be a potential way to 
minimise the risk involved in setting goals, for example goals could be tailored to everyone.  
WL5: I think setting goals is a good idea because it gives something to aim for. It’s 
the same problem in school. If you don’t give them something to aim for, they’ll do 
whatever they want. But you’re also, when you’re doing that, you need to account for 
not everybody, it’s not a level playing field. Some are far more ill than others. So, 
you’d have to give a personal goal...  
WL3: But then the physio, when you do the PR, the physio takes your initial baseline 
results.  
The current step diary was considered a way for patients to set their own goals, as patients 
could set their own targets based on their previous PA.  
WL3: That’s a good, that’s a good idea. Cos also if we’re getting the people as 
motivated as we are, then if you put down 3000, 3000, 3000, 1500, then you’re going 
to be disappointed in yourself a bit aren’t you, so you’re gonna go for 4 and a half 
thousand or even keel. But you’ve got a reminder. I mean I don’t know how many 




5.5.3 Health care professionals 
Seven HCPs that supported delivery of the intervention in the feasibility cluster randomised 
controlled trial (CRCT) participated in a Focus group which took place in September 2019. 
These included three Specialist Physiotherapists (Resp) and four assistant physiotherapists of 
LCHS. At least one HCP (responsible for supporting delivery of PR) present from each 
region of Lincolnshire, (North East, North West, South East and South West Lincolnshire). 
HCPs had been involved in the delivery of the intervention for at least 10 months.    
A thematic analysis was conducted to explore HCPs acceptability and feasibility of 
the intervention and research procedures. As HCPs only observed patients’ experiences of the 
research procedures and intervention during PR, the themes are mostly based on the 
introduction of the intervention during PR. The overarching themes included the ‘facilitators’ 
and ‘barriers’ of the acceptability and feasibility of the intervention and research procedures.  
 
Figure 5:5: A concept map illustrating HCPs’ acceptability and feasibility of an intervention, 




5.5.3.1 Barriers to the acceptability and feasibility of the intervention and research 
procedures 
There were various factors that impacted HCPs’ acceptability and feasibility of the 
intervention and research procedures, such as limited familiarity of patients with the 
intervention components, timing of the intervention and the delivery of the education session 
and finally, exclusion of patients from the trial.  
Limited familiarity of patients with the intervention components 
Technology was often considered an obstacle due to patients’ limited familiarity and 
confidence with the smartphone and pedometer. 
 Prior to the intervention there was scepticism about how patients would engage with 
technology. Information about the intervention was delivered during a PR education session, 
as it was considered important for all patients to receive this information: 
HCP1: I was sceptical, and I think we had a lot of conversations around that 
anyway…  
I think I felt a bit sceptical about individuals actually using smartphones. But that’s 
not me being ageist (laughs) that’s just concern ‘was it going to work’… 
In terms of technology and how that would in terms of people accessing your 
education, obviously on setting it all up. I think it was very pertinent to make sure that 
all those individuals that were interested were going to get that education on the 
smartphone and how was that being followed up. So, I was a little bit sceptical on that 
at first.  
The smartphone and pedometer were perceived as complicated, for example patients asked 




This highlighted the importance of training and education for patients to become familiar 
with the intervention components. 
HCP2: I really think that the technology is the bigger obstacle for them.  
HCP3: And some people did feedback about the pedometer. Sort of, I can’t remember 
it exactly because it was so long ago, but it was something to do with re-setting it 
each day and how it reset. If there was something they needed to do or if it was 
something automatically… 
HCP2: …for some people was complicated. The phone was complicated. So, the 
phone was like ‘no’ for a lot of people because it’s a phone. The pedometer was 
complicated as well. 
Timing of the intervention and the delivery of the education session 
HCPs did not have first-hand experience of the intervention components, and therefore 
offered limited insight into the acceptability of the content of the intervention for patients. 
HCPs mainly suggested various ways in which the research procedures and the introduction 
of the intervention within PR could be improved for future research.   
 Due to the complexity of the intervention, HCPs felt that the amount of information 
delivered to patients could have been overwhelming, which raised questions of the optimal 
method to deliver this information: 
HCP2: I would say no. It was quite a lot of information in quite a short period of 
time. That was my feeling cos I was ‘what? Talking on the phone and then the 
pedometer’, so it was a lot to take.  




HCPs reflected on there being a rapid evolution of technology, meaning that it would be 
difficult to predict what social networking site could be appropriate for a future trial:  
HCP1: and in terms of the apps and technology that’s available to use… 
We’re looking at a completely different ball game probably. 
However, HCPs believed that patients would be confident with any social networking 
application used in a future study, as long as they are confident in using a 
smartphone:HCP2: I think if they get on with their phone then they get on with the 
app.  
HCP1: Mm 
HCP2: That’s my observation.  
This highlights the importance of training patients to be comfortable in navigating the 
smartphone used in a further trial.  
 The optimal method and time to introduce the intervention to patients were based on 
various factors, such as the time available during PR, the workload of HCPs, time patients 
need to become familiar with the intervention components and whether intervention should 
be delivered as a group or individually. However, HCPs hoped to learn from the experiences 
of the intervention delivery during the study and were open to changing the method of 
delivering the information: 
HCP1: Yeah, it was a dilemma if I remember rightly. When looking at the protocol, 
how long it would take to teach a patient how to use the phone and the pedometer, 
and the accelerometer and everything together. And I think hence why that’s why we 
decided to do it in a group setting. I don’t know, I didn’t see one of those training 




more experience of them, but it’s difficult but one to one, do you think that perhaps 
patients would have got on with that better? 
Due to the complexity of the intervention, HCPs believed that the quality of the training and 
information provided to patients was important. However, due to their workload during PR, 
and particularly considering the change in the local PR programme since the study (now 
twelve classes instead of sixteen in the current study), HCPs were not sure how and when this 
information should be delivered:     
HCP2: But it’s another thing to do on pre assessment. And on pre assessment it’s 
already busy enough and a lot of information so from my selfish perspective I’d prefer 
if the University introduced this study rather than if I’d got another thing to talk to 
them.  
HCP2: Yeah or come into pulmonary rehab and just, I don’t know, after or use the 
rehab. You can use the rehab to do it so you don’t have to make another appointment 
or you don’t have to make another appointment because I know some patients have 
quite few appointments in their week (laughs). It’s also always a problem.  
There were different opinions of when it would be appropriate to introduce the intervention 
during PR, for example during the ‘introduction to PR’ or the ‘benefits of exercise’ session. 
Some physiotherapists believed it would be possible during the introduction to PR, whereas 
others did not believe they would have the time.  
HCP1: Yeah but you’re doing all the explanation to the exercise and you’ll have to 
say that I. Every session that I do, I fill that hour. With the explanations of what 
they’re doing or all the exercises.  
HCPs offered different methods of introducing the intervention to patients and discussed the 




and who the best person would be to deliver the information. HCPs often drew from their 
experiences during PR and with previous research studies: 
HCP3: There’s the open forum. And like we had the telehealth person. I know that’s 
not the right word for that project but they came in and gave a quick ten minute thing 
so it was like, if you had the volunteers to support you all the time then maybe that 
talk that you do wouldn’t have to be as long. And it could maybe be... 
HCP2: Yeah but then you’re thinking about introducing it a little bit earlier during 
pulmonary rehab as well. And then the open forum is at the end. So, we sort of leave 
them until we finish the programme. They finish one but then they want to start 
another.  
Delivering information about the intervention in person was perceived as a better way to 
engage patients in the intervention. Reliance on leaflets and written information was not 
considered effective, and this had not worked in previous studies: 
HCP2: In my opinion you won’t get much intake if you give them a leaflet rather than 
come and introduce yourself.  
HCP3: Well it happened with that telehealth thing that she came and did… 
HCP2: Yeah (laughs) 
HCP3: ...10 minutes and then was like ‘well I’ll leave these leaflets and… 
HCP2: yeah 
HCP3: …not a single person picked… 
HCPs questioned who the best person would be to deliver the information, and wondered if 




HCP1: Yeah what I was saying. X (Researcher X), is there anything that you can 
think of in terms of. You know if one of your team is there and selling the research. 
That is there a….do patients potentially feel more pressured to say yes but then not 
necessarily sign up to it in the long term? As opposed to potentially us introducing it 
so slightly earlier. Even if it was with literature and then you coming in. Is there 
element of ‘well I ought to say yes because they’re here in front of me’. I don’t know 
whether there’s a…a behavioural aspect. 
Delivering information about the intervention components individually, rather than in a group 
setting, could be more appropriate. Due to individual differences within the patient groups, 
HCPs suspect some patients struggled more than others. By identifying patients who 
struggled with the intervention components, information could be tailored for them: 
HCP2: Laughs. The only idea I have for this is for people that do struggle, that you 
see struggle, arrange another appointment and to just do it one to one and just 
individualise it.  
HCP1: So, a follow up after that individual follow up.  
HCP2: Cos the group introduced, but maybe an introduction, just not as much 
information. And then let them know, if you are interested and then I can show you the 
gadget and then you can show them the phone and things like that.  
The HCPs often provided the research team with assistance during the study. For example, 
sending GP letters for those involved in the study and following up with patients who were 
difficult to reach. Though HCPs were happy to help, they were concerned that this would not 
be feasible in the larger definitive trial. However, including other people in the delivery of the 




HCP3: So even just with this smaller scale one, there’s been a few people to follow up 
on. In terms of a few people that have dropped out and investigating their patient 
records and sending them a letter and that work has fallen on assistant type things. 
So, on a much larger scale… 
Volunteers from COPD patient support groups were involved in the delivery of the 
intervention. Involvement from patient volunteers in the introduction of the intervention 
could be a method to ease HCPs workload, but also a method to improve patients 
understanding of the intervention and perception of peer support. HCPs suggest that patients 
were embarrassed to ask questions about the intervention components during the education 
session. However, patients may feel more comfortable asking patient volunteers for support: 
HCP3: The volunteers that helped moderate the WhatsApp group. Could there be 
scope for those sorts of volunteers to support… 
HCP1: That’s a good idea… 
HCP3:..getting patients to, even if they came to pulmonary rehab classes or. Because 
a lot of them are expected to be familiar with us and the things we do and things like 
that.  
HCP2: yeah, well that’s what it is, isn’t it. Cos it’s like maybe they feel like they 
should know that.  
HCP1: Oh, ok so you maybe feel like they hadn’t asked the questions.  
HCP2: Yeah, I’ve seen people that were maybe a little bit embarrassed, especially 
men, and they’re a little bit embarrassed that they don’t know how to use the phone. 




more. And you know, maybe I can help, maybe this, maybe that. And if the peer doing 
it, it is different.  
HCPs recalled other research studies which were conducted during PR, meaning that HCPs 
had knowledge of the practicalities to consider when conducting research alongside PR. A 
previous study included the assistance of another HCP, with expertise in technology, whose 
role was to provide additional support to help patients become familiar with technology: 
HCP1: Ok. Just thinking about the work that they’ve been looking at with the COPD 
app, and that band 4… 
HCP4: Yeah, I was thinking about that earlier. 
HCP1: Ok, right. I was just thinking that if a similar thing happened, then potentially 
we could get an individual… 
HCP4: Oh, ok yeah, an individual that they could go to. 
HCP1: Yeah.  
HCP4: For support… 
HCPs considered that support from the research and development team is an option for a 
future larger scale trial: 
HCP1: So, on a larger scale then maybe it would be the administrator from the 
research side that would perhaps need to be… 
HCP2: Maybe the research team. If they could give us a hand, like they did with this 




The research team should consider the workload of HCPs and identify other HCPs and/or 
patient volunteers to help with the delivery of the intervention during PR in a larger scale 
trial.  
 The research team should consider the workload of HCPs during PR when 
introducing the intervention to patients. As PR is now a shorter programme, the research team 
needs to consider how and when to introduce the intervention. HCPs were clear that patients 
respond to information delivered in person, rather than written information, and may benefit 
from further support when familiarising themselves with the intervention components.  
Exclusion of patients from the trial 
PR programmes recruit patients with a variety of lung conditions, hence patients form 
friendships with non-COPD patients. However, the intervention was limited to the 
recruitment of patients with COPD and did not include other patients with different lung 
conditions. HCPs felt the non-COPD population felt excluded and considered it important 
that a future intervention is inclusive of all patients, not just those with COPD:  
HCP2: And the IPF patients felt left out.  
HCP1: Yeah. And I think really in terms of looking at your long term aims which is 
obviously to look at post pulmonary rehab, continuing to exercise, it should be 
inclusive of all those patients rather than just selective really, in the long run.  
Exclusion of patients with non-COPD lung conditions was a barrier to the trial. For example, 
exclusion of patients meant that WhatsApp groups were even smaller, and limited potential 
engagement of patients in the WhatsApp groups. PR included patients with various lung 
conditions, not limited to COPD, hence recruitment of COPD patients only may have 




throughout PR could not be maintained throughout the intervention. Inclusion of all patients 
may positively impact recruitment in a definitive trial.  
Inconvenience of the existing intervention components 
HCPs believed that convenience was a factor that influenced patients’ experiences of the 
intervention. Patients who enrolled in the intervention were provided with various study 
devices and materials, including a smart phone, pedometer, and a step diary. However, 
patients were using the study devices alongside their personal devices. HCPs suggested that 
some participants had difficulties wearing the pedometer and HCPs felt that using two 
smartphones would was inconvenient for participants.   
Measures to protect patients’ anonymity in the WhatsApp group included removing 
patients’ names from the WhatsApp groups and asking group members not to share personnel 
details.  HCPs believe the restrictions to protect patients’ privacy on WhatsApp meant that 
WhatsApp felt impersonal for patients. Patients often shared their personal details over 
WhatsApp and told other group members who they were, suggesting that patients were not 
concerned about this.  
 HCPs believed a future intervention should focus on reducing the number of devices 
that patients are provided. Enabling patients to use their own smartphone and to use the step 
counters on their smartphone are methods to reduce the complexity of the intervention: 
HCP2: The other thing with the phone is like you have two phones. They sort of. So 
for like app or something like that for somebody who wants to have a phone, rather 
than just on the phone, another thing to carry and to think about.  
HCP3: Do most phones have like a step count… 




HCPs considered other social networking applications, such as Facebook, as more 
appropriate than WhatsApp, as it enables patients to share personal information, such as a 
profile picture of themselves: 
HCP3: Oh, another thing that I remember about it was the sort of anonymity of sort 
of ‘patient 1, patient 2’… 
And you know, yeah, I don’t even know. Often times on WhatsApp, maybe like on 
Facebook you have a picture of the person and I guess maybe a patient could have 
put a picture, could they? 
I think patients quickly figured out who they were talking to, didn’t they? 
They just said ‘hi it’s me, X (patient name)’ or something like that (laughs).  
Facebook would provide patients the option to both join and exit groups when they wish: 
HCP1: If you set up Facebook messenger and get a messenger group set up, if you’ve 
got one particular set of patients that want to communicate with each other, but it’s 
also easy to come off it. 
Based on the HCPs suggestions, researchers should consider reducing the complexity of the 
intervention, and enabling patients the freedom to share their personal information.   
5.5.3.2 Facilitators to the acceptability and feasibility of the intervention 
Integration of the research study with the PR service 
Information about the study was circulated with HCPs prior to the study, and the research 
team communicated with staff to organise study practicalities such as the timing of patient 
recruitment and the education session. HCPs believed they had enough information to 
prepare for the intervention: 




So, I was very much aware of what your plans were…  
Obviously, I’m not sure about everyone else in the room.  
HCP4: Yeah sorry I was as well.  
HCP3: Yeah, we rearranged a lot of the dates between us with the courses with when 
would be the best times to come in… 
HCP3: And I feel like that worked fairly well, yeah.  
The feasibility study was designed in a way that the intervention would not impact the quality 
of PR. Time to enrol the patients in the study and to provide further information about the 
intervention was taken out of PR, however HCPs did not believe that this negatively 
impacted patients experience of the programme. Sometimes patients did not complete their 
exercises during PR, but this was not considered a problem because patients could complete 
these at home: 
I: Ok and again, in terms of us impacting on pulmonary rehab itself, do you think that 
happened in a negative way during this study? Did we take maybe people in 
pulmonary rehab and you know, had it any way affected… 
HCP2: I don’t think it… 
HCP1: I don’t think it did.  
HCP3: I think there was some people that maybe didn’t complete their exercise 
programme on that day.  
HCP2: Yeah but then you asked them to do it at home. So, you ask them to take 





HCP2: So, I don’t think it’s, its bad. I think it’s good.  
HCPs were satisfied with the delivery of the intervention and research procedures during PR. 
Regular contact between the HCPs and research team enabled the intervention to be 
integrated into PR.  
Overall, the HCPs were mainly concerned with how to improve the study in a future 
definitive trial. They offered suggestions as how to improve the introduction of the 
intervention, including the most appropriate time and people to deliver this. HCPs also 
provided suggestions for ways to improve patients’ comfort whilst wearing the activity 
monitor, as well as alternative intervention components and methods to improve the 






The aim of the qualitative findings were to explore the acceptability and feasibility of the 
intervention and the research procedures for patients, WhatsApp leaders and HCPs. The 
qualitative work has highlighted common facilitators and barriers of the intervention between 
all groups.  
All groups commented that patients would benefit from more familiarity with the 
intervention components, and therefore suggest that patients in a further trial would benefit 
from further education and training on the intervention components during PR. All groups 
also reported that the convenience of the intervention components and research procedures 
could be improved in the future and therefore researchers should consider alternative 
intervention components for a future trial, in addition to research procedures which suit all 
stakeholders. Rapport between the patients and WhatsApp leaders was also considered 
important and researchers should consider ways to support face to face communication 
between patients and lay volunteers in a future trial.  
5.6.2 Comparison to previous literature  
There was mixed familiarity and understanding of the intervention components, which 
therefore questioned the suitability of the use of technology and social media for people with 
COPD. This is an ongoing, evolving debate in research.332 For example, evidence suggests 
that older populations are less engaged in social networking applications and that digital 
interventions have limited beneficial impact on patient outcomes.333,334335 However, there has 
been a growth in the use of internet use for older adults333, and research suggests that internet 




systematic review of computer and mobile technology interventions for self-management in 
COPD, findings suggest that interventions incorporating smart technology was associated 
with higher levels of PA, compared to interventions using other means of support such as 
face-to-face or written.337  
For some patients, the smartphone used in this study (Nokia 1) required time and 
energy and was therefore not considered convenient. However, WhatsApp leaders had no 
problem navigating the smartphone, suggesting that WhatsApp was a user-friendly social 
networking application. These results highlight the mixed ability of patients, suggesting that 
patients should be offered intensive training to support them to become familiar with 
technology. The importance of training has been considered in a previous study, whereby lay 
health workers received three days of training to use phones to communicate with patients, 
who indicated they required longer to become familiar with the phones.185 Similarly, in a 
previous study including smartphone based PA telecoaching in COPD, some patients 
reported problems using technology and believed that the familiarisation period for the 
intervention was important.321 However, others in the telecoaching study had no problems in 
using the smartphone and application, suggesting that acceptability of digital interventions is 
subject to individual differences. It could be that digital interventions are more beneficial to 
those with a greater interest in digital interventions, and therefore it is important to give 
patients some flexibility in the type of intervention component they want to be involved in.337  
HCPs suggested that familiarity with a smartphone is more important to patient 
engagement than the type of social networking application used. However, WhatsApp leaders 
suggested that other social networking devices may be more appropriate than WhatsApp, as 
the interface of WhatsApp was restrictive and impersonal. These results reflect findings from 
similar interventions.321193 Facebook was a suggestion as a future social networking 




share personal details. Although a separate study which used both WhatsApp and Facebook 
for behaviour change purposes, found that there was less discussion on Facebook.193 
However, this may have been attributed to various reasons, such as patients’ limited exposure 
to Facebook compared to WhatsApp and the distraction of Facebook newsfeeds. There are 
limited interventions providing patients with smartphones and/or inviting them to social 
networking applications which have also reported patient acceptability of the devices.187,248,306 
Therefore, there is limited research to offer guidance into the optimal social networking 
application, the most acceptable device to use, and the level of training that patients need to 
become familiar with these devices. This requires more research. 
Social support was a key theme in this intervention, which reflects the importance of 
the BCT: social support (3.1-3.3). However, social interaction was perceived as both positive 
and negative, reflecting previous research.136,241,321 Previous literature has outlined that family 
can facilitate PA in patients with COPD.140,230 Throughout this intervention, families and 
partners took an interest in the study, offered support and sometimes even got involved by 
wearing a pedometer.321 However, some patients negatively compared themselves to their 
family and did not believe they could achieve as many steps. This may reflect previous 
research which suggested that a barrier to PA following PR was having an uncomfortable 
reminder of disease progression.241 However, there is limited research in involving family 
members and partners in interventions to promote PA following PR in COPD, and this 
requires further research.  
Interestingly, support from HCPs was not a theme from interviews with patients, 
though this has previously been considered an important factor in the maintenance of PA 
following PR in COPD. For example, patients reported that HCPs provide a sense of security 
and comfort which helps ease anxiety associated with symptoms.241 Inclusion of HCPs in the 




discussed as a method to keep people motivated to continue to be active. In a smartphone-
based PA telecoaching intervention, a determining factor for patients to maintain PA was 
feeling monitored by coaches (a HCP).321 However, WhatsApp leaders recognised that goal 
setting was dependent on input from HCPs, as goals were dependent on patients’ physical 
capabilities. WhatsApp leaders and HCPs recognised that HCPs may have limited resources 
to contribute to the intervention. Nonetheless, it is possible that the presence of a HCP may 
have boosted engagement and impact of the WhatsApp group. Patient acceptability of the 
intervention may be based on the type of social support they received, rather than the 
frequency of support, and the platform that support was delivered.  
Patients had competing demands in this study, and their days were often dictated by 
family and volunteering responsibilities and health concerns, which is reflected in previous 
literature.136,241 Patient engagement in the intervention was therefore influenced by the 
convenience of the intervention components. The pedometer and step diary were considered 
easier to use than the smartphone and WhatsApp due to their simplicity. A large amount of 
research has reported that patients have positive experiences with the step counters.306,338,326 
The pedometer used in this study was the Yamax Digi-walker CW-700, which has been used 
in previous studies91,327, and is considered the most reliable pedometer available.340,341 
However, difficulties associated with the wearability and sensitivity of this device have been 
reported both in previous research and in this study.340 Wrist worn devices were considered 
as more acceptable. 
A target of the intervention, which had been met, was to incentivise patients to be 
active based on their recognition of progress. This was possible via recording their step 
counts in the step diary. These results reflect findings from previous research that recognition 
of capabilities and improvements incentivises patients to maintain PA following PR.241 




diaries, on their impact on PA following PR in patients with COPD.331,91,121,137 Results from 
these studies are mixed, though most studies reported an increase in steps in the groups with 
the pedometer85,94,148, though one study reported no difference.91 However, there is limited 
understanding of the active ingredients of these interventions, meaning that little is 
understood about how and why these interventions were efficacious.  
Though the research team dedicated time to the recruitment of WhatsApp leaders 
(Chapter 4), the feasibility results outlined that some WhatsApp leaders in this study 
withdrew from the study prior to the delivery of the intervention, which therefore disrupted 
the fidelity of the intervention. These findings reflect previous literature185. WhatsApp leaders 
reported that they were committed to their role as WhatsApp leader and most commented that 
they wanted to continue to support patients in a larger scale trial. However, WhatsApp 
leaders also reflected on the time it took to recruit lay volunteers for the study and suggested 
that a longer recruitment period could be beneficial.  
5.6.3 Strengths and limitations 
The interviews and focus groups were an important component of a mixed method study to 
develop and test the acceptability and feasibility of an intervention to promote PA following 
PR in COPD. The MRC guidance states that feasibility and piloting is an important part of 
the development of a complex intervention.159 The interviews and focus groups enabled an 
assessment of the overarching acceptability of the intervention, including the identification of 
teething and/or contextual issues prior to a larger scale trial.159 
As reported in Chapter 1, there is limited understanding of the active ingredients of 
intervention components within similar previous studies aimed to increase PA in people with 
COPD.331–83,252,92,90,84,244,145,187,306,329,330 However, interviews in this study were able to explore 
the potential mechanisms of action of the intervention, and explore factors beyond the content 




Qualitative data therefore captured individuals’ insight and experiences of the intervention, 
going beyond the objective data on PA and health outcomes in this study.  
A clear strength of the interviews and focus groups was the range and depth of insight 
they provided from various stakeholders, including patients, WhatsApp leaders and HCPs. 
For example, the decision to purposefully select patients for interviews based on maximum 
variation meant that data voiced experiences and insights of a wide variety of patients, 
including those patients who had declined the intervention, partially engaged in the 
intervention, engaged in the entire interview, and those that withdrew.159,279 Similarly, there 
were a mix of individuals present at the focus groups. For example, for the HCP focus group, 
both physiotherapists and physiotherapist assistants participated, which was important as they 
had different levels of involvement in the study. There was also at least one HCP present 
from each region of Lincolnshire. Similarly, in the WhatsApp leader focus group, there was 
at least one WhatsApp leader present for each WhatsApp group in the intervention.   
It was possible that the subset of patients who agreed to the interview did not 
represent everyone in the intervention, potentially introducing an element of bias into the 
study.344 Also, only a limited number of patients who withdrew from the intervention agreed 
to participate in an interview, due to busy schedules and health concerns. However, 
maximum variation in the sampling meant that the interviews gained insight into patients’ 
experiences and experiences of the intervention. Furthermore, data was collected until 
saturation, so it was unlikely that further interviews would capture different themes. 
Patients had the option of engaging in interviews over the telephone or face-to-face, 
meaning that there was variation between the format of the interviews. This may have 
impacted the response from patients. For example, the setting of the interview may have 
impacted how comfortable they felt when answering the questions. However, freedom for 




comfort, and to provide patients with a sense of control, which is considered important when 
conducting interviews.345,346 
Another potential limitation was the fact that interviews and focus groups were 
conducted with the Chief Investigator of the study, potentially introducing a response bias 
whereby patients were inclined to be positive about the intervention347. However, patients, 
HCPs and WhatsApp leaders in this study did report negative experiences of the intervention, 
hence it was likely that patients felt comfortable to offer advice on how the intervention could 
be improved.  
A challenge of the study was delivering the study information to all patients during 
PR, as there is a high likelihood of patients missing PR sessions due to various reasons, such 
as illness, injury, and family responsibilities. This is a challenge with all PR research, based 
on the poor adherence and completion rates of PR.348 A method to improve this in further 
studies could be to provide study information earlier during PR, and for HCPs to provide 
brief reminders to patients throughout PR.    
The interviews and focus groups were conducted across different phases of the 
intervention, which may have impacted individuals’ acceptability of the intervention and 
research procedures. However, this is considered positive, as the interviews and focus groups 
were able to capture periods that the intervention had the most or least impact for patients 
across the 52-week period. Though some participants were sometimes unclear about the 
details relating to the start of the study, for example the familiarity and training period for the 
intervention, this was often overcome by reminding individuals about details of the study. 
HCPs and WhatsApp leaders had different roles in the intervention, as some were involved in 
the design of the protocol prior to the feasibility study, which may therefore impact their 
acceptability of the intervention. However, this meant they had an overarching understanding 




timing of the patient interviews across the 52-week period, meaning it was possible to 
consider individual quotes alongside contextual factors.  
A limitation of the trial was that there was limited data from patients who withdrew 
from the intervention. This was because most patients who withdrew from the trial refused to 
participant in an interview with the research team due to competing demands and health 
concerns. This means there was limited understanding of their acceptability and feasibility of 
the intervention and research procedures, but also limited understanding of the factors that 
impacted their PA following PR. However, it was unlikely that the data retrieved from 
patients in these subsets would capture different themes, due to maximum variation in 
sampling, and data collection until saturation. 
As reported in the quantitative results (5.3) the results of the intervention did not point 
towards a beneficial impact of the intervention on the patients’ disease specific QoL and 
anxiety and depression. In fact, the IG had a larger decline in their disease specific QoL and 
an increase in their anxiety and depression compared to the CG. The process evaluation 
mainly addressed patients’ acceptability of the intervention and research procedures and PA, 
and their PA (the key aim of the thesis, and the proposed primary outcome of the definitive 
trial, respectively). Limited attention was directed towards understanding the results of the 
secondary outcomes, such as disease specific QoL and anxiety and depression. Further 
investigation in a future trial is warranted to understand whether this negative association is 
attributed to the intervention, or whether this is due to other variables. To gain further insight 
into these findings, a process evaluation within a definitive trial should aim to identify if and 
why this association exists.  
The development of the intervention was facilitated by the APEASE criteria145 and 
contributed to a systematic and comprehensive intervention development process. However, 




intervention were excluded in the intervention development. For example, stakeholders 
excluded the BCT ‘goal setting’ as it was not considered acceptable to stakeholders due to 
health and safety concerns i.e. the chance of patients over-exerting themselves and not having 
a HCP nearby. Despite this, the results of this study highlighted the potential beneficial 
impact of goal setting, and this is therefore represents’ a recommended addition to the 
intervention, subject to agreement with HCPs. These findings highlight the challenging and 
iterative, non-linear process of intervention development, which requires dedicated time145. 
Use of the BCW, and the APEASE criteria are integral to the further modification and 
evaluation of the trial.145  
Patients who contributed to the development of the intervention were limited to those 
who were active members of COPD patient groups. Though a strength of this thesis was 
collaborations with patients from COPD support groups, such as Breathe Easy138, it is 
unlikely that these individuals represent the overarching patient population. For example, 
these patients were motivated to maintain social contact and to maintain PA. Therefore, it 
could be suggested that the intervention did not account for the factors that impact patients 
who struggle to be active and/or stay active following PR, or those who do not prioritise face 
to face social support. To address this potential limitation, feedback should be sought from 
those patients who are not actively involved in COPD patient support groups and those who 
are involved in social networking COPD support groups. 
5.6.4 Conclusion 
The interviews and focus groups represent an important stage in the development of a 
complex intervention. Overall, the intervention and research procedures were considered as 
positive and acceptable and feasible to deliver in a future definitive trial. However, 
researchers should consider the reported facilitators and barriers of the intervention and 




patients during PR to become familiar with the intervention components, incorporating 
alternative intervention components to suit patient preferences, and offering face to face 
communication between WhatsApp leaders and patients may improve patient and patient 
volunteers’ experiences of the intervention. Research procedures could be improved by 





6 Chapter 6: Integration of quantitative and qualitative results 
6.1 Abstract 
Background:  The previous chapter outlined that the intervention was considered acceptable 
and feasible for all stakeholders, and that higher intervention engagement was associated with 
a lower mean reduction in mean daily steps following pulmonary rehabilitation. However, 
limited attention has been directed at understanding the factors which impacted patients’ PA 
following PR, and whether there were differences between those with different levels of 
intervention engagement. Furthermore, previous chapters have not reported how the factors 
relate to the COM-B model and the targets of the intervention. 
Aim: This chapter reports the facilitators of PA following PR which were unique to those 
who engaged in the intervention, the barriers unique to those who did not engage in the 
intervention, and the common factors between both groups. Finally, this chapter mapped 
these factors onto the COM-B model to identify if the targets of the intervention had been 
met. 
Methods: Patients were split into different subsets to identify those who did or did not 
engage in the intervention (higher or lower intervention engagement). A deductive thematic 
analysis of the interviews with patients was conducted to map the results onto the COM-B 
model. The facilitators unique to those who engaged in the intervention, the barriers unique to 
those who did not engage in the intervention, and the common factors which impacted PA 
following PR were reported. Finally, the targets of the intervention which had been met were 
identified.  
Results: Facilitators unique to those with higher intervention engagement related to physical 
capability and reflective motivation. Barriers unique to those with lower intervention 
engagement related to automatic motivation and physical opportunity. 
Only one factor which was unique to the sub-groups was categorised as an unmet target of 
the intervention, which related to the distance of PA opportunities. However, a common 
facilitator of PA for both sub-groups, which related to a target of the intervention, related to 
the pedometer and step diary which incentivised patients to be more active. 
Conclusion: Integration of the quantitative and qualitative results offered further insight to 
explain the findings from previous chapters and previous literature. Though the results 




interventions in COPD, these results will be important for informing the modifications of the 
intervention prior to a definitive trial. 
6.2 Introduction 
This thesis has identified the facilitators and barriers of PA following PR for patients with 
COPD (Chapter 2), which then informed the development of the intervention tested in the 
feasibility cluster RCT (Chapter 3, 4 and 5). The previous chapter identified the likely impact 
of the intervention on patients’ PA and secondary health outcomes and patients’ acceptability 
and feasibility of the intervention (Chapter 5). Key facilitators included benefits of support 
(peer and family), recognition of progress and convenience and preference of the intervention 
components. Key barriers included limited familiarity and confidence with the intervention 
components, competing demands and inconvenience of the intervention, and a negative 
perception and experiences of social interaction. 
Interestingly, the quantitative results outlined that higher engagement in the 
intervention was associated with a smaller reduction in mean daily steps at 52 weeks. 
Understanding the facilitators of PA following PR behaviour for those with higher 
intervention engagement, as well as the barriers for those with lower intervention engagement 
would provide further insight and understanding the acceptability of the developed 
intervention. However, limited attention in previous literature, and this thesis, has been 
directed at understanding the differences between those with different levels of intervention 
engagement. The results would inform a future definitive trial by identifying whether the 
intervention was successful in targeting patients’ PA following PR, and any important factors 
missing from this intervention, which could be incorporated into a future trial.  
The development of the intervention was based on the COM-B model, which is 
situated at the core of the BCW (Chapter 3).145 All sources of behaviour in this model, minus 
physical capability, were targeted in the developed intervention (Chapter 3,). So far there is 




targets of the intervention. As reported in the literature review (Chapter 1), there is limited 
research to identify if and how behaviour change is related to behaviour change models.225 
The following chapter goes beyond the inductive analysis of the previous chapter and 
reports a deductive analysis to identify the factors which impacted PA following PR in 
patients with higher vs lower intervention engagement.  
6.3 Methods  
A deductive analysis of the interviews identified the facilitators of PA unique to those who 
engaged in the intervention, the barriers unique to those who did not engage in the 
intervention, and the common facilitators and barriers of PA following PR. These factors are 
mapped onto the COM-B model to identify the sources of behaviour which are important for 
PA maintenance following PR.145 ‘Engagement’ in the study was based upon engagement in 
the step diary, as this implied engagement in both the pedometer and step diary. ‘Intervention 
engagement’ was based on the number of days that participants reported their steps. This was 
calculated by splitting participants into lower or higher engagement groups based on whether 
participants had reported their steps for more or less than half of the intervention period. 
Lower engagement was categorised as <50% engagement and higher engagement was 
categorised as >50% engagement. Data is only displayed for participants who were 
interviewed and returned their step diary following completion of the intervention. 
6.4 Results  
6.4.1 Patients 
Of the twelve patients included in this analysis (patients who engaged in interviews during 
the study), six participants had ‘lower’ engagement in the intervention and six had ‘higher’ 
engagement in the intervention. In total, 5 patients were males (42%), and the mean (SD) age 
between groups were similar (MD, 1.5, CI, -8.89, 11.9). Patients’ MRC score and BMI were 




engagement did have a lower post-PR ISWT distance which exceeded the MCID of 37m349, 
with a large effect size between groups (MD, -107, (CI, -281, 68.3). In the lower engagement 
group, the number of steps recorded ranged from 0-78 days, and in the higher engagement 
group, the number of steps recorded ranged from 245-377 days, with a large effect size 






Table 6:1: Level of intervention engagement for participants in the intervention group who were 
interviewed 
Participant ID  Gender 
(M/F) 
Age  BMI MRC ISWT Number of days 
engaged in the step 
diary 
Lower engagement in 
the step diary 
      
P5 (Full) F 63 35.5 3 90 0 
P8 (Full) F 67 21.6 3 260 0 
P10 (Full, withdrawn) M 80 20.5 4 120 0 
P4 (Full) F 58 17.8 4 260 0 
P2 (Full) F 69 43.6 MD 110 44 
P11 (Partial) M 69 23.3 3 330 78 











in the step diary  
      
P7 (Full) F 63 19.5 3 230 245 
P9 (Full) F 65 31.7 3 200 306 
P3 (Full) M 70 24.3 3 310 314 
P12 (Full) F 75 21.2 4 90 326 
P6 (Full) M 73 28.7 3 450 339 
P1 (Full)   M 51 29.5 4 530 377 










MD (between groups) x 1.5  1.23 .07  -107 -298 












Effect size (d) x .19 .15 .19 .79 7.69 
Full = received all study components (WhatsApp, pedometer, step diary); partial = received pedometer and 
step diary only; full, withdrawn = enrolled in the intervention and subsequently withdrew: P: Person; CI: 
confidence interval; M: Mean; SD: Standard Deviation; MD: Mean Difference; d: Cohen’s d; M: Male; F: 
Female; BMI: Body Mass Index; ISWT: Incremental Shuttle Walk Test; MD: Missing Data; MRC: Medical 




6.4.2 Facilitators and barriers to PA following PR 
The following text provides examples of the facilitators unique to those who with higher 
intervention engagement, and the barriers unique to those will lower intervention 
engagement. The unique factors are categorised as the behaviour source (capability, 
opportunity and motivation) that they relate to145 and are defined as ‘facilitators’ or ‘barriers’ 
to PA. Following this text, the common facilitators, and barriers in both sub-groups are 
summarised. Finally, the text outlines if and how these factors related to the targets of the 
intervention, Figure 6:1 and Figure 6:2.  
6.4.2.1 Capability 
A facilitator of PA following PR which was unique to one patient who had higher 
intervention engagement was that the frequency of their exacerbations had declined since PR 
(P3), which was therefore related to their physical capability:  
P3: Now I think if I…funnily enough, since I walked, since I started to wear it 
(pedometer), I haven’t had a chest infection.  
No barriers, related to capability, were unique to patients with lower intervention 
engagement.  
6.4.2.2 Motivation 
Those with higher intervention engagement reported two unique facilitators to PA follow PR. 
One of these facilitators included the ability to overcome mental obstacles (P6, P9, P12), 
which was therefore related to reflective motivation: 
P12: Sometimes it’s not very good I must admit (motivation). …I had a spell where I 
thought as though I couldn’t do it but that’s not like me, I usually pull myself out of 
that pretty quick and get on and do things. So, I motivate myself in other words. Yeah. 
P6: mm it would be so easy just to sit there and say ‘oh I can’t breathe, I’m not doing 
anything because if I get the hoover out and I do this and I do that, then I get short of 
breath and I’m not going to do it’. Cos that would make you worse…so you’ve gotta, 
in a sense you gotta make yourself get up and do it.  
Secondly, those with higher intervention engagement also reported that PA was part of their 
identity (P3, P9) and that they had always been active:  
P9: Oh, I’m definitely motivated, yeah, yeah, couldn’t vegetate…I mean I’ve always 




The lower intervention engagement group did not report unique barriers of PA related to their 
reflective motivation, though reported three unique barriers of PA related to their automatic 
motivation. One patient reported being frightened of certain activities (P8):  
P8: Yeah but you see, I panic in water.  
One patient reported that their mood could negatively impact their motivation to be active 
(P10). Similarly, another patient reported having a busy schedule which impacted their 
motivation to be active (P2): 
P10: No, it’s (PA) just dependent on my mood.  
P2: Not having the time easily. I’ve lost a bit of the inclination to do it (PA).  
6.4.2.3 Opportunity 
Patients with higher intervention engagement did not report unique facilitators related to their 
opportunity to be active. Only one barrier that was unique to patients with lower intervention 
engagement was identified, which related to the distance of PA opportunities (P8, P2):  
P2: There’s nowhere to go.  
… that would be, if there was something nearer, because I think there is sort of a 
meeting club or something in Skegness isn’t there. 
6.4.3 Common facilitators and barriers of PA following PR  
Both subsets of patients reported several similar facilitators and barriers of PA following PR. 
The common facilitators related to all behavioural sources except physical capability and the 
common barriers related to physical opportunity and physical capability. The facilitators 
mostly related to opportunity, followed by motivation and capability, and are reported below 
in this order. 
Common facilitators related to physical opportunity related to having a garden and 
proximity to town facilitates walking (P12, P8, P2); having pets that require walking (P1, P8, 
P2). Facilitators related to social opportunity included having an active and encouraging 
family who supports PA (P9, P3, P12, P8). Common facilitators of PA related to patients 
reflective motivation, included: motivation to avoid worsening health status (P7, P3, P2); 
reminding self to be active (P6, P11); and understanding the benefits of PA following PR (P7, 
P9, P6, P8). Facilitators related to patients’ automatic motivation included being incentivised 




(P12, P11). Finally, common facilitators of PA related to patients’ psychological capability 
included being more knowledgeable about exercises from PR (2). 
The common barriers of PA following PR mainly related to patients’ physical 
opportunity, followed by their physical capability, and are reported below in this order: 
Common barriers of PA related to patients’ physical opportunity, which include the weather 
and temperature impacting PA (P12, P8, P11) and family and volunteering responsibilities 
limit time for PA (P6, P2). Common barriers related to patients’ physical capability related to 
their poor health and breathlessness, which impacted their ability to plan or complete PA (P7, 
P2), Figure 6:1 and Figure 6:2.  
6.4.4 Targets of the intervention  
No facilitators of the intervention reported above, unique to those with higher intervention 
engagement, were related to the targets of the intervention, and only one barrier of the 
intervention reported above, unique to those with lower intervention engagement, was related 
to an unmet target of the intervention, which included ‘PA opportunities being too far away’. 
For example, WhatsApp messages aimed to inform patients of their proximity to PA 
opportunities, and/or to encourage patients to be active at home (see Appendix K, p333 for 
examples of the WhatsApp messages within the WhatsApp guidelines).  
 Nevertheless, a common facilitator of PA, for those with both higher and lower 
engagement in the intervention, included being incentivised by the pedometer and step diary 
to do more PA (P9, P8). This related to a target of the intervention (Figure 6:1 and Figure 
6:2), see Chapter 3, Table 3:4 for a detailed report of the targets of the intervention 
components. A few barriers of PA, unique to those with higher intervention, were related to 
unmet targets of the intervention. However, these were not considered as salient, as they did 






Figure 6:1: Facilitators of PA for participants with different levels of step diary engagement, mapped onto the COM-B behaviour change model. Highlighted text indicates the 





Figure 6:2: Barriers of PA for participants with different levels of step diary engagement, mapped onto the COM-B behaviour change model. Highlighted text indicates the 







The aim of this chapter was to report the facilitators of PA, unique to those with higher 
engagement in the intervention, and to report the barriers of PA, unique to patients with lower 
intervention engagement. Furthermore, this chapter aimed to identify if the factors which 
impacted patients PA were related to targets or unmet targets of the intervention. Overall, 
facilitators unique to those with higher intervention engagement related to physical capability 
and reflective motivation. Barriers unique to those with lower intervention engagement 
related to automatic motivation and physical opportunity. 
Only one factor which was unique to the sub-groups was categorised as an unmet 
target of the intervention. This included the PA opportunities being too far away, though this 
was only reported for one patient. However, a common facilitator of PA for both sub-groups, 
which related to a target of the intervention included being incentivised by the pedometer and 
step diary to be more active. 
6.5.2 Comparison to previous literature 
The results outlined that the intervention was successful in incentivising patients from all 
subsets to do more PA via the pedometer and step diary. These results support the inclusion 
of these intervention components in a future trial and support previous reviews which outline 
the potential efficacy of these intervention components on patients’ PA following PR.85,94,148 
However, as patients with both lower and higher intervention engagement reported being 
incentivised by the pedometer and step diary to be more active, these results suggest that this 
intervention component is simply not enough to increase PA in all patients. These results 
reflect findings from previous literature that simply understanding the benefits of PA, and 
owning a pedometer, is not enough to support long term PA.130 Patients therefore require 
further support to stay active.  
The results outline the importance of reflective motivation in impacting patients PA 
following PR in patients with COPD. This intervention aimed to target patients’ reflective 
motivation by enabling them to reflect on their PA progress via the step diary and pedometer. 
However, the facilitators unique to those with higher intervention engagement, which 




were not targets of the intervention. Nevertheless, these results highlight the importance of 
reflective motivation in PA in COPD following PR, which has been reflected in previous 
literature. For example, previous research which mapped responders and non-responders 
facilitators and barriers of PA following PR in COPD, reported that PA was associated with 
higher perceived competence and controlled motivation following PR, for example the need 
to complete a task based on external or internal pressures.225 The systematic review of the 
facilitators and barriers of PA following PR in patients with COPD also identified self-
efficacy as a determinant of PA (Chapter 2). For example, previous PA experiences 
influenced patients’ beliefs of their capability and confidence of being active. Similarly, 
previous findings have reported that PA was positively associated with self-efficacy for PA.83 
These findings contrast other reports that self-efficacy is only weakly associated with daily 
PA in patients with COPD.83,350,351 Furthermore, the ability to plan PA and to overcome 
mental obstacles was not a target of the intervention, but it was important in influencing 
patients’ PA in this intervention. These results provide a potential explanation for the 
proposed efficacy of previous interventions which target PA regulation, for example health 
coaching and goal setting.130 These results also support the suggestions for modifications of 
the intervention from WhatsApp leaders, which include setting step goals for patients (0), 
which therefore rely on patients ability to plan their PA behaviour and their perseverance to 
complete these goals.  
No subsets of patients reported that connection with peers or WhatsApp leaders via 
social networking facilitated their PA, therefore it could be suggested that social support is 
not an important contributing factor for patients following PR. Though these results may 
simply reflect the method chosen to measure intervention engagement. For example, 
interviews with patients based on their WhatsApp engagement may have focused on the 
perceived importance of peer connection. Nevertheless, the results highlight that social 
interaction was an important contributing factor to PA following PR, as reported in previous 
literature221–186,221,73,339–341 and previous chapters in this thesis (Chapter 2, 3 and 4). For 
example, not having peers and/or HCPs to push patients to be active following PR was a 
barrier to PA reported by one patient with higher engagement in the intervention. Patients’ 
families were also associated with both facilitators and barriers of PA, for example, a 




patients to be more active, and family routine was a facilitator to PA. The results from the 
systematic review in Chapter 2 reported that families and partners could both discourage and 
encourage patients to be active, for example, it was reported that negative pressure from 
relatives and family sometimes led to avoidance of PA. However, the findings from Chapter 
5 and this study report that patients’ only considered family support as positive. Nonetheless, 
family, and social responsibilities were a barrier to PA, as limited time prevented patients 
from engaging in PA. These findings reflect those in Chapter 5, for example competing 
demands was a common barrier to the acceptability and feasibility of the intervention. These 
results outline the need for families to understand the importance of PA for patients (as 
reported in the systematic review in Chapter 2) and to identify the activities which benefit 
their health.  
The limited reports of peer support as a facilitator to patients’ PA was surprising, 
based on the reported importance of this in previous literature189 and results from previous 
Chapters (2 and 3). It was clear that patients do benefit from social support, due to the 
reported benefits of family support following PR. The results of the inductive analysis 
(Chapter 5) outlined that patients had limited understanding and confidence surrounding 
smartphones and WhatsApp, which has also been reported in previous literature.321 This 
provides an explanation for limited interaction with peers. It is therefore likely that patients 
would benefit from peer support, but not solely via social networking, as suggested by 
patients, WhatsApp leaders and HCPs in Chapter 5.  
Barriers unique to patients with lower intervention engagement, such as varying 
mood, and being frightened of participating in new activities, were related to patients’ 
automatic motivation. These results outline the importance of automatic motivation in PA 
behaviour following PR. Although the intervention aimed to promote emotional social 
support via WhatsApp, the results from Chapter 5 reported that only a limited number of 
patients engaged in WhatsApp, for a limited period, possibly due to limited familiarity and 
confidence with the smartphone and WhatsApp. As reported above, it is possible that social 
support may address these barriers, but not solely via social networking. These results offer 
insight into the findings from the quantitative chapter, in that the disease specific QoL, and 
anxiety and depression of patients in the IG declined during throughout the study. Though, of 




interviews being limited to a small sample of patients. Another barrier, unique to those with 
lower engagement in the intervention was that PA opportunities were too far away, which 
reflects the findings in previous chapters (Chapter 2 and 5). Though WhatsApp leaders 
informed patients of their local PA opportunities, the results suggest these messages were not 
sufficient to meet patients’ needs. However this may be due to the rurality of the 
Lincolnshire, for example ‘local’ opportunity PA opportunities may still be inaccessible for 
patients with reduced mobility and limited transport .355 
Overall, the results outline the importance of the behavioural sources which were 
unique to those with higher and lower engagement in the intervention. These factors included 
physical capability, reflective and automatic motivation, and physical opportunity. However, 
the results also outlined the common facilitators and barriers of PA between both groups, and 
the suggest that facilitators related to all behavioural sources minus physical capability, and 
the common behaviour related to physical opportunity and physical capability. These results 
reflect those from the Chapter 2, which outline the complexity of PA behaviour, and how 
factors which impact PA in this population span patient’s beliefs, social support, and the 
environment.  
Health concerns were negatively associated with patients’ PA, which is also reflected 
in previous literature225, for example health concerns were reported as a barrier to PA 
maintenance following PR in Chapter 2. Physical capability was not a target of the 
intervention. The research team and stakeholders believed that individuals who completed PR 
would likely have the exercise capacity to maintain PA, which is also supported by the 
findings in the systematic review of the facilitators and barriers of PA following PR in 
patients with COPD (Chapter 2). When using the APEASE criteria145 to develop the 
intervention, HCPs did not consider it feasible to offer additional support to patients 
following PR, due to HCPs limited capacity. However, these results suggest otherwise, and it 
is therefore necessary to re-evaluate the potential involvement of HCPs in offering support to 
target patients’ physical capability.  
The results outline that those with higher engagement in the step diary had a higher 
score in the post-PR ISWT. Though previous literature has outlined that exercise capacity 
following PR has limited association with maintenance of PA following PR149, the results 




to engage in the intervention. The results from this chapter, and previous chapters (Chapter 2, 
section 0 Chapter 5, section 0) reported that positive feedback, i.e. from the pedometer (a 
higher number of steps) increased patients’ motivation to be active. Hence a higher level of 
baseline exercise capacity, and positive feedback from the pedometer, may be important in 
incentivising patients to engage in the intervention components. These findings support 
previous literature which suggests that baseline exercise capacity can be predictive of a 
beneficial response to interventions to promote PA.356 Therefore, further research should 
investigate whether lower baseline step counts negatively impact patients’ motivation to 
engage in PA, and if so, the measures to control for this issue.  
6.5.3 Strengths and limitations 
Though application of mixed method research is a relatively recent method, it is considered 
as a powerful approach in addressing health research, and management of chronic 
conditions265–252, and it is supported by the MRC159 in process evaluations of complex 
interventions within RCTs.160 The qualitative data provided complementary data in 
understanding the quantitative results.261–263 As well as understanding the acceptability and 
feasibility of the intervention, the results outline the factors which influence patients’ PA, 
hence provided further understanding into potential active ingredients of the intervention.145 
There is limited research in the use of behaviour change models in the development 
and evaluation of behaviour change interventions.225 This study added further understanding 
of the potential mechanisms of the intervention, how the determinants of PA related to the 
COM-B model, and how the facilitators and barriers of PA related to the targets of the 
intervention. In the development of the intervention, reflective motivation was identified as 
an important behavioural source to target patients’ behaviour, which the results of this study 
support. However, this study identified that improvements in PA did not necessarily only 
relate to the targets of the intervention, but other factors related to reflective motivation. This 
study therefore offers further insight into the mechanisms of the trial, and further informs the 
modification of the intervention for a definitive trial. These results also offered tentative 
explanations for the clinical quantitative outcomes reported in Chapter 5 (5.3.5). However, as 
these interviews were limited to patients in the IG, it was not possible to determine the 
facilitators and barriers of patients in the CG, hence this study provided limited insight into 




from this study were valuable in understanding the differences between those with higher or 
lower intervention engagement. 
The results from this study also offer explanations to support the reported importance 
of intervention components used in previous trials. For example, in a systematic review of the 
interventions to modify PA in patients with COPD130, the findings identified that counselling 
and coaching interventions could potentially have larger impacts on PA in patients with 
COPD. The results from this study suggest that this may be due to the focus of on 
intervention components to promote patients’ reflective motivation, such as the ability to 
overcome mental obstacles.  
A potential limitation of this study was that analyses were based on a small sample of 
participants who were in the IG, and it could be argued that the results do not represent all the 
possible facilitators and barriers of PA faced by patients with COPD, following PR. As 
reported previously (discussion of the inductive analysis), the decision to purposefully select 
patients for interviews based on maximum variation (e.g. those involved in the full 
intervention and those in the partial intervention) meant that data voiced experiences and 
insights of a wide variety of patients. The interviews were valuable in understanding the 
factors which impacted a subset of patients’ PA following PR.159,279  
6.5.4 Conclusion 
The aim of this chapter was to identify the facilitators and barriers of PA for patients in the 
IG and to provide further insight into potential differences in the facilitators and barriers of 
PA between those with higher and lower intervention engagement. The facilitators unique to 
those with higher intervention engagement were related to their reflective motivation and 
physical capability, and the barriers unique to those with lower intervention engagement were 
related to their automatic motivation and physical opportunity. A common facilitator of PA 
for both groups included being incentivised by the step diary and pedometer. However, this 
facilitator was clearly not enough to engage patients in the PA intervention. A barrier, unique 
to those with lower intervention engagement, was that PA opportunities were too far away, 
which suggested that the target of the intervention to inform patients of their local PA 
opportunities was not sufficient. These results were able to offer insight into the findings 
from previous chapters and previous literature. Though the results support the statement that 




these results are important in the development of potential modifications of the intervention 





7 Chapter 7: General Discussion  
The aim of this thesis was to develop and test the feasibility of an intervention to promote PA 
following PR in patients with COPD. This thesis addressed the gaps in previous literature, 
which included the limited: understanding of the determinants of PA following PR in patients 
with COPD (Chapter 2); application of theory and behaviour change frameworks in 
intervention development (Chapter 3); understanding of the processes that contributed to the 
efficacy of an intervention (Chapter 5); involvement of stakeholders in the research process 
(Chapter 3, 5), and the short time-frame in the delivery of interventions (Chapter 4 and 5). In 
line with the MRC recommendations, a step wise approach was adopted in the development 
and feasibility testing of the intervention159, whereby the successes and challenges of these 
steps were reported.   
A systematic review (Chapter 2), collaboration with stakeholders (Chapter 3 and 5), 
adoption of the BCW (Chapter 3), and use of mixed methods (Chapter 4 and 5)facilitated the 
development of the feasibility cluster RCT with a qualitative process evaluation (Chapter 4). 
Following the trial, integration of the quantitative and qualitative data provided further 
insight into the acceptability of the intervention (Chapter 6). The overarching results from the 
trial outlined that the intervention was considered acceptable and feasible for a definitive 
trial, and data supports the likely impact of the intervention on patients’ PA. However, the 
results from the trial confirmed that important modifications are required to optimise the 
acceptability and feasibility of the study prior to the definitive trial. An intervention revision 
period is considered necessary to make the recommended modifications to the trial. The 
results provided important implications for policy, practice and for researchers with an 
interest in COPD management, but also researchers with an interest in behaviour change and 
intervention development. 
7.1 Structure of the general discussion 
The following text reports the strengths and limitations of the thesis, the recommended 
modifications for the intervention and research procedures, the future directions of the 




7.2 Strengths of the thesis  
A clear strength of this thesis included addressing the gap in knowledge and limitations in 
previous research in promoting PA following PR in patients with COPD. Limited 
maintenance of PA following PR negatively impacts patients and contributes to social and 
economic demands (Chapter 1),15,1617,18 for example, provision of care and the expense 
involved in treating COPD exacerbations. This thesis contributed novel knowledge and 
outlines an intervention which may beneficially impact patients’ health and well-being 
following PR. The results from this thesis provided complementary evidence to aid 
evaluations of PA interventions already attempted in this area197–199,130, but also adds further 
insight into future development of interventions targeting PA maintenance in COPD. 
As reported in the literature review (Chapter 1), the MRC states that intervention 
development should be based on a relevant theoretical framework.159 There has previously 
been calls for further adoption of the BCW framework within intervention development in 
the area165,175, yet the BCW has had limited application in the development of interventions to 
promote PA following PR.176 The BCW was beneficial in this study as it was able to 
categorise the many facilitators and barriers of PA following PR according to the behavioural 
sources (COM-B components) which they related to145 (Chapter 3). The BCW facilitated the 
decision making processes involved in the development of the intervention, which also 
considered context-based factors.145. Consequently, a strength of this thesis was the use of the 
BCW in the development and evaluation of the intervention (see Chapter 3 and 6 for further 
detail about use of the BCW). 
An important aspect of this thesis included collaboration with patients, patient 
volunteers (WhatsApp leaders), and HCPs, as they provided valuable input into the 
development of the intervention. They also offered insight into the different aspects of the 
acceptability and feasibility of the trial, which would not have been apparent from the 
quantitative data alone (Chapter 3 and 5). As reported in the literature review (Chapter 1), 
Patient and Public Involvement (PPI) facilitates research at various stages of the 
development-evaluation-implementation process of complex interventions.159,343 Minimal 
involvement of patients in previous research has been attributed to limited understanding of 
the determinants of PA following PR in patients with COPD.155 In this thesis, individuals 




development of the intervention, based on their own experiences and barriers and facilitators 
to PA following PR. Furthermore, inclusion of patients in the development of the trial meant 
that the intervention was guided by context-specific factors, such as limited opportunities to 
be active, and cost and travel associated with attending these opportunities. Though these 
barriers reflect those reported in previous literature (Chapter 2), they are arguably more 
salient in Lincolnshire, given the rurality of the county.355 
Despite the benefits of conducting COPD research with input from stakeholders181, 
the involvement of so many stakeholders in the development and evaluation of an 
intervention in previous research is rare. In addition to the involvement of patients and HCPs 
in the development of the intervention, other personnel in the NHS (e.g. communications 
officer) and staff at the University (e.g. the research and governance officer and the 
information compliance officer), were involved in the design of the digital component of the 
intervention, including the use of mobile phones and the use of social networking 
applications. Without their input, the development of the intervention may have been more 
time consuming, and less acceptable to participants. 
As reported in the literature review and methodology (Chapter 1 and 4), mixed 
methods are associated with various strengths261–263,278. In the feasibility study (Chapter 5), 
the data from the interviews and focus groups provided further insight into the quantitative 
results, for example the qualitative data provided insight into patients’ acceptability of the 
intervention, and why some patients declined to enrol in the intervention. Furthermore, the 
interviews provided insight into the factors which impacted patients’ PA following PR and 
offered key stakeholders an important voice in the research process. The qualitative data 
offered an explanation into the differences between those who engaged in the intervention, vs 
those who did not (Chapter 6). This enabled further understanding of the mechanisms of the 
intervention159,153 and contributed to recommendations for the modification of the study and 
implications for further research, which are reported below (7.4). Mixed method research is 
reportedly more time consuming than collection of qualitative or quantitative data alone265, 
which could have been limiting if there was not enough time dedicated towards this 
approach. However, this approach did not interfere with any other aspect of the study and the 




7.3 Limitations of the thesis 
Though the sample size was acceptable for a feasibility study296 (Chapter 5), the sample size 
was not powered for statistical data analyses, hence the quantitative data was only able to 
highlight the likely impact of the intervention on patients’ PA and secondary health 
outcomes. Nevertheless, in accordance with the guidance from the MRC159, the main aim of 
the feasibility study was to measure the acceptability and feasibility of the intervention and 
research procedures prior to a larger scale trial159,296. The results from this thesis have 
therefore informed the modification of this intervention which can be tested in a definitive 
trial.  
The experiences of the CG were not gathered in this thesis, as the key aim was to 
measure the acceptability and feasibility of the intervention and research procedures. It was 
likely that the systematic review in Chapter 2 identified the key factors which impacted 
patients’ PA following PR. Nonetheless, as this was a feasibility study, with a smaller sample 
size, it is not clear whether these results would be reflected in a definitive trial. Nevertheless, 
the process evaluation in a future trial should not ignore the CG, and researchers should aim 
to capture their experiences PA following PR.  
Due to the complexity of PA behaviour change following PR in patients with COPD, 
there were a multitude of factors which impact patients’ behaviour (Chapter 2). HCPs 
reported that limited time and funding was a barrier in supporting patients to keep active 
following PR (Chapter 3), and decided that it was not feasible to provide support for patients 
following PR. Despite this, the results of the process evaluation (Chapter 5) clearly outlined 
the need for continued support from HCPs after PR, hence the process evaluation was 
successful in identifying an intervention component that had previously been dismissed 
during the development of the intervention. These results outline the iterative and time-
consuming nature of intervention development.145 However, the feasibility study was 
successful in outlining modifications to the intervention (7.4), and implications for policy, 
practice and research, also reported below (7.1).  
7.4 Modifications to the intervention  
The overarching results of the feasibility study outlined that the developed intervention was 
acceptable and feasible for a definitive trial (Chapter 5). However, modifications to the 




should be continued, added to, or removed. The following text outlines the recommended 
modifications to the intervention, including: support from HCPs; face to face support with 
peers and lay volunteers; involvement from family and partners; freedom for patients to use 
their personal devices; use of a different social networking application; and a change in the 
role of the lay volunteers, also outlined in Table 7:1.  
Support from Health Care Professionals 
Maintenance of support from HCPs following PR is a recommended modification prior to a 
definitive trial (Chapter 5). The systematic review in Chapter 2 identified the importance of 
support from HCPs, for example they provided a sense of security in helping patients 
overcome anxiety surrounding physical symptoms. During the development of the 
intervention HCPs did not consider it feasible for them to provide additional support to 
patients following PR, due to limited time and resources of HCPs (Chapter 3). Time 
constraints from HCPs was also reported in Chapter 5, whereby they were limited in the 
amount of time where they could support patients. However, barriers to patients with lower 
intervention engagement included being frightened by certain activities, which discouraged 
patients from being active (Chapter 6). This suggests that patients would benefit from having 
support from HCPs in times of uncertainty. Previous interventions which included remote 
support from HCPs following PR have had a beneficial impact on patients’ PA.94,148 These 
interventions provided remote support to patients at monthly intervals between 6 to 12 
months and provided evidence of the acceptability and feasibility of such interventions. 
Remote support is an alternative to face to face support, which is less time consuming and 
expensive for patients.94,359 In the focus group with HCPs, it was reported that involvement 
and support from an additional HCP and/or a lay volunteer would facilitate the delivery of the 
education surrounding the intervention (Chapter 5). In a future trial, the inclusion from other 
HCPs and/or the research and development team, would assist PR staff. For example, PR 
staff would have more time to remotely follow up with patients following PR. Though there 
were limited resources for this feasibility study, a funded definitive trial could provide funds 
for additional HCP support. Furthermore, evidence suggests that support from HCPs can be 




alternative to face to face support.94,359 HCP support therefore represents a feasible addition 
to the intervention.  
Goal setting  
Based on the results in the systematic review of PA following PR in patients with COPD 
(Chapter 2), goal setting was not considered a salient facilitator, nor was it a priority by other 
stakeholders in the development of the intervention (Chapter 3). However, in the results from 
the interviews in the inductive analysis, WhatsApp leaders discussed the potential beneficial 
impact of introducing individualised step count goals to patients, but recognised the need for 
these goals to be proposed by a HCP (Chapter 5). Also, in recognition of the facilitators and 
barriers of PA for patients involved in the IG, reflective motivation was reported as an 
important behavioural source for responders of the intervention (Chapter 6). As such, 
intervention components which focus on behavioural regulation would target the facilitators 
of PA reported by patients whose steps improved following PR. The addition of goal setting 
is a recommended modification of the intervention prior to a definitive trial. By setting a 
tailored step count target for patients, the intervention may address the reported barrier from 
patients; they did not feel pushed or motivated to achieve more PA (Chapter 5). Goal setting 
has been considered beneficial in previous research130 and represents a feasible addition to the 
trial. Goal setting has been implemented in various interventions to promote PA for patients 
following PR91,90, and this method should be based on those studies which have identified a 
beneficial impact of the intervention on patients’ daily steps.94 Therefore, it is recommended 
that goal setting is introduced throughout PR by HCPs, based on patients’ baseline (pre-PR) 
daily steps. These goals should be short term and an increase in the step count goal should be 
dependent on achievement of the previous goal. Based on previous research, the increase in 
step count goals has been based on the addition of approximately 800 steps.94 However, based 
on the results in this study, the mean daily steps decreased in both the IG and CG, and such 
an increase in the step count goal may not be feasible for many patients. Furthermore, 
Chapter 2, 5 and 6 reported the importance of self-efficacy on PA following PR. To nurture 
self-efficacy, it is therefore recommended that step count goals should be tailored to each 
patient, with recognition of differences in patient fitness levels and capabilities, and the 




previous research, patients should maintain the step goals, with contact from the HCPs every 
month94148 via social networking..  
Face to face support with peers and lay volunteers 
WhatsApp leaders and patients suggested that they would benefit from building a rapport 
prior to the intervention (Chapter 5). Despite the costs and time associated with regular face 
to face contact between patients and WhatsApp leaders, this was considered an important 
method to complement social networking support and to maintain a rapport after PR. Face to 
face contact may also address the barriers reported by those with low intervention 
engagement which related and physical opportunity and automatic motivation, such as the 
distance to attend physical activities, and low mood and motivation to be active (Chapter 6). 
Face to face support with peers and lay volunteers is therefore a recommended modification 
to the intervention, which could take the form of regular (e.g. monthly) local meetings 
following PR to supplement the social networking component of the intervention. However, 
based on patients’ reported restrictions with travel and cost (Chapter 5 and 6) it is important 
that these sessions are accessible to all patients in terms of location and cost of attendance. A 
viable option would be to rent a local community centre, for example, near to the local PR 
centre, to ensure that the location is accessible for those who attend PR. Though there is 
limited research on the effectiveness of non-formal follow-on groups following PR, there is 
evidence to support the social and educational benefits of formal groups such as Breathe 
Easy138, which also aim to support patients with COPD139.  
Family and partner involvement 
In the development of the intervention, inclusion of patients’ families in the intervention was 
not prioritised by stakeholders, and was not pursued as the results from the systematic review 
in Chapter 2 reported mixed findings for the role of family members in patients’ PA 
maintenance following PR. For example, negative pressure from family could result in 
avoidance of PA. On the other hand, families understanding of importance of PA was a 
facilitator to PA following PR (Chapter 2), as was family support and routine. This reflects 
the results from the feasibility study, of the benefits of support, whereby family members 
took interest in the intervention and supported patients following PR (Chapter 5). Inclusion 
and support from family members should therefore be pursued as a potential modification to 




setting step-count goals, to inform family members of the PA tasks set for patients. This 
would facilitate family members to provide support and reminders for patients to complete 
their goals. In addition, family members of patients who report lower confidence and 
familiarity navigating social networking should be encouraged to join the social networking 
groups, as they could support patients to read and post messages to the groups. However, as 
barriers to the acceptability of the intervention for some patients was negative perception of 
social interaction with other patients following PR, this highlights the diversity in patient 
preference of social support following PR and provides further evidence that interventions 
should be tailored to individual patients following PR127,192,361, as a ‘one-size fits all’ approach 
does not exist.254 Family members should be encouraged to support patients, but refrain from 
comparing their own PA achievements.  
Use of personal devices 
A barrier that was unique to those with lower intervention engagement included patients 
having competing demands, which was also reported in Chapter 6 and supported by previous 
literature (Chapter 2). Recommendations to address patients’ competing demands included 
making the intervention more accessible and convenient for patients. Provision of study 
phones in the feasibility study was based upon optimising patients’ privacy throughout the 
study (Chapter 3). However, the results from the feasibility study (Chapter 5) suggest that 
patients are comfortable with using their personal devices and sharing their personal 
information, such as their contact number, name, and profile picture. Patients should be 
allowed to use their own step counter to record their PA and mobile device when connecting 
with other patients. Patients who do not have personal step counters should continue to be 
provided with a step counter from the research team. The pedometers (Yamax CW700/701 
model) used in this study were not considered comfortable and convenient, as they were 
difficult to strap onto patients’ waistbelts, and they also fell off easily, hence were lost at 
various points, which reflects previous research91 (Chapter 5). All stakeholders suggested use 
of wrist worn devices, such as those used in previous interventions91,327 rather than clip on 
devices, as these were considered more comfortable (Chapter 5). The flexibility for patients 
to use their own devices would also be beneficial in reducing the costs of the study.  




Use of an alternative social networking application, such as Facebook, is a recommended 
modification to the trial. Facebook enables a further level of anonymity than WhatsApp and 
does not require patients to share any personal information, including their mobile number 
(unlike WhatsApp), if they choose not to. Similarly, patients are easily able to exit, and 
potentially re-join Facebook groups, dependent on whether they perceive social interaction as 
beneficial to them. Stakeholders also outlined that Facebook enables patients to have private 
conversations with peers or lay volunteers, but also provides less pressure for patients to 
communicate if they choose not to (Chapter 5). It is recommended that patients are added to a 
closed Facebook group, populated by all other patient cohorts who sign up for the 
intervention. This enables patients to have a wider group forum. To nurture the friendships 
made in PR, patients should be added to their own Facebook messenger chat. Finally, it is 
recommended that HCPs maintain contact with patients via video chat, enabling a check in 
with their step count goal progress. This modification addresses the finding that patients 
respond differently to different types of social interaction241(Chapter 5), thus is it important to 
provide patients with the flexibility to choose who they interact with, and when and how 
often.. Facebook enables patients to join groups and identify other people that they would like 
to communicate with. Therefore, Facebook provides patients with more opportunity to 
communicate with peers, and develop sub-groups, in which they can chat with other people. 
This is beneficial, as stakeholders reported that the small size of the WhatsApp groups 
contributed to the limited patient engagement (Chapter 5). The mode of delivery of the 
intervention is important to patients, therefore patients should be asked if and how social 
support could encourage them to be active following PR, from whom, through what medium, 
and how often e.g. face to face, online, or a mixture of the two.  
Role of the lay volunteer 
Lay volunteers should be provided with more freedom in the messages they choose to send to 
patients. Prior to a future trial, researchers should emphasise that the lay volunteers have 
flexibility to send any appropriate messages to the group of participants. However, to ensure 
that patients across the groups receive similar levels of support, training is necessary before 
the delivery of the intervention, whereby lay volunteers agree on the type and level of support 
that they will provide to patients. As reported in the focus group with WhatsApp Leaders 




suggested method to improve their confidence in their role as a lay volunteer. Finally, the 






Table 7:1: Modifications of the intervention, outlining the elements of the intervention to 
be continued, added to, or removed prior to a definitive trial  
Continuation Addition Removal 
Use of pedometers 
and step diaries to 
measure and record 
patients’ daily steps 
and to promote 
patients’ PA 
 
Step count goal setting, initiated by a HCP 
during PR and supported following PR via 
monthly video calls with a HCP over 
Facebook 
 
Replacement of the 
Yamax pedometer 
(CW700/701 model) 
with a wrist worn 
pedometer.  
Provision of the Nokia 
1 smartphone for 
patients with restricted 
access to social 
networking (e.g. 
patients who do not 
own a phone, tablet or 
computer)   
 
Option for patients to use their personal 
devices (e.g. mobile phone and step 
counter) 
 
Use of social 
networking to 
maintain peer support 
following PR 
Use of Facebook as an alternative social 
networking application to WhatsApp, 
including addition to an overarching 
Facebook group (involving all patients in 
the IG) and subgroups to maintain 
connection with fellow PR graduates 
 
Removal of 





 Family and partner involvement in social 
networking and step count goals 
 
 
Lay volunteers to send 
regular messages to 
patients following PR  
Flexibility for lay volunteers to choose the 
messages sent to the patient group based 
on a group training session prior to the 
delivery of the intervention 
 
Removal of the 
WhatsApp 
checklists   
Involvement of lay 
volunteers to support 
and promote patients’ 
PA following PR 
Face to face support with peers and lay 
volunteers to supplement social 
networking 
 
 Connection of the lay volunteers via 




Support from HCPs 
during PR to educate 
and familiarise 
patients with the 
intervention 
components 







7.5 Modifications to the research procedures  
As reported above, the results from Chapter 5 outlined that the research procedures involved 
in the feasibility study were acceptable and feasible for a future trial. However, the results of 
the feasibility study and process evaluation highlighted various methods to improve and 
increase the acceptability and feasibility of these procedures. The following text outlines the 
aspects of the research procedures that should be continued and aspects that should be 
modified. The recommended modifications to the research procedures relate to the inclusivity 
of the trial for wider respiratory conditions; the introduction of the intervention and the 
delivery of study information to patients; methods to accommodate patients’ comfort and 
convenience, and alternative methods to measure intervention fidelity and engagement, as 
outlined in Table 7:2. 
Inclusivity of the study  
A recommended modification to the trial is to recruit all patients with lung conditions, not 
limited to patients with a diagnosis of COPD, as stakeholders believed this was important 
(Chapter 5). A main component of the intervention was to facilitate social support among 
patients following PR. The results of the feasibility study identified that the exclusive 
recruitment of patients with a diagnosis of COPD inadvertently restricted existing social 
groups in PR to remain in contact following PR (Chapter 5). Other lung conditions, such as 
Bronchiectasis and Pulmonary Fibrosis present similar symptoms to COPD, such as coughing 
and breathlessness362, and these conditions often overlap, but they are separate conditions to 
COPD. Literature outlines the beneficial impact that PR has on patients’ short-term exercise 
capacity and disease specific QoL.363,364 However, there is relatively limited research in the 
long-term maintenance of PA following PR in these conditions365, and patients may report 
different facilitators and barriers to PA following PR, as well as differences in their 
acceptability of the intervention and research procedures. For example, competing demands 
was a reported theme in this study (Chapter 5 and 6), though patients with Bronchiectasis 
often have an even higher treatment burden due to airway clearance regimes.362 Though 
inclusion of non-COPD patients in the trial is an important modification to the trial, it is 




lung conditions in the definitive trial. It is therefore important for the differences in lung 
conditions to be reported and to outline any differences between clinical outcomes between 
the conditions. However, irrespective of any clinical differences in the lung conditions, all 
patients contribute to the friendships and peer support provided throughout PR. Therefore, it 
is important to maintain these groups as much as possible. 
Introduction of the intervention and the delivery of study information to patients 
Patients reported limited familiarity and understanding of the intervention components, 
particularly the phone and WhatsApp, during the intervention (Chapter 5). This was 
attributed to limited confidence in navigating these devices, and limited time for patients to 
familiarise themselves with the intervention, particularly if patients had low PR attendance 
due to health concerns and other responsibilities (Chapter 5 and 6). A recommended 
modification for the trial is to provide study information earlier during PR, and for HCPs to 
provide brief reminders to patients throughout PR, a method which was supported by all 
stakeholders in Chapter 5. 
Methods to accommodate patients’ comfort and convenience 
Patients should also have the flexibility to wear the accelerometer on their wrist, rather than 
their waist. As reported above, a recommended modification to the trial is to provide patients 
with wrist worn pedometer, rather than the clip-on pedometer (Yamax CW700/701 model) 
used in this intervention. However, the pedometer used in this feasibility study represents a 
method to accurately record daily steps to the standard of the accelerometer (wGT3X-BT) 
(Chapter 5). Therefore, the pedometer should be an alternative primary outcome measure for 
patients if they refuse to wear the accelerometer. Previous recommendations have outlined 
that triaxial accelerometers, such as the accelerometer used in this study, are the optimal 
outcome measures for PA in patients with COPD.53 However, the results identified that the 
pedometer and accelerometer used in this study counted similar daily steps (Chapter 5), 
which may suggest that the two measures are a valid tool in measuring patients’ daily steps. 
The flexibility for patients to wear the pedometer would potentially increase the number of 
valid activity measurements, thus increase the validity of the results. Nonetheless, as the 
accelerometer has been validated and is considered the most reliable PA outcome 




To gather more feedback on the mechanisms of the intervention from harder to reach 
subsets, a process evaluation of the trial should provide patients with less time-consuming 
methods to provide feedback of their experiences of the trial. In addition to conducting semi-
structured interviews, short surveys which identify patients’ numerical ratings of the 
intervention and research procedures, should be provided to patients. Similarly, surveys 
which map individuals’ capability, opportunity and motivation to participant in the target 
behaviour (PA), as used in previous research366,367, would also facilitate the research team’s 
understanding of the potential mechanisms of the trial, and the factors that impact patients’ 
PA.  
Measures of intervention fidelity and engagement 
A method to increase the fidelity of the intervention was to provide WhatsApp leaders with 
checklists (Chapter 3), however, WhatsApp leaders did not use these, and they were time 
consuming and not considered necessary (Chapter 5). The definitive trial should be as 
convenient for lay volunteers as possible, thus checklists such as these will not be provided. 
Alternatively, lay volunteers should continue to be encouraged to send monthly exports of the 
conversations with participants, as this is less time consuming.  
During the intervention, it was challenging to identify patients’ engagement in social 
networking, as it was not possible to record how often patients read the messages sent by the 
WhatsApp leader (Chapter 5). In a future trial, to identify patients’ intervention engagement 
in social networking and the step diary, researchers should collect data at various stages 
throughout the intervention to measure their engagement in the intervention, similar to 
previous studies193,321. Furthermore, it was also challenging to report patients’ engagement in 
the step diary(Chapter 5). As some participants did not return their step diary at 52 weeks, it 
was challenging to measure patients engagement in this intervention component, therefore a 
copy of patients’ step diary should be collected at the 12-week follow-up visit.248,306  
Physical activity outcome measures  
The primary PA outcome of the intervention, mean daily steps (Chapter 5), should remain the 
same in the definitive trial, as daily steps was connected to the intervention component 
(pedometer and step diary) and supported by previous research which states that steps are a 
common outcome measure which is readily interpretable.53 The secondary PA and health 




this study outlined interesting patterns of SB, LPA and MVPA throughout the study period 
and previous literature has outlined the importance of investigating these patterns.82–78 
Additional outcomes to measure intervention engagement and fidelity are defined in the text 





Table 7:2: Modifications of the research procedures, outlining the continuation or addition of 
the research procedures prior to the definitive trial  
Continuation Addition 
Lay volunteers to continue to send monthly 
exports of the conversations with participants 
to measure intervention fidelity 
 
 
Promotion of peer support following PR with 
fellow PR graduates 
Increase the inclusivity of the study: recruit all 
patients from PR i.e. other lung conditions (e.g. 
Bronchiectasis and Pulmonary Fibrosis), not 
limited to COPD 
 
Introduction of the intervention during PR; 
inclusion of a familiarity period 
Earlier introduction of the intervention to 
patients during PR from HCPs 
 
Measurement of patients’ mean daily steps as 
the primary PA outcome of the intervention 
Provide patients with options to measure their 
daily steps for the primary PA outcome of the 
study: e.g. accelerometer worn on the wrist or 
to wear the Yamax pedometer (CW700/701 
model) 
 
Measurement of the secondary outcomes 
measured in the feasibility study: time spent in 
SB, LPA and MVPA; disease specific quality 
of life (CRQ); anxiety and depression (HADS); 
and patient reported difficulty and amount of 




Interviews with patients and focus groups with 
lay volunteers and HCPs to understand their 
acceptability of the intervention and research 
procedures  
 
Provide patients with brief surveys to measure 
their experiences of the intervention and the 
COM-B factors145 which impacted their PA 
following PR  
Measurement of patient engagement in the 
intervention components via collection of the 
step diary and measurement of messages sent 
over social networking 
Collection of patients’ step diaries at 12 weeks 
in addition to collection at 52 weeks and 
measurement of patient engagement in the 
intervention via brief surveys 
 
 
7.1 Future directions of the study ahead of a definitive trial 
In moving forward with the modification of the intervention and research procedures, the 
results from the feasibility study should be shared with all stakeholders, to understand 
whether the recommendations and conclusions within this thesis reflect their views. As 
reported in previous chapters above, it is important to identify a wide range of individuals 
with COPD to contribute to the modification of the trial. All patients in the feasibility study 
who confirmed their interest in the findings will be sent a copy of the results and all patients 
will be invited to share their opinions of the results, hence widening the sample from which 




Furthermore, to facilitate further communication with different stakeholders in this study, 
patients with all lung conditions, lay volunteers and HCPs will be invited to attend an open 
stakeholder event, to encourage discussion surrounding the acceptability and feasibility of the 
recommended modifications to the intervention and research procedures.   
Based on the recommended modifications to the intervention and research procedures, 
the study requires a revision period prior to the definitive trial. A revision period represents 
an important element in the development of a definitive trial and is recommended by the 
MRC.1 This would enable the stakeholders to examine the practicalities of the recommended 
modifications, such as facilitating face-to-face social support in addition to social networking 
alone, and identifying an acceptable wrist worn pedometer.   
Further modification of the trial should be mapped onto the BCW, and the associated 
behavioural model (COM-B)2, as this framework provides a comprehensive, systematic, and 
transparent process in the development and evaluation of an intervention.2 The COM-B 
model is appropriate in this study as the model accounts for a wide range of behavioural 
sources that impact behaviour, such as those identified in this study, compared to previous 
behavioural models.3,4  
Following stakeholders’ consensus on the modification of the intervention and 
research procedures (Chapter 5), it is prudent to conduct small scale pilot studies to test the 
feasibility and acceptability of the intervention modifications.1,6 These small-scale pilot 
studies would inform the training and support that patients may need to become familiar with 
aspects of the intervention, for example with Facebook.   
For the design of a definitive trial, it may be appropriate for the sample size to be 
based on the current estimate of MCID for daily steps in COPD (350-1100).7 To detect a 
between group mean difference of 350 daily steps (lower limit of the MCID range)/ 1357 (SD 
based on Chapter 5) with 80% power and 5% level of significance, 236 participants are 
needed per arm. The feasibility study (Chapter 5) in thesis provided further parameters that 
could help to inform a sample size calculation of a 52-week definitive cluster randomised 
trial. Findings revealed an average cluster size of 5 patients at baseline, intra-cluster 
correlation coefficient (ICC) for daily steps of 0.58 and a study attrition rate of 35%. To 




and 35% attrition, the required sample of a definitive cluster randomised trial would be 1058 
per arm. There were approximately 326 patients in LCHS who completed PR in 2018-2019, 
in 44 programmes. Considering that the consent rate in the feasibility study (Chapter 5) was 
55%, the definitive trial would need to recruit PR sites beyond Lincolnshire.  
Previous literature, however, has suggested that estimates of sample sizes for 
definitive trials based on feasibility studies can lead to significant over or underestimation.8,9  
This is because feasibility studies are usually too small to inform the parameters (e.g. ICC 
and recruitment rates) needed to estimate the sample size for a cluster RCT. It has been 
considered as more appropriate to calculate the sample size based on the ICC reported in 
previous larger scale trials in a related field of research.8 However, there is only one recently 
reported cluster RCT which aims to promote PA in participants with COPD10, which reported 
an ICC of 0.005. A sample size calculation based on this figure would significantly decrease 
the estimated sample size for the definitive trial, thus increase the feasibility of a definitive 
trial. Based on the limited accuracy of the ICCs in calculating the target sample size in a 
definitive trial8, the decision to continue to a definitive trial should also be based on other 
factors, such as the feasibility and the acceptability of the intervention and research 
procedures, success of the intervention revision period, and stakeholder input. Nevertheless, 
to move forward with a future trial, it is important to continue to gather information (e.g. 
ICCs reported in upcoming cluster RCTs) to inform the parameters needed to estimate the 
sample size for the definitive trial.8 
Surrounding areas, such as South Yorkshire and Nottinghamshire, could support the 
recruitment of PR programmes in a definitive trial. The identification of sites is dependent on 
various factors, particularly as the current health and economic climate has been severely 
impacted by COVID-19.11 For example, access to funding, the workload of HCPs who 
deliver PR, and the number of patients who agree to participate in PR is not yet well 
understood. Consequently, the decision to conduct a definitive trial should be based on 
discussions with stakeholders, including patients with lung conditions, lay volunteers who 
were involved in the feasibility study and HCPs involved in the delivery of PR in 
Lincolnshire and HCPs involved in PR in the surrounding areas.   
If stakeholders agree that it is feasible to deliver the definitive trial, an internal pilot 




whether the trial should continue after a set period. For example, stakeholders would set a 
target recruitment rate per site per month12, and regularly assess whether the sites can achieve 
a sufficient number of participants per cluster. This technique is in line with the traffic light 
system used in previous trials which has been used to reduce unnecessary funding in clinical 
trials.13 The target recruitment rate would be dependent on discussion with stakeholders, and 
calculations based on the number of sites and the average number of patients who enrol and 
complete PR per month. 
7.2 Implications for policy, practice, and research  
Each study in this thesis identified implications for policy, practice, and future research. In 
fact, many of the implications identified in each chapter supported those in previous chapters 
throughout the thesis, hence these are reported together. The implications reported below 
extend beyond the aim of this thesis but need to be addressed in further research. 
7.2.1 Policy and practice 
As reported above, it was clear that HCPs involved in the delivery of PR have limited time to 
provide support for patients to be active following PR (Chapter 5). This was more apparent 
following the delivery of the intervention, as the duration of PR had been reduced during the 
study to 6 weeks (12 sessions), as opposed to 8 weeks (16 sessions). Though the results from 
the study highlighted the value that patients place on support from HCPs (Chapter 5). 
Providing HCPs with the opportunity to follow up with patients after PR is a modification of 
the intervention which may beneficially impact patient outcomes following PR. 
Theoretically, this would reduce the economic burden on the NHS, for example reduce the 
money spent on exacerbations and health concerns associated with physical inactivity. Hence 
the results from this study outlined the need for further resources for HCPs involved in the 
delivery of PR. 
The results from the systematic review (Chapter 2) and the feasibility study (Chapter 
5 and 6) outlined that barriers to patients’ PA, particularly for the non-responders of the 
intervention (Chapter 6), were related to their social and physical opportunity to be active, 
and required further support to help them act on their positive intentions to maintain their 
activity. For example, patients had limited transport and funds which were necessary in 




These results highlight the need for patients to be supported following PR, and for these 
barriers to be addressed, for example including, but not limited to, free transport and 
attendance for structured PA classes.  
Successful self-management is integral to the physical health and QoL for all patients 
with chronic conditions374, and theoretically results in a reduction of the burden on patients’ 
social network and the economic burden on the NHS. As reported in the literature review 
(Chapter 1), there is a substantial gap between the economic burden of respiratory conditions, 
and the money spent on research directed at respiratory conditions.19 This is also apparent in 
the funding directed at treating other chronic conditions, such as Stroke and Coronary Heart 
Disease.375 The implications from this study outline that there is limited funding for the NHS 
to deliver beneficial support to help patients self-manage their chronic condition. Hence these 
findings outline the need for policy makers to direct funding for acceptable and feasible 
methods to improve self-management of chronic conditions.  
Results from this thesis have important implications for HCPs with an interest in 
COPD management. The results from the systematic review of the facilitators and barriers of 
PA following PR in patients with COPD (Chapter 2), which are support by the results of the 
feasibility study (Chapter 5), supported the statement that there is no ‘one size fits all’ 
approach to managing behaviour change following PR.254 It is therefore recommended that 
physiotherapists consider these factors when discussing individualised self-management 
plans on discharge from PR. The results from this thesis provide important information for 
clinicians and HCPs in these settings to consider when delivering long-term COPD 
management. Furthermore, Chapter 3 and 4 have provided an example of how the facilitators 
and barriers of PA following PR can be used to inform the development of an intervention 
which is relevant to the local setting.  
The development and testing of the feasibility study (Chapters 3 and 4) was 
conducted prior to the outbreak of the severe acute respiratory syndrome coronavirus 
2 (SARS-CoV-2), and the COVID-19 pandemic, which resulted in mass social isolation and 
the shielding of people with lung diseases such as COPD.376 The development of the 
intervention reported in this thesis was based on the factors which impacted patients’ 




in COPD than those that have been identified in this thesis (Chapter 2, 3, and 6), for example 
social isolation means that patients are further limited in how and where they can remain 
active.371,377 Many PR providers have had no option but to deliver digital and remote PR. This 
thesis is particularly important, as it outlines a method on the development of an intervention 
to promote PA following PR which can also be delivered digitally and remotely (minus the 
addition of face to face contact with peers). This is important, as recent literature has outlined 
remote contact, such as social media, as the optimal method to support patients during 
COVID-19.376–378 Furthermore, this intervention has the potential to improve and maintain 
patient outcomes following PR, and therefore reduce the growing economic burden on the 
NHS.379 The implications from this thesis are not limited to management of COPD. Due to 
the importance of restricted physical social contact, all digital interventions are becoming 
increasingly important and socially desirable.380 The results from this thesis outline a method 
to develop a digital, remote intervention which can be applied to other health promoting 
behaviours.  
7.2.2 Research  
Results from this thesis also have important implications for researchers. These relate to: 
reporting of qualitative studies (Chapter 2); reporting of an intervention (Chapter 5); 
behavioural framework and behaviour change theory (Chapters 1, 3, 5, 6); mixed methods 
research (Chapter 1, 4, 5 and 6); collaboration with stakeholders (Chapter 1, 3, 4 and 5); 
informing future interventions (Chapter 5); lay volunteers for future research (Chapter 5) and 
digital exclusion (Chapter 5).  
Reporting of qualitative studies 
The systematic review (Chapter 2) reported limitations within the reporting of previous 
qualitative studies and outlines recommendations for researchers. For example, researchers 
should strive to be transparent in the relationship between researcher and individual, clearly 
list the study limitations, and increase access to participant quotations. It would be prudent 
for future studies in the area to therefore adhere to the Consolidated Criteria for Reporting 
Qualitative Research381 which facilitates critical appraisal and interpretation.  




The results from the feasibility study outlined that patients had limited interaction in 
WhatsApp (Chapter 5). Though these findings alone suggest that patients are indifferent to 
peer support, results from the process evaluation outlined that patients highly valued social 
support, and that limited interaction in WhatsApp was attributed to the mode of delivery of 
the intervention. For example, patients had limited familiarity and confidence in using this 
social networking application, hence avoided using WhatsApp. It was therefore apparent that 
slight differences in the delivery of the intervention can potentially result in different patient 
outcomes. However, there is limited reporting of the mode of the delivery of previous 
interventions, including the provider of interventions, and the frequency and intensity of the 
interventions in previous literature.145 Limited understanding of the procedures in previous 
interventions, and the active ingredients of interventions145 is both detrimental for researchers 
interested in intervention development, and the patients/individuals who should benefit from 
the intervention. For example, limited evidence-based interventions are less likely to result in 
beneficial outcomes for patients145 and are not a good use of resources from researchers.  
It was challenging to compare the results of this intervention to previous literature. 
Researchers should clearly list the intervention development process to enable other 
researchers to identify the rationale of the intervention components, for example to highlight 
any context specific factors which impacted the development of the intervention. This would 
inform other researchers of the potential suitability of this intervention in other contexts.145 
Similarly, it is recommended that researchers clearly describe the intervention delivered in a 
study, for example to adhere to the Tidier checklist.382 Researchers should also ensure that the 
level of patient engagement in the intervention components is reported in the studies.  
Behavioural framework and behaviour change theory 
Based on the reported strengths associated with using the BCW, and the included behaviour 
change model (COM-B), these are recommended tools for researchers in the development 
and evaluation of an intervention (Chapters 1, 3, 5, 6). In particular, the COM-B model is 
recommended for behaviours in which there is limited understanding of the determinants of 
behaviour and/or those who identify a broad range of behavioural sources which impact 
behaviour.382  




Based on the reported strengths in adopting a mixed methods design (Chapter 1, 4, 5 and 6), 
it is recommended that future research should also adopt mixed methods designs, 
incorporating qualitative methods within RCTs to provide a more comprehensive evaluation 
of the factors influencing the efficacy of their interventions but also provide evidence as to 
how such interventions can be implemented in practice. 
Collaboration with stakeholders 
Based on the reported strengths associated with collaboration with stakeholders (Chapters 1, 
3, 4 and 5), it is therefore recommended that researchers seek to include as many stakeholders 
as appropriate to guide the development of an intervention, as this would likely increase the 
acceptability and feasibility of the intervention and research procedures, but also reduce the 
time taken to decide upon the proposed intervention.  
Informing future interventions 
This thesis cannot inform other researchers on the type of intervention to deliver for different 
health promoting behaviours, across different populations, as the optimal intervention is 
dependent on the unique behavioural sources that impact patients’ behaviour.382 However, 
based on the results from the feasibility study (Chapter 5), it is unlikely that a ‘one-size fits 
all’ approach is possible in the development of a health promoting intervention, as behaviour 
change is a complex phenomenon, and is often determined by individual differences.241 As 
such, dependent on the behavioural sources that are identified as important in behaviour, 
intervention developers should consider including a variety of BCTs which target various 
factors which may impact patients’ behaviour. Patient preference should be prioritised in an 
intervention, for example patients should have the freedom to only engage in the intervention 
components that suit them.  
However, researchers may decide to incorporate similar intervention components in 
the delivery of their intervention. Therefore, the results from the feasibility study (Chapter 5)  
which outline the successes and challenges in the delivery of these components are useful in 
the development of these interventions. Researchers should identify the modifications which 
are recommended in this trial and consider whether these modifications are appropriate in 
their study.  




Lay volunteers in this study reported that they were enthusiastic about supporting patients to 
be active following PR (Chapter 5), and previous literature has outlined patient preference of 
the inclusion of lay volunteers during PR.189,383 Given the successes in the involvement of lay 
volunteers in the delivery of previous health promoting interventions188,384 and the limited 
resources of HCPs during PR, further involvement from lay volunteers is a potential method 
to decrease pressure on the NHS. Further research should be directed at understanding the 
feasibility and acceptability of the inclusion of lay volunteers in health promoting services 
including, but not limited to, PR for COPD management. 
Digital exclusion 
As reported above, there is growing importance and application of digital and remote health 
care provision during COVID-19. Consequently, digital health literacy is also becoming more 
important, as this impacts patients’ capability and opportunity to access digital health 
services. According to previous research, older adults (65+) are less likely to use the 
internet385, hence placing COPD patients at increased risk of digital exclusion. The results 
from the feasibility study implied that many COPD patients who enrolled onto the 
intervention did not regularly use social media (Chapter 5). This was mainly due to barriers 
such as limited familiarity and confidence in navigating social networking, but also due to 
internet access and connection issues. These results provide further evidence of potential 
digital exclusion, and the possibility that COPD patients are inadvertently excluded from 
health services. Prior to COVID-19, there were mixed views on the appropriateness of digital 
interventions, such as social networking applications, for patients with COPD and/or older 
individuals332–334,336,386 (Chapter 5). Evidence suggested that there has been a growth in the 
use of internet use for older adults333, and that internet and social media were becoming more 
popular with people with COPD.336 However, it is still not clear the extent to which patients 
would choose to use technologies which support digital interventions.385 These findings imply 
that more research should be directed at understanding the digital health literacy of patients, 
and methods to support the inclusivity of patients who may struggle to access digital health 
services.   
7.3 Conclusion 
The aim of this thesis was to develop and test the feasibility of an intervention to promote PA 




adopted a step wise approach in the development and feasibility testing of the intervention. 
Overall, the results outlined that the intervention was considered acceptable and feasible for a 
definitive trial, and data supports the likely impact of the intervention on patients’ PA. 
Modifications are required to optimise the acceptability and feasibility of the intervention and 
research procedures prior to the definitive trial, which are possible during an intervention 
revision period. The results provided an original contribution to knowledge and outlined 
implications for policy, practice, and research relevant for stakeholders interested in 
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Appendix A Example of a search strategy used in MEDLINE 
Medline  Search term  Field  
1 (MH"Lung disease, Obstructive") MH 
2 (MH "Pulmonary Disease, Chronic Obstructive+") MH (Explode) 
3 “COPD” TX 




6 “AECB”  TX 
7 “Emphysem*” TX 
8 “Chronic N3 bronchit*” TX 
9 “Obstruct* N3 airflow*” OR “airway*” OR 
“bronch*” OR “lung*” OR “pulmonary” OR 
“respirator*” 
TI, AB 
10 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9  
11 Exercise (MH "Exercise+") 
12 Exercise movement techniques (MH "Exercise Movement Techniques+") 
13 Physical and rehabilitation medicine (MH "Physical and Rehabilitation Medicine+") 
14 (MH ”Physical fitness”) MH 
15 Exercise therapy  (MH "Exercise Therapy+") 
16 Activities of daily living 
 
(MH "Activities of Daily Living+") 
17 Self-care  (MH "Self Care+") 
18 Physical endurance (MH "Physical Endurance+") 
19 Health behavior (MH "Health Behavior+") 
20 Health N3 behav* TX  




22 Physical* N3 rehabilitat* TX 
23 Physical* N3 mobil* TX 
24 Physical* N3 fit*  TX 
25 Endurance  TX  
26 maintain* N3 exercis*  TI/AB 
27 maintain N3 activ* TI/AB 
28 “Program*” or “training” TI/AB 
29 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 
18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 
25 OR 26 OR 27 OR 28  
 
30 Facilitat* TI/AB  
31 Enabl* TI/AB 
32 Barrier* TI/AB 
33 Hinder* TI/AB 
34 Overcom* TI/AB 
35 Promot* TI/AB 
36 Limit* TI 
37 Support*  TI  
38 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 
37 
 
39 Qualitative research (MH "Qualitative Research+") 
40 Interview  (MH "Interview") 
41 Focus groups (MH "Focus Groups") 
42 Qualitativ*  TI, AB 
43 Interview*  TI,AB 
44 Mix* N3 method* TX 
45 Process* N3 eval*  TX 




47 Method* N3 triangulat*  TX  
48 Focus group*  TX 
49 Ethnograph* TX 
50 Phenomenol* TX 
51 Ground* N3 theor* TX 
52 Discourse analys*  TX 
53 Purposive  TX 
54 Narrative* TX 
55 Content* N3 analys* TX 
56 thematic TX 
57 Verbatim TX 
58 Theme* TX 
59 Belief*  TI 
60 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 
46 OR 47 OR 48 OR 49 OR 50 OR 51 OR 52 OR 
53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59  
 





Appendix B A full list of excluded studies, together with reasons for exclusion 
 Study reference  Exclusion based on:  
Study design, Population, Outcome  
 
 
1 Apps et al., 2013 
 
Population: History of PR participation not 
reported 
(Conference abstract)   
 
2 Arnold, Bruton, & Ellis-Hill, 2006 
 
Population: Not all individuals had completed 
PR 
Outcome: Focus on experiences during PR only 
 
 
3 Beauchamp et al Data already included in review.  
 
4 Burge et al., 2013 
 
Population: COPD patients could not be 
distinguished from other participants.  
Outcome: No discussion of PA. 
 
5 Caress, Chalmers, & Luker, 2010 
  
Population: Not all individuals had completed 
PR 
 
6 De Sousa Pinto et al., 2013 
 
Study design: Systematic review   
 
7 Desveaux, Goldstein, Mathur, & Brooks, 2016 Outcome: Quantitative data only  
 
8 Fabienne Dobbels et al., 2014 Population: History of PR not reported.  
 
9 Fabienne Dobbels et al., 2011 Population: History of PR not reported. 
(Conference abstract) 
 
10 Halding, Wahl, & Heggdal, 2010  Outcomes: No discussion of PA. 
   
11 Hamir et al., 2012 
 
Outcome: No discussion of the barriers and 
facilitators to PA.  
 
12 Hardy & Coe, 2011 
 
Outcome: No discussion of the barriers and 
facilitators to PA 
(Conference abstract) 
  
13 Hartman, ten Hacken, Boezen, & de Greef, 
2013  
Outcomes: No discussion of PA 
 






 Study reference  Exclusion based on:  
Study design, Population, Outcome  
 
 
15 Langley-Johnson et al., 2010 Conference abstract without access to primary 
data 
Mentioned in the discussion  
 
16 Larson, Fernandez, & Vos, 2015 
 
Population: History of participation in PR not 
reported   
 
17 Leidy & Haase, 1996 
 
Population: History of participation in PR not 
reported   
18 Matheson et al., 2010 
  
 
Conference abstract without access to primary 
data 
Mentioned in the discussion  
 
19 Meis et al., 2014  
 
Population: Not completed PR 
 
20 Nonoyama, Holmes, King, & Brooks, 2010 
 
Population: No distinction between participants 
with COPD and participants with Asthma. 
Outcome: Quantitative data only 
 
21 O'Connor et al., 2009  
 
Population: No participation in PR 
22 O'Shea, Taylor, & Paratz, 2007  Population: No participation in PR  
 
23 Pillard, 2014 
 
Outcome: Quantitative data only  
 
24 Poureslami et al., 2017 
 
Population: Not all individuals had completed 
PR 
25 Small et al., 2012 
 
Population: No history of participation in PR  
26 Thomas, Williams, & Stern, 2015 Population: Not exclusively COPD patients 
Outcome: No discussion of PA  
(Conference abstract) 
 
27 Thorpe, Kumar, & Johnston, 2014   
 
Population: Not participated in PR 
 
28 Valenson et al., 2016 
 
Population Not participated in PR 
 
29 Verwey et al., 2014 
 
Population: No history of participation in PR 
 
30 Walters et al., 2012  
 
Population: Not participated in PR 
 






 Study reference  Exclusion based on:  
Study design, Population, Outcome  
 
 
32 Williams, Hardinge, Ryan, & Farmer, 2014  Population: Not all individuals had completed 
PR 
 
33 Wong et al., 2014 Study design: Quantitative data only  
 
34 Wortz et al., 2012  Population: No history of PR completion  
  
35 Yang & Chen, 2005 
 
Outcome: Quantitative data only  
 
36 Yorke et al., 2012  Conference poster: Restricted access to primary 
data  
 
37 Young et al., 2014 
 
Population: History of PR not reported  
38 Zanaboni et al., 2016 
 






Appendix C Characteristics of Included studies 
Author, year, 
country  




















Data collection context: 
duration after pulmonary 
rehabilitation;  
participation in usual care or 
intervention; 
duration/intensity of the 
intervention  










participants home;  
 
*established 
guidelines for data 
analysis.  
 
7  M2/F5 Range: 82-
86  
Severe to moderately severe; 
 
(FEV1 % predicted mean (SD), 
43 (14)), range = 23-69; 
 
Smoking (pack-years): mean (SD) 





5 weeks;  
 
3 x weekly sessions 
<2 weeks;  
 













12 M6/F6 Range: 52-
85 
Severe;  
(FEV1 % predicted mean (SD): 
44 (18));  





Hospital based PR; 
 
Inpatient PR: 6 weeks 
 






Individuals were participating in 
community exercise 
maintenance programme;  
 
12 months/  
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Data collection context: 
duration after pulmonary 
rehabilitation;  
participation in usual care or 
intervention; 









or at the 










Mild to severe;  
Smoking status (n): Former = 11, 
Current = 5 
 
 






(1 day ⁄ week) 
 
T1 = <2 months, 



















10 M5/F5 Mean: 55.2 
years 
Moderate to severe  









T1: <18 months 
 
T2: <30 months 
 



































71 (10);  
 
Group B: 
67 (11)  
 
Mild to severe (FEV1 % predicted 
mean (SD): Group A: 67 (16); 
Group B: 59 (17));  
 
MRC: mean (SD):  
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Data collection context: 
duration after pulmonary 
rehabilitation;  
participation in usual care or 
intervention; 



















Moderate to very severe;  
 
MRC: 2 (n= 5) 4 (n=1)  
 
 
NR <48 months; 
 





Qualitative  Semi-structured 
interviews;  
 






   





Disease length (years): 0.25 -20;  







2 x week 
 
 





















Smoking status (n): had a 
smoking history (7), current 
smoker (1); 
 
Oxygen users (n): kept oxygen in 
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Data collection context: 
duration after pulmonary 
rehabilitation;  
participation in usual care or 
intervention; 





Qualitative Focus groups; 
 
Setting: NR;  
 
Template analysis  
 
23 M14/F9 Range: 63- 
70 years  
 
FEV1 in litres per minute: mean 
(SD) [% predicted]  
(range between focus groups 1-4):   
0.87 (0.28) [40%] - 1.26 (0.63) 
[49%]; 
MRC median: (range between 





6 weeks;  
 

























Mild to very severe;  
FEV1, % predicted: Mean (SD): 
52.5 (14.4); range 25- 90; 
Disease length (years) mean (SD): 
5 (3.9); range: 0-13; 














Participants were involved in an 
ongoing nutritional supplement 





















Moderate to severe;  









1+ session daily.  
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Data collection context: 
duration after pulmonary 
rehabilitation;  
participation in usual care or 
intervention; 





















Moderate to very severe;  
Disease length range (years): <5 - 
>10;  





2 x weekly 
T0: interview pre-PR, 
 
T1: interview post-PR; 1-2 
weeks; 
 






















Moderate to severe; 
 
FEV1 (% of predicted): Mean 
(SD): 46 (10); range: 27–67 
Smoking status (n): Current 





2hrs per week 
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country  




















Data collection context: 
duration after pulmonary 
rehabilitation;  
participation in usual care or 
intervention; 
duration/intensity of the 
intervention  
n = number; COPD = chronic obstructive pulmonary disease; PR = pulmonary rehabilitation; M/F = male/female; FEV1 (% predicted) = percentage of forced expiration volume in one 
second divided by the average FEV1% in the population for any person of similar age, sex and body composition; SD = standard deviation; NR = not reported; PHC = primary health care; 
GOLD stages = global initiative for chronic obstructive lung disease stages; MRC dyspnoea = medical research council dyspnoea scale; T1/T2 = time 1/time 2 etc;  
 
*Camp 215: Analytical approach was: “established guidelines for data analysis.”; *Desveaux 220: This study involved participants with heart failure but only the COPD subgroup was reported 
in this table; *Halding 222: two people did not provide follow up interviews because of death, and one could not be reached; *Hoaas
211,212
: T3 refers to a second paper which followed up the 
same participants’ experiences of PA following tele-rehabilitation;*Hogg192: Using records held by the pulmonary rehabilitation team, eligible participants were placed into two groups 
(Group A: had received input from pulmonary rehabilitation staff to assist with ongoing exercise following completion of the pulmonary rehabilitation course; Group B: had not received any 
input from pulmonary rehabilitation staff regarding ongoing exercise); *Norweg230: estimated duration of PR programme, based on “six, 1-hour weekly sessions of occupational therapy” and 
“15 sessions held twice weekly” of the exercise training programme;* Rabinowitz232: All participants had oxygen in the home which was used as needed, mainly upon exertion, however 
only participant used oxygen continuously; *Stewart225: individuals were involved in an “ongoing NUTRAIN trial investigating the efficacy of nutritional supplementation during 4 months 
of supervised exercise training on physical performance and cardio-metabolic risk, in a placebo-controlled design.”; Zakrisson 233 data collection timescale post-PR estimated from reported 













Appendix E Brief script read by the HCPs to inform patients (intervention and 
control group) of the research study 
 
Script: Intervention Group 
 
Title of Project: Physical activity following pulmonary rehabilitation in patients with Chronic 
Obstructive Pulmonary disease (COPD) 
 
We, at the Lincolnshire Community Health Services NHS Trust, are currently working with 
the Lincoln Institute for Health at the University of Lincoln.  
We will be inviting all people diagnosed with COPD to take part in a research study, which is 
part of an educational project at the University. If you agree to take part, you will be provided 
with additional support to remain active after the pulmonary rehabilitation programme and you 
will be asked to provide information about your physical activity and health status.    
This information sheet describes the study and research procedures. Participation is entirely 
voluntary. The research team from the University will attend pulmonary rehabilitation next 
week to talk to you about this study and to provide you with a consent form which you will be 
asked to complete if you agree to participate. 
The research team’s contact details are listed at the end of this sheet. If you have any questions 




Script: Control Group 
 
Title of Project: Physical activity following pulmonary rehabilitation in patients with Chronic 
Obstructive Pulmonary disease (COPD) 
 
We, at the Lincolnshire Community Health Services NHS Trust, are currently working with 
the Lincoln Institute for Health at the University of Lincoln.  
We will be inviting all people diagnosed with COPD to take part in a research study, which is 
part of an educational project at the University. If you agree to take part, you will be asked to 
provide information about your physical activity and health status.    
This information sheet describes the study and research procedures. Participation is entirely 
voluntary. The research team from the University will attend pulmonary rehabilitation next 
week to talk to you about this study and to provide you with a consent form which you will be 
asked to complete if you agree to participate. 
The research team’s contact details are listed at the end of this sheet. If you have any questions 





























































Title of Project: Physical activity following pulmonary rehabilitation in patients with Chronic 
Obstructive Pulmonary disease (COPD) 
 
IRAS project ID: 229697 
REC reference: 18/SC/0199 
Participant identification number:       Date:  
Step Diary 1 
Date Number of steps Comments (optional) 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   




Appendix J Patient intervention manual 
Title of project: Physical activity following pulmonary rehabilitation in patients with Chronic Obstructive Pulmonary Disease (COPD) 










This leaflet will provide you with information and instructions on how to 
use the pedometer, step diary and WhatsApp. 
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• Individuals with COPD have been shown to benefit from small improvements in the number of steps walked. For example, it was 
recently reported that an improvement in 600-1100 steps per day is associated with a meaningful reduction in hospital admissions for 
COPD patients. 
 
• Pedometers are used to provide an indication of your daily activity levels by displaying your daily step count. The regular use of 
pedometers has been found to improve physical activity levels and quality of life in people with COPD. 
 
• We hope that by using a pedometer to identify your daily steps, you will become motivated to keep active following pulmonary 




To open the pedometer: 









Step 2: Use the other hand to pull the silver clip down and away from the top of the case.   












1. Clip the pedometer onto a piece of clothing  
(e.g. trouser pocket, waist belt, top of skirt).  
 
2. Wear this device everyday (take off before sleep). 



















• No activity monitor is completely accurate, they only give an indication of how active you are. 
 
• Your stride length and walking pace can affect the number of steps you do. This means that the number of steps can vary between people 
even when they are doing the same activity. 
 






Average number of steps in different activities 
Physical activity Steps per hour 
Golf 4,200 
Gardening (low intensity) 4,380 
Housework, general, vacuuming 5,400 





• It is understood that people enjoy recognising their progress during pulmonary rehabilitation. Recording your steps every day will help 
you identify any progress that you make after pulmonary rehabilitation.  
 
• You have been provided with a step diary. We hope that the step diary will motivate you to keep active after pulmonary rehabilitation. 















Example step diary 
Date  Number of steps  Comments (optional) 
01/04/2018 2606 Felt motivated  
02/04/2018 …… Felt tired so I did less steps.  
03/04/2018 …… Cycled today. Pedometer did not 





1. Use the pedometer to identify how many steps you complete every day and record this in the diary. 
 
2. We recommend writing a brief comment about the number of steps you complete. This can help you identify the reason for any changes 
in the number of daily steps you do throughout the 12 months. 
 
 
3. Aim to record your steps every day at the same time (preferably before you go to sleep). We recommend setting a daily alert to remind 
yourself to report your steps (e.g. on your phone or watch).   
 
4. Recording your steps shouldn’t take you more than 1-2 minutes. 
Note: 
• The number of steps you do in a day is only an indication of how active you are. You might do other activities such as swimming, 
cycling or upper body activities and the pedometer will not register this activity. It might be useful to record these activities in your step 






• Research suggests that one of the main benefits of attending pulmonary rehabilitation is meeting and socialising with other people 
who have a lung condition.  
 
• We have provided you with a phone, to allow you to stay in touch with other members involved in pulmonary rehabilitation once you 
have finished the programme. We hope this will help you keep active after the programme. 
 
• You have been added to a group chat on “WhatsApp”, which is populated by other members of pulmonary rehabilitation and led by a 
volunteer from a COPD support group (Breathe Easy). Their role is to encourage you to keep active after pulmonary rehabilitation.  
 
• You will be able to send and receive instant messages to and from other people in this group chat. Any messages sent/received in this 
chat will be visible to all members of the group. 
 







• WhatsApp uses the internet to send messages, meaning that it is free to use.  
• The messages sent by the WhatsApp leader will be structured around guidelines written by the research team. However, you will still 
be encouraged to ask the WhatsApp leader any questions you may have. 
 
• You are free to participate in the group to a level that benefits you. If you do not wish to send messages, that is completely fine.  
 
• Respect all group members and act in a manner that is considered polite, friendly and helpful. 
 
• Be patient with the phones as they can occasionally be slow. Wait up to 10 minutes to use your phone after you have turned it on, as 
it may need this time to load. Pop ups may appear on the phone but please ignore these.  
 






To turn the phone on:  
 





To charge the phone: 
  
• Connect the charger to the mobile phone and plug this into a plug socket. It may take up to 1 hour for 
















To unlock the phone: 
 
• Press the top right-hand button. 







To unlock the phone: 
 








• This screen will then show numbers. 
• Enter the PIN: 1234 

















To access WhatsApp: 
 
• Tap on the WhatsApp logo 





To access the WhatsApp group chat: 








To write a message to the group:  
• Tap on the white bar at the bottom of  






























A keyboard will be 
displayed. Write 
your message using 
this keyboard and 
press send when 
you are ready to 
send your message 





To check when the 
message has been 
sent: 
 
One grey tick next to 
the message will how 
when the message 

























Two grey ticks 
next to the 
message will 
show when the 
message has 




To know when your 
message has been 
read: 
 
Two blue ticks will 
show when 
everyone in the 















A message will appear 
at the top of the 
WhatsApp group to 
show when someone 
is typing a message.  
 






A notification at the top of your screen will show when someone writes a message in the “PR WhatsApp group”.  
 










A number will also appear next to the “PR WhatsApp group” which will show how many messages have been sent to the group from other 










Your health and safety 
 
• The WhatsApp leader is not medically or clinically trained and is not a member of the research team. 
• If you have questions or concerns about your health, please contact your GP or other relevant healthcare services. 
Problems 
• If you have further questions about the phone or pedometer, please read the specific manuals for these devices. 
• Alternatively, please ask a member of the research team (contact details on the last page). 
Please report to a member of the research team if: 
• If you encounter any problems with the pedometer or mobile phone (for example the device is lost or broken).  
• If you wish to report any inappropriate comments on WhatsApp.  
If you have any questions about the study, or your involvement in it, either now or in the future, please contact the research team on the 






Miss Hayley Robinson 
Chief Investigator/PhD Student 




Dr Arwel Jones 
Academic Supervisor 




If you would like to speak to someone about the  



















WhatsApp Group Leader Guidelines and Checklists 
 
Title of the project: Physical activity following pulmonary rehabilitation in patients with 
Chronic Obstructive Pulmonary Disease (COPD) 
 
The Checklists and guidelines are to help you during the study and to make sure that the 
intervention is consistent across different areas in Lincolnshire.   
WhatsApp Checklists   
• The research team will send you a Checklist for Week 1 (see below for the example). 
• After Week 1, the research team will send you two WhatsApp Checklists every four 
weeks (Checklist 1 and Checklist 2). See below for the examples.  
Checklist Week 1 
• This Checklist will show you which messages to send every day during Week 1. 
Report in the table whether you sent these messages.  
Checklist 1 
• Checklist 1 will show what type of message to send every day.  
• See the lists of messages below to find the different types of messages. 
• For each type of message, choose a message (or a selection of messages) from the list 
and send these to the WhatsApp group.   
• Complete Checklist 1 every day to report whether you have sent the indicated 
message type/s.  
Checklist 2  
• This Checklist will be blank (see below).  
• Use this Checklist every day to record any additional messages that you have sent.  
• Choose a message from the list and send to the group if/when you think it is 
appropriate. For example, if group members report that they have made an effort or 
report any physical activity progress, send them a message from the List titled 
‘Congratulatory messages’. If group members report that they are worried about being 
active, send them a message from the list titled ‘Social Support’ (See page 7 for the 
full list of messages).  
After each 4-week period 
• The research team will send you a reminder to send across your completed WhatsApp 





Week 1 Checklist: WhatsApp message schedule 
Day  Messages to send Y/N  
1 6pm:  
• Hello and welcome to the WhatsApp group. My name is XXX and I am your 
WhatsApp leader. My role is to motivate you to keep active now you have finished 
pulmonary rehabilitation.  
• I will send the group a message every day of this week except for Sunday. Listen 
out for your phone so you don’t miss any messages that I send. I recommend 
charging your phone every day, so it does not run out of battery. If your phone isn’t 
on, you might not see any messages from the WhatsApp group. 
• Become familiar with the manuals you have been provided as they may help answer 
any questions you may have about the devices or WhatsApp. I recommend keeping 
these with you, or keeping them somewhere you remember, e.g. on your bedside 
table.  
• Remember that I am not medically trained, and therefore cannot give 
medical advice. If you are concerned about any aspect of your health, please 
seek professional help as you would otherwise. 
• I recommend recording your daily steps in the Step Diary each day, starting today. I 
will send a message to the group every day during the first week to remind you to 




• Good afternoon, I will send and/or reply messages to the group in two, 2-hour slots 
every day. One time slot in the afternoon (12-2pm) and one time slot in the evening 
(6-8pm).  
• I can change these timeslots to be earlier/later if that suits the group? Let me know 
if these times do not suit you.  
Leave time for the group to respond 
• Starting from next week, I will send information about the different activities that 
you could participate in. If these interest you, I will send out reminders  three days 
before the activities/classes. Will this be enough time to prepare you to attend the 
activities/classes?  
Leave time for the group to respond 
• Has everyone managed to use the pedometer today? If you are struggling to use the 
pedometer, please check the manual or ask a question in this group.  
Leave time for the group to respond 
• Remember to record your daily step counts in the Step Diary. It might be helpful to 
put your Step Diary somewhere that you can see it easily. For example, you could 
stick it to your wall, put it on a pin board, hang it on the fridge etc. Has anyone got 
any other suggestions of where to put the Step Diary?   
 











Agreed time:  
 
 
3 Time 1 
• You might be surprised at the number of activities where you live that are suitable 
for someone with a lung condition. For example, there are various activities, 
exercise classes and a number of walking activities and walking sports that are 
popular with people with lung conditions. In addition, local gyms, community halls 
etc. may have a lot of activities in your area. If you also like being active at home, 
there are plenty of ways that you can do this. 
• Next week I will start sending you information about the local physical activity 
opportunities in your area. Make a note of any activities that you would be 
interested in attending.    
• Remember to record your daily step counts in the Step Diary. 
 
4 Time 1 
• You might find that being active with other people helps motivate you to keep 
active after pulmonary rehabilitation. You could be active with other members of 
this group, or friends, family or colleagues. Look out for opportunities to be active 
with other people.  
• This WhatsApp group is to encourage you to keep active after pulmonary 
rehabilitation. If you need some encouragement to be active/feeling unmotivated, 
post a message to this group and together we can offer each other support. 
Remember that other people in this group are going through a similar experience, so 
don’t feel nervous about sending a message to the group.  
• Remember to record your daily step counts in the Step Diary. 
 
5 Time 1 
• Some people find it easier to be active by sticking to a schedule or a routine. Does 
keeping a routine/schedule help any of you in the group?  
Leave time for the group to respond 
• Prompt: If so, is there anything that you do that helps you stick to a routine? 
Leave time for the group to respond 
• Remember to record your daily step counts in the Step Diary. 
 
6 Time 2 
• Good afternoon/evening.  
• Remember to record your daily step counts in the Step Diary.  
• I won’t be posting any messages to the group tomorrow but remember to 
record your steps! 
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Checklist 1: Essential messages; Month 1 (Week 2-4) 
Day  Week 1 Y/N Week 2 Y/N Week 3 Y/N Week 4 Y/N 
Mon Time 1         






















 Reminders   Vitality  
(Thu) 
 Vitality  
(Thu) 
 Vitality  
(Thu) 
 

















 Reminders         
Wed Time 1   Activities at 
home 
 Activities at 
home 
 Activities at 
home 
 










 Reminders         
Thu Time 1         










 Reminders         






























Sat Time 1         




















Sun          
          





Checklist 2: Additional message checklist; Month 1 (Week 1-4) 
Day  Week 1 Week 2 Week 3 Week 4 
Mon Time 1     
 Time 2     
Tue Time 1     
 Time 2     
Wed Time 1     
 Time 2     
Thu Time 1     
 Time 2     
Fri Time 1     
 Time 2     
Sat Time 1     
 Time 2     
Sun Time 1     
 Time 2     




Instructions and message types 
 
Active Lincolnshire 
Instructions for WhatsApp leaders  
Active Lincolnshire lists the activities/sports that are running across Lincolnshire. There are 
reminders in the Checklists to send the group messages about the different physical 
activities/classes around Lincolnshire. The full details for these classes will be sent to you 
with the Checklists every 4 weeks. 
(Example of a class listed near Gainsborough) 
Exercise prescription 
• Day/time: Monday, 1-3.30pm; Venue: Roses Sports Ground, North Warren Road, 
Gainsborough, Lincolnshire, DN21 2TU; Cost: free for a 10-week course 
When you have received the Checklists with the full details of the activity classes, double 
check the website: http://www.activelincolnshire.com/activityfinder/: and ‘What’s on this 
week’ at: http://activelincolnshire.com/activityfinder/whats-on to check upcoming activities 
and to see whether these classes are still running. If they are not, do not list these in the 
group. If there are any additional classes/activities running that the group could be interested 
in, report these to the group. If you are unsure whether this activity is relevant, you could 
contact the class leader from the details listed on the website or contact the research team.   
Report these activities/classes to the group, informing them of the day/time, venue and cost. 
If you report any more activities/classes, inform the group of the day/time, venue and cost of 
the activity. 
When to send these messages: 
• Send the group a summary of the activities at the start of each Week (when indicated 
on the Checklist) 
• If group members ask for information about how they can keep active. 
• Send a follow-up message and question/s (follow-up) after sending information about 
the different ways for people to keep active. This may help generate discussion and 
get some feedback about what type of activities people are interested in. 
Note: 
• There may be a lot of information listed for Active Lincolnshire. However, many of 
the activities will not be relevant.  
• Do not report the Vitality classes listed on the Active Lincolnshire website. 
VitalityLincs shows a Live update of the Vitality classes and will provide more up to 
date information (see below). 
• If you do find additional relevant classes/activities (that aren’t already reported in the 
Checklist), send the group information/reminders about these. Try to send reminders 
about the classes when you can give people at least 3 days warning before the 
activities/classes. For example, if a class is on Thursday, try to report this to the group 
by Monday.  
Messages to send to the group 




(report the day/time, venue and cost of each indicated activity in the Checklist for that week) 
• XXX is coming up in 3 days’ time. Here are the details:  
(report the day/time, venue and cost of the indicated activity in the Checklist) 
• I have searched for local activities in your area. XXX will be held at:  
(report the day/time, venue and cost of the activity that you have found on 
ActiveLincolnshire) 
Follow-up messages 
• Here is the link to the Active Lincolnshire website, where these activities are listed: 
http://activelincolnshire.com/activityfinder/ 
• If you would like more information about any of these activities, please visit this 
website or ask me. I can provide you with the link to the activity website where you 
can find more information about the activity/class, as well as contact details for this 
activity. 
Questions (follow-up)  
• I may not be aware of some activities that are going on and therefore I might have 
missed some activities off this group. Does anyone know of any other activities that 
are scheduled in this area? I am sure it would be helpful for other people in the group 
to hear about the different physical activity opportunities.    
• How do you feel about those options? 
• Is anyone thinking of going to any of these activities this week? 
• What would you be interested in attending/Would anyone like to attend this week? 
• Are these physical activity classes/events of interest to anyone in this group? 
• Would anyone like more information on the activities that I have listed here? 
• Are there any other activities, not listed here, that anyone would be keen to have more 
information about? 
• These activities are up to X miles from (postcode). How far would people be 
interested in travelling to get to these classes/activities? 
• You might find that travelling to these classes together could be helpful. If anyone is 
thinking of driving to the class and would like to offer lifts, let the group know. 
Vitality exercise classes 
Instructions for WhatsApp leaders 
Vitalitylincs.co.uk lists the classes that are running across Lincolnshire. There are reminders 
in the Checklists to send the group messages about the different Vitality classes around 
Lincolnshire. The full details for these classes will be sent to you with the Checklists every 4 
weeks 
(Example of a class in Ruskington) 
• Day/time: Monday/11:30-12:15pm; Venue: Ruskington- Winchelsea Centre, 11 High 
Street North; Type of Class: Seated; Teacher: Kimberley; Cost: The first class is 
FREE, after that it’s £4.00 per class as a visitor with no commitment or £12.00 per 




When to send these messages: 
• Send the group a summary of the Vitality classes at the start of each Week (when 
indicated on the Checklist) 
• If group members ask for information about how they can keep active. 
• Send a follow-up message and question/s (follow-up) after sending information about 
the Vitality classes. This may help generate discussion and get some feedback about 
whether/if people are interested in attending the classes. 
Note: 
• These classes can get cancelled, so remind group members to double check that these 
are on: e.g. recommend that they phone the group leaders on the day of the class.  
• If you do find additional Vitality classes on the website (that aren’t already reported in 
the Checklist), send the group information/reminders about these. Try to send 
reminders about the classes when you can give people at least 3 days warning. For 
example, if a class is on Thursday, try to report this to the group by Monday.  
Messages to send to the group 
• Vitality is a specialist exercise class that runs across the UK for people living with a 
lung condition.  
• The classes vary in levels from seated to part seated, part standing to fully standing routines 
all to a wide range of music. The classes cater for all levels of abilities and participants are 
encouraged to work to their own level at all times.  
• There’s no need to book, although we advise checking with the office or the website before 
coming along for the first time.  The first class is FREE, after that it’s £4.00 per class as a 
visitor with no commitment or £12.00 per month as a member. 
• The classes also cater for those younger than sixty with medical conditions which prevent 
them from exercising in any other way. Please note that you will be required to complete brief 
health screening process with your teacher at your first session, just to ensure that it’s safe for 
you to exercise. 
• There is a short video on Vitality’s website which explains what it is and how it works: 
http://www.vitalitylincs.co.uk/about/ 
• Here is a list of Vitality classes near you that may help you to keep active:   
(Report exercise class, including the day/time, venue, type of class, teacher and cost.) 
Follow-up messages  
• Here is the link to the Vitality website, where these activities are listed: 
http://www.vitalitylincs.co.uk/find-a-class/ 
• If you would like more information about any of the Vitality classes, please visit this 
website or ask me.  
Follow up questions 
• Is anyone thinking of going to any of these classes this week? 
• Are these classes of interest to anyone in this group? 




• These classes are up to X miles from (postcode). How far would people be interested 
in travelling to get to these classes? You might find that travelling to these classes 
together could be helpful. If anyone is thinking of driving to the class and would like 
to offer lifts, let the group know.  
Activities at home 
Instructions for WhatsApp leaders  
When to send these messages: 
• When indicated on the Checklist. 
• If group members ask for information about how they can keep active at home. 
British Lung Foundation (BLF) has a number of resources that could help patients keep 
active at home. Report the link to BLF’s exercise handbook and DVD if people request this: 
• BLF Active: Resources  
• Report the link to BLF’s exercise handbook and DVD if people request this: 
• https://shop.blf.org.uk/ 
• Report the link the BLF’s YouTube videos: 
• XXX 
Messages to send to the group 
• Being active at home can allow you to work at your own pace, in the comfort of your 
own home. If you would prefer to keep active at home, there are a number of ways 
that you could do this.  
• The British Lung Foundation has an exercise DVD and a handbook to support you 
through these simple activities. You can order this DVD online or call for more 
information on: 03000 030 555. I can provide you with the link to the website.  
• The British Lung Foundation also have online videos of similar exercises you 
completed in pulmonary rehabilitation. They can be found here:  
(Insert link) 
Follow-up messages 
• Do home activities interest any of you in the group? 
• Has anyone used the exercise DVD? If so, how did you find it? 
• Has anyone watched the online videos from the British Lung Foundation? If so, how 
did you find them? 
 
Social support 
Instructions for WhatsApp leaders  
When to send these messages: 
• When indicated on the Checklist. 
• If group members say that they do not feel motivated or they report feeling 





• There are numerous messages in this list. Only choose one/or a select few from this 
List. It is up to you to choose which ones you think are most relevant. 
Messages to send to the group 
• Research suggests that one of the main benefits of attending pulmonary rehabilitation 
is meeting and socialising with other people who have a lung condition. This 
WhatsApp group is to encourage you to be active. If you need some encouragement to 
be active/feeling unmotivated, post a message to this group and together we can offer 
each other support.  
• Is anyone attending any physical activity classes this week? It might help to meet up 
with other people in this WhatsApp group so that you can support each other to be 
active. Please let other group members know if you would be interested in meeting up 
and being active together.   
• Walking groups are popular for people who have COPD. What do you all think about 
arranging a time to meet up for a walk? What day and time would suit people? 
• Ask family or friends to do daily activities with you, for example go out for a walk or 
go cycling. They might make it more fun or provide you with a distraction. 
• Friends, family, neighbours, colleagues etc. may provide you with emotional 
support/support if you are struggling to be active. Share your plans to be active with 
them so that they can support you. 
• If you are worried about being active by yourself, attend a group activity session or 
ask someone else to be active with you. 
• If you are worried about being active by yourself, arrange to be active with a “buddy”. 
• Another member of this group could be an exercise buddy. If anyone in this group 
wants an exercise buddy, please let the group know. With an exercise buddy, you 
could meet up to go for walks, or discuss attending any activity classes together? You 
might find that this keeps you motivated to keep active after pulmonary rehabilitation.   
Monitor activity levels 
Instructions for WhatsApp leaders  
When to send these messages: 
• When indicated on the Checklist. 
Note:  
• There are numerous messages in this list. Only send one/or a select few from this list. 
It is up to you to choose which ones you think are most relevant.  
• Listed here are several closed and open questions. The closed questions encourage the 
group members to reflect on their step counts. The open questions encourage the 
group members to discuss their physical activity experiences. Send the closed 
questions to the group first and use the open questions to prompt the group to discuss 
their experiences with physical activity.  
Messages to send to the group 
Closed questions  




• How many steps have you done since last Thursday? 
• How many steps have you done since last Tuesday? 
• Did anyone do more steps than yesterday? 
• How long have you spent being active today? 
• What activities have you done today? 
• Did anyone go walking outside today? 
• Did anyone manage to be active today? 
• Has anyone noticed improvements in their step counts since pulmonary rehabilitation? 
• Has anyone noticed improvements in their step counts since last week?  
• Has anyone noticed any improvements in their activity levels? This doesn’t have to be 
related to the number of steps you have done.  
Open questions  
• It would be interesting to hear how you got these steps. Perhaps tell the group what 
activity you have done today/how you got this many steps. 
• It would be interesting to hear about any improvements you have noticed in your step 
count since pulmonary rehabilitation. Perhaps tell the group about any improvements 
you have noticed 
Habits/routines 
Instructions for WhatsApp leaders  
When to send these messages: 
• When indicated on the Checklist. 
• When group members report that they are struggling to keep active 
• When group members report that they are struggling to form a habit/routine.  
Note: 
• There are numerous messages in this list. Only send one/or a select few from this list. 
It is up to you to choose which one/s you think are most relevant.  
• The suggestions about habits/routines are to encourage group members to get into a 
regular pattern of being active. The suggestions about activities of daily living are to 
remind group members that there are simple things they could do every day to help 
them keep active. The open questions may encourage group members to discuss their 
habits/routines.  
• Send suggestions to the group and then send open questions. This might help start a 
group discussion.   
Messages to send to the group 
Suggestions: habits/routines 
• Some people find it easier to be active by sticking to a schedule. Try and do your 
daily activities every day at the same time (for example XX). 
• If it helps, set an alert on your phone to remind you to be active at a certain time. 
• Try and do your daily exercises at the same time every day. This may help you form a 




• Try and attend the same class every week. Organise your schedule so that you can try 
to attend every week. 
Suggestions: Activities of daily life/living 
• There are simple habits that you could get into which would increase your physical 
activity levels. During your daily life, a few things you could do would be to sit less, 
take the stairs or walk and carry the shopping instead of driving/getting the bus.  
• You could use prompts to remind yourself to stay active. You could: put your trainers 
by the front door; hang the clothes you do exercise in outside your wardrobe; put your 
daily steps diary on the wall/somewhere you can easily see it.  
• Would these help to remind you to be active? 
Open questions  
• Can you think of any other ways to remind yourself to stay active? 
• Can you think of any other ways to help you form a habit/routine to keep active?   
• You could increase your steps by walking around the house when the TV adverts 
come on;  
• What things could you change in your current routine to be more active? Any tips or 
advice from anyone in this group may be helpful for other people. 
Congratulatory messages 
Instructions for WhatsApp leaders  
There are numerous messages in this list. Only send one/a select few from this list. It is up to 
you to choose which one/s you think are most relevant.  
When to send these messages: 
• When indicated on the Checklist. 
• When group members have reported: making an effort, making progress, being active, 
maintaining their activity levels.   
Note: 
• There are numerous messages in this list. Only send one/or a select few from this list. 
It is up to you to choose which one/s you think are most relevant. 
Messages to send to the group 
• Well done! 
• Good effort! 
• Congratulations on maintaining your step count (since… yesterday/last week/since 
you finished pulmonary rehabilitation) 
• Congratulations of achieving a higher step count (than… yesterday/last week/since 
you finished pulmonary rehabilitation)  
• Well done for being active! 
Health 




We do not expect you to advise group members about their health. If group members report 
their symptoms, or ask for medical advice, please send them any relevant messages from 
these standardised messages. 
Messages to send to the group 
• Please remember that I am not medically trained, and therefore cannot give medical 
advice. If you are concerned about any aspect of your health, please seek professional 
help as you would otherwise. 
• You should call 111 if you don’t know who to call for medical help or need 
information about a health issue.  
• If you require non-urgent medical advice please contact your GP, your local NHS 
walk-in centre or local pharmacist.  
• You can call 111 if you think you need to go to A&E or another NHS urgent care 
service.  









We have provided lists of messages for you to send in the WhatsApp group. Become familiar 
with the lists of messages. This will help you choose which messages you think are most 
suitable to send to the group.  You are free to choose and send which message/s you think are 
most relevant at the time. However, if you feel that these messages are not suitable, please 




1. Send and reply to the messages from individuals in two time slots (12-2pm and 6-8pm 
or the times you agree on with the WhatsApp group) on Monday to Saturday. Posting 
in other time is optional. 
 
2. Complete the checklist every day during the study and send to the Chief Investigator 
(Hayley Robinson) at the end of the 4-week period.   
WhatsApp Security  
• Do not change the security settings on your phone. These setting will make sure that: 
• A passcode or pin is set on your mobile phone as soon as you start using it.  
• Your phone will automatically lock 5 seconds after it is set to ‘sleep’.  
• WhatsApp notifications are hidden on your phone when it is locked 
(notifications are on private). 
• Only use this phone to communicate with individuals involved in the intervention.  
• Check that you are communicating with the correct person or group.  
• Take care of your phone as losing it may impact individuals’ experience of the 
intervention.  
• Don’t let anyone else use your phone at any time.  
• Keep all the posts in the group confidential and do not share and discuss the 
information in the group to others except the research team. 
WhatsApp behaviour 
• Be the role model for the group and do not post offensive statements. 
• If individuals post inappropriate/offensive comments, remind them to adhere to 
appropriate standards. Remove group members if they continue to post 
inappropriate/offensive comments.  
• Respect all group members and act in a manner that is considered polite, friendly, 
helpful and unbiased. 
• Respect individuals’ decisions to interact at different levels within the group. 
Individuals also have the right to withdraw from the social group. 
End of the study 
• At the end of the study, we will collect the mobile phones used in the intervention.  
Contact with the research team  
• At the end of the 4-week period, export the content of the WhatsApp conversation, 




• If you encounter any problems during the study, please contact the research team 
(contact details below). 
• If you have any questions about your involvement in the study, either now or in the 
future, please contact the study team on the contact details provided below. 
 
Miss Hayley Robinson 
Chief Investigator/PhD Student 
Lincoln Institute for Health, University of Lincoln, LN6 7TS 
Tel: 01522 835483 
Email: hrobinson@lincoln.ac.uk 
 
Dr Arwel Jones 
Academic Supervisor 




If you would like to speak to someone about the project, who is not a member of the 
research team, please contact: 
 
Katy Ward  














Patient Demographics Record Sheet 
 
Title of Project: Physical activity following pulmonary rehabilitation in patients with Chronic 
Obstructive Pulmonary disease (COPD) 
  
IRAS project ID: 229697 
Participant identification number:  
 
Age: Date of birth: 
Gender: Ethnicity:  
Race: 
Body Mass (kg): Height (cm): 
Body Mass Index (BMI):  
COPD diagnosis (severity): 
 




Medications (including dosage): 
 
Smoking history (no. of years smoked/no. of cigarettes per day):   
 

















Interview topic guide for patients 
 
Title of project: Physical activity following pulmonary rehabilitation in patients with Chronic 




Introduce yourself to the participant. Talk through the topic of conversation for the telephone 
interview and how long it may last. Provide opportunity for questions about the interview, re-confirm 
that patients agree to take part.  
 
Note: Ask the questions that are relevant to each patient (account for cluster allocation, 
participation/length of participation). Only ask the questions and use the prompts when required, e.g. 
do not repeat questions or prompts.  
 






Q. Can you tell me how did you first hear about this research?  
Prompt: Information sheet from the lead health care professional, spoke to the research team. 
 
Q. What was your initial reaction to receiving the invitation to take part in this research?  
Prompt: What were your reasons for deciding to take part? 
  
Q. What did you think about the way that you were recruited to participate? 
Prompts: provided with an information sheet, approached by the research team, what did you 
like/dislike about this process? Could this be improved? 
 
Q. What do/did you like/dislike about the written information about the research?  
Prompts: Could the information sheet be improved? If so, how? 
 
Patients that declined participation (additional questions) 
 
Q. What was/were your reason/s for deciding not to take part in this research? 
Prompts: Was there anything that you didn’t like about the recruitment process? Could this be 
improved? If so, how? Was there anything that you didn’t like about the research procedures? 
  





Q. What was/were your reason/s for deciding to withdraw from this research? 
Prompts: Was there anything that you didn’t like about the research procedures? Could the research 
procedures be improved? If so, how? 
 
Experiences of using the devices  
 
Intervention group only  
 
Q. What did you think of the pedometer? 
Prompt: Did you use the pedometer? Was it comfortable/uncomfortable to wear? How many days did 
you wear it for? If you didn’t remember to wear it, how might we make it easier for you to remember 
to wear it (e.g. receive reminders)? What did you like about it? What did you dislike about it? 
 
Q. What did you think of the step diary? 
Prompts: Did you record your steps in the diary during the study? If yes, how often did you record 
your steps in the diary? How might we make it easier for you to record your steps (e.g. receive 
reminders?) How might we encourage other people to use it? What did you like about it? What did 
you dislike about it?  
 
Q. What did you think of the study mobile phone (Nokia 1)?   
Prompts: Did you use it? What did you like/dislike about the phone? 
 
Q. What did you think of the WhatsApp group? 
Prompts: Were you able to view the WhatsApp messages? Did you engage in WhatsApp? Was there 
anything that you liked/disliked about the group chat? Do you think anything could be done to 
improve these messages (e.g. timing, frequency)? 
 
Patient training  
 
Intervention group only  
 
Q. What did you think about the education session for the phone, pedometer and step diary?  
Prompts: Were you provided with enough information during the education session? Was the training 
easy to follow? Did you understand how to use the phone and pedometer after the education session? 
Was there anything that you liked/disliked about the education session? Do you think anything could 
be done to improve the education session? 
 
Q. What did you think about the device manual? 
Prompts: Did you use this manual? Was this manual easy to read? Was this manual useful in 
answering any questions about the pedometer, step diary, phone (if used)? What did you like/dislike 




Intervention group only  
 
You were provided with a phone 2-weeks before the end of pulmonary rehabilitation. This allowed 
you to communicate with the WhatsApp leader before you were added to the WhatsApp group chat.  
 
Q. What did you think about the familiarisation period for the phone? 
Prompts: Did you have enough time to become familiar with the phone (2 weeks)? If not, how much 
time do you think we should give people? Was there anything that you liked/disliked about the 





Q. What did you think about the familiarisation period for the pedometer? 
Prompts: Did you have enough time to become familiar with the pedometer (2 weeks)? If not, how 
much time do you think we should give people? Was there anything that you liked/disliked about the 
familiarisation period? Do you think anything could be done to improve the familiarisation period? 
 
Capability, Opportunity and Motivation  
All patients: Control/Intervention and those that declined/withdrew 
These questions will be based on COM-B components, based on those provided in the BCW 
guide (p68-69)387, adapted to physical activity maintenance following pulmonary 
rehabilitation.  
Q. Do you believe that you were/are capable of maintaining physical activity following 
pulmonary rehabilitation? 
Prompts:  
Do you need to: 
- Know more about why it was important e.g. to have a better understanding of the 
benefits of maintaining physical activity 
- Know more about how to do it e.g. have a better understanding of effective ways to be 
active 
- Have better physical skills e.g. learn how to perform certain activities/ use equipment 
to help me to be active 
- Have better mental skills e.g. learn how to plan and structure physical activity into a 
daily/weekly routine 
- Have more physical strength e.g. increase my exercise capacity/train my muscles so I 
can perform more activities 
- Have more mental strength e.g. develop more resilience against falling back into 
unhealthy routines 
- Overcome physical limitations e.g. get around mobility/breathlessness issues 
- Overcome mental obstacles e.g. reduce anxiety surrounding physical activity and 
breathlessness 
- Have more physical stamina e.g. develop greater capacity to maintain physical effort 
- Have more mental stamina e.g. develop greater capacity to maintain mental effort 
Q. Do you believe that you had/have the opportunity to maintain/perform physical activity 
following pulmonary rehabilitation?  
Prompts:  
Do you need to: 
- Have more time to do it e.g. create dedicated time during the day  
- Have more money e.g.  be provided funds to support the behaviour 
- Have the necessary materials e.g. acquire materials/equipment for physical activity 
(trainers, sports clothing/gym equipment etc.) 
- Have it more easily accessible e.g. provide easier access to facilities 
- Have more people around them doing it e.g.  be part of a ‘crowd’ who are doing it   
- Have more triggers to prompt them e.g. have more reminders at strategic times 
- Have more support from others e.g.  have friends and family’s support     
Q.  Do you believe that you had/have the motivation to maintain/perform physical activity 
following pulmonary rehabilitation? 
Prompts:  




- Feel that you want to do it enough e.g. feel a sense of pleasure/satisfaction from doing 
it 
- Feel that you need to do it enough e.g. care more about the negative consequences of 
not doing it 
- Believe that it would be a good thing to do e.g. have a stronger sense that one should 
do it 
- Develop better plans for doing it e.g. have clearer and better developed plans for 
achieving it 
- Develop a habit of doing it e.g.  get into a pattern of doing it without having to think 
 
Data collection (including accelerometer) and measurement time points  
 
Both Intervention and Control 
 
Follow up visits: 
 
Q. We asked to collect data from you during this research. We collected data from you during 
pulmonary rehabilitation. We then contacted you to arrange two follow-up visits (3 and 12 
months) after pulmonary rehabilitation to collect data from you. How did you find this 
process?  
Prompts: Were you contacted by the research team before the follow-up visits? Were you able to 
attend both follow-up visits? If you didn’t, what would have helped you to attend? (time/place); Was 
there anything that you liked/disliked about these follow-up visits? How might we improve these 
follow-up sessions?  
 
Q. What did you think about the Activity monitor?  
Prompts: Was it comfortable/uncomfortable to wear? How many days did you wear it for? If you 
didn’t remember to wear it, how might we make it easier for you to remember to wear it (e.g. receive 
reminders)?  
 
Q. What did you think about the PROactive daily questionnaire that we provided you with when 
you wore the Activity Monitor? (list the types of questions provided in the questionnaire)  
Prompt: Were they easy/difficult to complete every day? How might we make it easier for you to fill 
in these questionnaires (e.g. receive reminders, computerised copy, etc.)  
 
Q. What did you think about the Sleep diary that we provided you with when you wore the 
Activity Monitor?  
Prompt: Was it easy/difficult to complete every day? How might we make it easier for you to fill in 
this sleep diary? (e.g. be asked to put it on bedside table, asked to set alerts, etc.) 
 
Q. What did you think about the other Questionnaires that we provided you with when you 
attended the follow up visits? (remind participants about the HADS and CRQ questionnaires)  
Prompt: What did you think about the length/number of questionnaires? Were they easy/difficult to 
complete? 
 
Q. What did you think about the Incremental Shuttle Walk Test? 
Prompt: Were you prepared to perform this test? Were you confident in performing this test? 
General Prompts: What went well? What went less well? How can we make this easier for patients?  
 
Impact of the Intervention on Physical Activity  
 





Instructions: Ask patients whether they thought the following had any impact on their physical 
activity levels using the below prompts.  
 
I will now ask you a series of further questions about the factors that may have influenced your 
physical activity levels following pulmonary rehabilitation. 
 
You talked about the XX earlier…. 
(If patients have mentioned the use of the Intervention components, use the prompts below to ask 
about the components) 
 
Pedometer: 
Q. Did you check/monitor your daily steps on the pedometer display screen? 
Did the pedometer have any impact on your physical activity levels?  
Prompts: change, increase, decrease? If so, why? If not, why? 
 
Step diary: 
Q. Did you report your daily steps in this diary? 
Did you check/monitor your physical activity progress during the past 12 months?   
Did the step diary have any impact on your physical activity levels?  
Prompts: change, increase, decrease? If so, why? If not, why? 
 
WhatsApp communications: 
Q. Did the WhatsApp group have any impact on your physical activity levels? 
Prompts: (provide a reminder about the WhatsApp messages)  
Did the WhatsApp group change, increase, decrease your activity levels? If so, why? If not, why? 
 
The WhatsApp leader sent the group messages which: 
Told you about the physical activities your local area. 
Q. What did you think about these messages? 
 
Told you about the different ways to be active at home 
Q. What did you think about these messages? 
 
Encouraged you to be active with other people.  
Q. What did you think about these messages? 
 
Suggested that you to seek support from other people if you were worried about being 
active/struggling to motivate yourself. 
Q. What did you think about these messages? 
 
Suggested that you form habits/routines to stay active. 
Q. What did you think about these messages? 
 
You were sent congratulatory messages when you reported being active/making an effort to be active, 
Q. What did you think about these messages?  
Prompts: did they have any impact on your physical activity levels? 
 
Q. Finally, is there anything else you want to tell us about your experiences of physical 
activity after pulmonary rehabilitation? 
Prompts: Was there anything else (other than what we discussed) that you think had any 
impact on your physical activity levels after pulmonary rehabilitation? 





Prompts: Could any component/s be added/removed from the Intervention e.g. WhatsApp, 
pedometer, Step Diary?  
 
Plans to keep active    
 
Patients who declined or withdrew from the study  
 
• Do you have any plans to keep active after pulmonary rehabilitation? 
Prompts: If you do, how do you plan to keep active? 
 
Intervention and Control  
 
Q. Do you have any plans to keep active following the study?  
Prompts: If you do, how do you plan to keep active?  
 
Intervention group only  
 
Q. Will you continue to use any components of the intervention now the study has ended? 
Prompts: will you continue to use WhatsApp, the pedometer or the step diary? If so, what plans do 
you have to continue using these (e.g. use personal phone/pedometer or buy these?) If you do not plan 
to continue using WhatsApp, pedometer or the step diary, what are your reasons? 
 
End interview  
 
All patients  
 
Q. Thank you for taking part in this telephone interview. Do you have any questions 
about the study?  
If you have any further questions about the study in the future, please contact the research 















Focus Group Topic Guide Healthcare professionals 
 
Title of project: Physical activity following pulmonary rehabilitation in patients with Chronic 




Introduce yourself to the healthcare professionals. Talk through the topic of conversation for the focus 
group and how long it may last. Provide opportunity for questions about the focus group, re-confirm 
that healthcare professionals agree to take part.  
 
Note: Only ask the questions and use the prompts when required, e.g. do not repeat questions or 
prompts.  
 
Pulmonary rehabilitation programme recruitment  
R. Can you tell me how did you first hear about this research?  
Prompt: participant information sheet. 
 
R. What did you think about the information you were provided about the study? 
Prompt: Was it enough information? Was anything unclear? Did you have enough time to prepare for 
the study procedures (e.g. patient training?) Could anything be improved? If so, how? 
 
Q. What was your initial reaction to the intervention?  
Prompt: What did you think about providing patients with phones, pedometers and step diaries? Did 
you think that it was/was not a good idea? Why? 
  
Patient recruitment  
 
R. What did you think about the way that patients were recruited to participate? 
Prompts: Patients were provided them with an information sheet and they were then approached by 
the research team a week later. What did you like/dislike about this process? Could this be improved? 
 
You provided patients with an information sheet.   
 
R. What did you like/dislike about the written information about the research?  




During an education session, the research team and WhatsApp leader provided patients with 
information and training about how to use the phone, pedometer and step diary.  
 




Prompts: Did you think patients were provided with enough information during the education 
session? Do you think the training was easy to follow during the education session? Do you think 
patients understood how to use the phone, WhatsApp, pedometer and step diary after the education 
session? Did the patients report any difficulties or ask about any of the components? Was there 
anything that you liked/disliked about the education session? Do you think anything could be done to 
improve the education session? 
 
R. What did you think about the device manual? 
Prompts: Do you think patients found this manual easy to read? What did you like/dislike about this 
manual? Do you think anything could be done to improve the device manual? If so, what? 
 
Phone and pedometer familiarisation period 
 
The patients were then provided with the phone and pedometer before they finished pulmonary 
rehabilitation (2 weeks/couple of days) to become familiar with the devices.  
 
R. What did you think about the familiarisation period for the phone? 
Prompts: Do you think patients had enough time to become familiar with the phone (2 weeks)? If not, 
how much time do you think we should give patients? Was there anything that you liked/disliked 
about the phone familiarisation period? Do you think anything could be done to improve the 
familiarisation period? 
 
Q. What did you think about the familiarisation period for the pedometer? 
Prompts: Do you think patients had enough time to become familiar with the pedometer (couple of 
days)? If not, how much time do you think we should give patients? Was there anything that you 
liked/disliked about the familiarisation period? Do you think anything could be done to improve the 
familiarisation period? 
 
Impact of the study on the Programme 
 
Q. Do you think the study impacted the on the delivery of your usual service? 
Prompts: Did it change any aspect of the patients’ experience? Did the Intervention integrate well 
with the usual pulmonary rehabilitation programme? Did you have enough time to prepare for being 
involved in the project/delivering the standard care? 
 
Impact of the study on Healthcare professionals  
 
Q. Do you think that the study impacted you during pulmonary rehabilitation? 
Prompts: Did it affect your workload? Could anything have been done to make your role in the study 
easier during pulmonary rehabilitation? 
 
Impact of the Intervention on Physical Activity  
 
Ask healthcare professionals about their view of the Intervention 
 
R. Do you think that this Intervention could be improved to help patients keep active after 
pulmonary rehabilitation? 
Prompts: Could any component/s be added/removed from the Intervention e.g. WhatsApp, 
pedometer, Step Diary?  
 
Feasibility questions  
 
Q. Is there anything that could be done to improve the study procedures? 





Q. What do you think about this Intervention being conducted on a larger scale?  
Prompts: Would this be feasible?  
 
Q. What do you think about recruiting patients for a larger scale study? 
Prompts: Do you think this would be easy/hard? 
 
End Focus Group 
 
R. Thank you for taking part in this Focus group. Do you have any questions about the 
study?  
If you have any further questions about the study in the future, please contact the research 


















Focus Group Topic Guide: WhatsApp leaders 
 
Title of project: Physical activity following pulmonary rehabilitation in patients with Chronic 




A focus group moderator and note taker should be present. The note taker should list the seating 
arrangements and capture any nonverbal behaviour e.g. positive or negative reaction towards a certain 
topic/question. 
 
Introduce yourself and each WhatsApp leader to each other. Talk through the topic of conversation 
for the focus group and how long it may last. Provide opportunity for questions about the focus group, 
re-confirm that WhatsApp leaders agree to take part in an audio recorded focus group.  
 




- Where are you from? 
- Which WhatsApp group are you/have you been sending messages to? 
 
2) Recruitment:  
- How did you first hear about the research? 
- What did you think about the information you received about the research?  
 
3) Training:  
- Could you tell us about your understanding of the research at the beginning of the 
study?  
- Could you tell us about your experiences becoming familiar with all aspects of the 
study? E.g. the phone, pedometer and step diary. 
 
4) Experience of using the intervention components:  
- Could you tell us about your experience of using the phone?  
- Could you tell us about your experience of using the pedometer? 
- Do you think these devices could be improved for a future study? 
- Could you tell us about your experience of using the step diary? 
- Do you think the step diary could be improved for a future study? 
 
 
5) Experience of messaging the WhatsApp group: 
- Could you tell us about your experiences of talking with the WhatsApp groups? 
For example, were there positive or negative experiences during the study? 
- Could you tell us about your relationship with other WhatsApp group members?  





6) Messages:  
- Were there any messages that did/did not work well (e.g. monitor activity, social 
support, information about opportunities). 
- How did you feel about the content of the messages?  
- How did you feel about the frequency of the messages?  
- How much time did you spend messaging the group each week? 
- Prompts: was it too much/too little time? 
- Do you think that any changes should be made to the messages before a future 
study? Please explain.  
 
7) Support: 
- Could you tell us about your levels of contact with the research team? E.g. do/did 
you feel that you had enough support from the research team? 
- Could you tell us about your levels of contact with the other WhatsApp group 
leaders? E.g. did you talk with other individuals involved as a WhatsApp leader? 
- Do you think that there are ways to improve upon the levels of support individuals 
receive during the study? Please explain.  
 
8) Future involvement:  
- How would you feel about getting involved in a future study? 
- Prompt: would you be willing to participate in the future? Please explain.  
 
 
 
 
 
